{"text": "Finally , the antidepressant effect of the atypical antipsychotic Quetiapine , indicated for the treatment of bipolar depression , is likely to be related to the noradrenergic action of its metabolite Norquetiapine .", "label": "", "metadata": {}, "score": "21.166153"}
{"text": "The broad spectrum of efficacy demonstrated by quetiapine XR against symptoms of anxiety and depression may be explained by its mechanism of action .Quetiapine and norquetiapine ( the major active metabolite of quetiapine ) have moderate to high affinity for serotonin 5-HT2A and dopamine D2 receptors ; norquetiapine is also a potent inhibitor of the norepinephrine transporter ( NET ) .", "label": "", "metadata": {}, "score": "25.335556"}
{"text": "When adjusted for dose and weight , the pharmacokinetics of the metabolite , norquetiapine , was similar between children and adolescents and adults [ see Use in Specific Populations ( 8.4)].", "label": "", "metadata": {}, "score": "27.073137"}
{"text": "Since norquetiapine is not formed in rodents we here investigated in rats whether NET - inhibition may , in principle , contribute to the clinical effectiveness of quetiapine and allow for its low D(2 ) receptor occupancy , by combining quetiapine with the selective NET - inhibitor reboxetine .", "label": "", "metadata": {}, "score": "27.532747"}
{"text": "Recently , norquetiapine has been found to be a potent inhibitor for norepinephrine transporter shared commonality with TCAs and SNRIs , and a moderate - to - high affinity for D2 , 5HT1A , 5HT2A , and 5HT2C receptors shared some properties with SSRIs [ 20 , 21 ] .", "label": "", "metadata": {}, "score": "30.850307"}
{"text": "There are no clinically relevant pharmacokinetic interactions of quetiapine on other drugs based on the CYP pathway .Quetiapine and its metabolites are non - inhibitors of major metabolizing CYP 's ( 1A2 , 2C9 , 2C19 , 2D6 and 3A4 ) . 8.1 Pregnancy .", "label": "", "metadata": {}, "score": "31.748009"}
{"text": "The effect that symptomatic suppression has upon the long - term course of the syndrome is unknown .Given these considerations , quetiapine should be prescribed in a manner that is most likely to minimize the occurrence of tardive dyskinesia .", "label": "", "metadata": {}, "score": "31.890783"}
{"text": "Studies providing measures of efficacy and tolerability of quetiapine , either as monotherapy or as augmentation , for bipolar depression were considered .Seven short - term studies and four maintenance studies were included .", "label": "", "metadata": {}, "score": "33.04961"}
{"text": "Quetiapine exposure is increased by the prototype CYP3A4 inhibitors ( e.g. , ketoconazole , itraconazole , indinavir , ritonavir , nefazodone , etc.)and decreased by the prototype CYP3A4 inducers ( e.g. , phenytoin , carbamazepine , rifampin , avasimibe , St. John 's wort etc . ) .", "label": "", "metadata": {}, "score": "33.611717"}
{"text": "Recently , some randomized - controlled trials of quetiapine have been conducted in patients with MDD [ 30 - 33 ] .Since most of these studies have small samples , a meta - analysis , which is more powerful in estimating the true effect size , may be a strategy to confirm its efficacy and safety .", "label": "", "metadata": {}, "score": "33.782833"}
{"text": "Further studies in this area are warranted .Implication of key findings .Quetiapine may be an alternative antidepressant .However , both risk and benefit of this agent should be taken into account for an individual patient with MDD .", "label": "", "metadata": {}, "score": "34.855453"}
{"text": "2007 ) .Quetiapine was tested in the four EMBOLDEN and BOLDER studies under rigorous conditions .The only other agent that has been tested under similarly robust circumstances in bipolar II depression is lamotrigine , and the data are inconsistent among studies ( Swartz and Thase 2011 ) .", "label": "", "metadata": {}, "score": "34.920975"}
{"text": "There are no adequate and well - controlled studies of quetiapine use in pregnant women .In limited published literature , there were no major malformations associated with quetiapine exposure during pregnancy .", "label": "", "metadata": {}, "score": "34.969208"}
{"text": "a One patient had both an adjunctive quetiapine trial and an adjunctive lamotrigine trial .Lamotrigine and quetiapine dosing ; other psychotropic medications taken concurrently .", "label": "", "metadata": {}, "score": "35.17723"}
{"text": "The risks of using quetiapine in combination with other drugs have not been extensively evaluated in systematic studies .Given the primary CNS effects of quetiapine , caution should be used when it is taken in combination with other centrally acting drugs .", "label": "", "metadata": {}, "score": "35.246056"}
{"text": "The use of concomitant anticholinergic medications was infrequent and similar across the three treatment groups .The information below is derived from a clinical trial database for quetiapine consisting of over 1,000 pediatric patients .", "label": "", "metadata": {}, "score": "35.409225"}
{"text": "PubMed View Article .Bakken GV , Rudberg I , Molden E , Refsum H , Hermann M : Pharmacokinetic variability of quetiapine and the active metabolite N - desalkylquetiapine in psychiatric patients .", "label": "", "metadata": {}, "score": "35.481354"}
{"text": "Thus , particular caution must be used when considering the effects of adjunctive lamotrigine compared with adjunctive quetiapine .In spite of the above - mentioned limitations , our observations support the contention that more research is indicated .", "label": "", "metadata": {}, "score": "35.70455"}
{"text": "There is no specific antidote to quetiapine .Therefore , appropriate supportive measures should be instituted .The possibility of multiple drug involvement should be considered .", "label": "", "metadata": {}, "score": "35.844414"}
{"text": "The investigators are therefore designing this pharmacokinetic study to evaluate the the systemic absorption of quetiapine in oral , rectal and topical formulations .If the investigators are able to demonstrate detectable levels from rectal and topical quetiapine formulations compared to the oral form , this knowledge will enhance clinical psychiatric practice by providing a more broad route of administration for quetiapine which is a commonly used drug for psychiatric symptoms .", "label": "", "metadata": {}, "score": "36.089886"}
{"text": "However , efficacy parameters for such patients were assessed at the time of adding an antidepressant or aripiprazole in order to avoid overestimating the efficacy of the lamotrigine plus quetiapine combination .", "label": "", "metadata": {}, "score": "36.19335"}
{"text": "Translational pharmacology of quetiapine and norquetiapine : preclinical findings support multifunctional psychotropic properties .Eur Psychiatry .2010 ; 25(suppl 1 ) : 1446 .Jensen NH , Rodriguiz RM , Caron MG , et al .", "label": "", "metadata": {}, "score": "36.239967"}
{"text": "In this observational study , selection bias could contribute to clinical differences encountered with treatment .For example , patients with an inadequate response to quetiapine may have a more treatment - resistant illness than the patients who did not respond to lamotrigine .", "label": "", "metadata": {}, "score": "36.47187"}
{"text": "Quetiapine was associated with a reduced risk of any mood event or depressive relapse compared with placebo ( Young et al .2012 ) , suggesting that it is an efficacious treatment in both the short and long term in patients with bipolar II depression .", "label": "", "metadata": {}, "score": "36.553513"}
{"text": "2010 ) .The efficacy of quetiapine in patients with bipolar II depression has been previously reported in a pooled analysis of the BOLDER I and II studies ( Suppes et al .", "label": "", "metadata": {}, "score": "36.748734"}
{"text": "Increased doses of quetiapine up to 5 fold may be required to maintain control of symptoms of schizophrenia in patients receiving quetiapine and phenytoin , or other known potent CYP3A4 inducers [ see Dosage and Administration ( 2.6 ) and Clinical Pharmacology ( 12.3 ) ] .", "label": "", "metadata": {}, "score": "36.981598"}
{"text": "Furthermore , several clinical variables moderated outcomes under investigation .In conclusion , quetiapine could have some advantages over traditional treatments for the treatment of bipolar depression .", "label": "", "metadata": {}, "score": "36.98301"}
{"text": "Quetiapine at 400 mg / day and 800 mg / day was superior to placebo in the reduction of PANSS total score .The primary efficacy results of this study in the treatment of schizophrenia in adolescents is presented in Table 19 .", "label": "", "metadata": {}, "score": "37.110638"}
{"text": "Concomitant benzodiazepine use was specifically excluded in the aforementioned quetiapine XR monotherapy studies .At week 8 , significant reductions in CGI - S total score were seen with quetiapine XR compared with placebo .", "label": "", "metadata": {}, "score": "37.279415"}
{"text": "Moreover , concomitant administration of quetiapine and reboxetine resulted in a synergistic increase in cortical , but not accumbal , dopamine output .The combination of low , clinically relevant concentrations of quetiapine ( 60nM ) and reboxetine ( 20nM ) markedly facilitated cortical NMDA receptor - mediated transmission in contrast to either drug alone , an effect that could be inhibited by the D(1 ) receptor antagonist SCH23390 .", "label": "", "metadata": {}, "score": "37.44683"}
{"text": "View Article .Altamura AC , Moliterno D , Paletta S , Buoli M , Dell'osso B , Mauri MC , Bareggi SR : Effect of quetiapine and norquetiapine on anxiety and depression in major psychoses using a pharmacokinetic approach : a prospective observational study .", "label": "", "metadata": {}, "score": "37.47869"}
{"text": "Results and discussion .Common adverse events associated with quetiapine ( both doses ) included dry mouth , somnolence , sedation , dizziness , and headache .", "label": "", "metadata": {}, "score": "37.906536"}
{"text": "In clinical trials quetiapine was not associated with a persistent increase in QT intervals .However , the QT effect was not systematically evaluated in a thorough QT study .", "label": "", "metadata": {}, "score": "37.911243"}
{"text": "In clinical trials quetiapine was not associated with a persistent increase in QT intervals .However , the QT effect was not systematically evaluated in a thorough QT study .", "label": "", "metadata": {}, "score": "37.911243"}
{"text": "Aside from 4/39 ( 10.3 % ) patients who discontinued combination therapy due to adverse effects , the combination of lamotrigine plus quetiapine was generally well tolerated .", "label": "", "metadata": {}, "score": "38.05513"}
{"text": "These lines of evidence suggest that almost all antidepressants , including quetiapine , have the same profile of comparable acceptability to and less tolerability than placebo .", "label": "", "metadata": {}, "score": "38.165497"}
{"text": "The treatment effect was present for increasing time to recurrence of both manic and depressed episodes .The effect of quetiapine was independent of any specific subgroup ( assigned mood stabilizer , sex , age , race , most recent bipolar episode , or rapid cycling course ) .", "label": "", "metadata": {}, "score": "38.198677"}
{"text": "2010 ; Swartz and Thase 2011 ) .Among these agents is quetiapine , which is the only medication approved by the United States Federal Drug Administration for monotherapy of both bipolar I and II disorder depressive episodes ( Seroquel Prescribing Information 2012 ) .", "label": "", "metadata": {}, "score": "38.40753"}
{"text": "None of these trials has yet been published , although two of them have been presented as congress communications , both of them suggesting that quetiapine could be a potential alternative treatment for fibromyalgia .", "label": "", "metadata": {}, "score": "38.50587"}
{"text": "In addition , many tricyclics , such as Desipramine and Nortriptyline , have prevalent noradrenergic effect .Monoamine oxidase inhibitors ( MAOIs ) , moreover , block the breakdown of serotonin , noradrenaline , dopamine and increase the availability of these monoamines .", "label": "", "metadata": {}, "score": "38.566887"}
{"text": "Several lines of research suggest that quetiapine may have an antidepressant effect .Some clinical trials found that quetiapine reduced depressive symptoms considerably in schizophrenic patients [ 25 ] and bipolar depression [ 26 , 27 ] .", "label": "", "metadata": {}, "score": "38.639236"}
{"text": "Quetiapine fumarate tablets dose should be reduced to one sixth of original dose when co - medicated with a potent CYP3A4 inhibitor ( e.g. , ketoconazole , itraconazole , indinavir , ritonavir , nefazodone , etc . ) .", "label": "", "metadata": {}, "score": "38.741432"}
{"text": "The conditions and duration of treatment with quetiapine varied greatly and included ( in overlapping categories ) open - label and double - blind phases of studies , inpatients and outpatients , fixed - dose and dose - titration studies , and short - term or longer - term exposure .", "label": "", "metadata": {}, "score": "38.769333"}
{"text": "In nearly all cases , cessation of quetiapine treatment was associated with a reversal of the effects on total and free T4 , irrespective of the duration of treatment .", "label": "", "metadata": {}, "score": "39.075962"}
{"text": "Among the 39 trials included , quetiapine was added in 26 ( 66.7 % ) patients already taking lamotrigine ( adjunctive quetiapine group ) , while in the other 13 ( 33.3 % ) trials , lamotrigine was added in patients already taking quetiapine ( adjunctive lamotrigine group ) .", "label": "", "metadata": {}, "score": "39.157692"}
{"text": "Other Adverse Reactions Observed During the Pre - Marketing Evaluation of Quetiapine .All reported reactions are included except those already listed in the tables or elsewhere in labeling , those reactions for which a drug cause was remote , and those reaction terms which were so general as to be uninformative .", "label": "", "metadata": {}, "score": "39.537582"}
{"text": "Quetiapine duration 218.8\u00b1274.6 [ -330.4 to +768.0 ] .Lamotrigine or quetiapine dose when starting other agents ( mg / d , mean\u00b1SD , 95 % CI ) .", "label": "", "metadata": {}, "score": "39.639206"}
{"text": "An oral antipsychotic drug that acts as an antagonist of multiple neurotransmitters including serotonin and norepinephrine is used in the treatment of schizophrenia .It is a selective monoaminergic antagonist with high affity for the serotonin type 2 ( 5HT 2 ) and dopamine type 2 ( D 2 ) receptors .", "label": "", "metadata": {}, "score": "39.926872"}
{"text": "The safety and effectiveness of quetiapine in the maintenance treatment of bipolar disorder has not been established in pediatric patients less than 18 years of age .", "label": "", "metadata": {}, "score": "40.110867"}
{"text": "2010 ; Thase et al .2006 ; Young et al .2010 ) .The prescribing information for quetiapine recommends appropriate clinical monitoring for alterations in lipids , including blood lipid testing at the beginning of and periodically during treatment ( Seroquel Prescribing Information 2012 ) .", "label": "", "metadata": {}, "score": "40.136"}
{"text": "PubMed View Article .Jensen NH , Rodriguiz RM , Caron MG , Wetsel WC , Rothman RB , Roth BL : N - desalkylquetiapine , a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist , as a putative mediator of quetiapine 's antidepressant activity .", "label": "", "metadata": {}, "score": "40.190033"}
{"text": "Short - term Trials - Adults .The efficacy of quetiapine in the treatment of schizophrenia was established in 3 short - term ( 6-\u00adweek ) controlled trials of inpatients with schizophrenia who met DSM III - R criteria for schizophrenia .", "label": "", "metadata": {}, "score": "40.315216"}
{"text": "Although different kinds of drugs have been studied for the treatment of fibromyalgia , the most widely used drugs that have the higher degree of evidence for efficacy include the ? ligands pregabalin and gabapentin , and the tricyclic antidepressants ( TCAs ) and serotonin noradrenaline ( norepinephrine ) reuptake inhibitors ( SNRIs ) .", "label": "", "metadata": {}, "score": "40.568253"}
{"text": "This was the first randomized , placebo - controlled study to evaluate the efficacy of quetiapine XR as an adjunct to antidepressants for the treatment of GAD in patients with an inadequate response to SSRI / SNRI treatment in a large patient population .", "label": "", "metadata": {}, "score": "40.68464"}
{"text": "However , randomized , double - blind , placebo - controlled studies are warranted to confirm the possibility that combination therapy with lamotrigine and quetiapine is effective and well tolerated in patients with treatment - resistant bipolar depression .", "label": "", "metadata": {}, "score": "40.74295"}
{"text": "It is not yet known whether these differences reflect the true lower remission rate of quetiapine treatment or only the dissimilarity of participants and study designs among the studies .", "label": "", "metadata": {}, "score": "40.779182"}
{"text": "The following adverse reactions were identified during post approval of quetiapine .Because these reactions are reported voluntarily from a population of uncertain size , it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure .", "label": "", "metadata": {}, "score": "40.783463"}
{"text": "In this study , statistical separation from placebo with adjunctive quetiapine XR was not achieved in patients with GAD and an inadequate response to previous therapy for the primary efficacy variable .", "label": "", "metadata": {}, "score": "40.9986"}
{"text": "Some second - generation antipsychotics , mainly quetiapine , aripiprazole and amisulpride , have demonstrated antidepressant activity , with quetiapine approved for the treatment of bipolar depression and refractory major depression , and aripiprazole approved as an adjunctive treatment for major depressive disorder .", "label": "", "metadata": {}, "score": "41.075325"}
{"text": "In this study , the overall tolerability and safety results in quetiapine XR - treated patients were consistent with the known profile of quetiapine .12 - 16 , 37 - 39 , 41 , 43 , 47 - 49 Patients received concomitant SSRI / SNRI therapy and were permitted to receive benzodiazepines ; therefore , safety / tolerability data reported here may be due to the effects of several agents .", "label": "", "metadata": {}, "score": "41.45788"}
{"text": "Quetiapine 's antagonism of histamine H 1 receptors may explain the somnolence observed with this drug .Quetiapine 's antagonism of adrenergic \u03b1 1 receptors may explain the orthostatic hypotension observed with this drug .", "label": "", "metadata": {}, "score": "41.580147"}
{"text": "Following a single oral dose of 14 C - quetiapine , less than 1 % of the administered dose was excreted as unchanged drug , indicating that quetiapine is highly metabolized .", "label": "", "metadata": {}, "score": "41.65853"}
{"text": "[ 0042 ] Exemplary autoimmune disorder agents include remicade , enbrel and humira .[ 0043 ] Exemplary anti - impotence agents include sildenafil citrate , vardenafil , and tadalafil .", "label": "", "metadata": {}, "score": "41.69206"}
{"text": "In vitro enzyme inhibition data suggest that quetiapine and 9 of its metabolites would have little inhibitory effect on in vivo metabolism mediated by cytochromes CYP 1A2 , 2C9 , 2C19 , 2D6 and 3A4 .", "label": "", "metadata": {}, "score": "41.712646"}
{"text": "In all cases , the period of overlapping antipsychotic administration should be minimized .When switching patients with schizophrenia from depot antipsychotics , if medically appropriate , initiate quetiapine fumarate tablets therapy in place of the next scheduled injection .", "label": "", "metadata": {}, "score": "41.79416"}
{"text": "2011 ; Gao et al .2008 ; Judd et al .2003 ; Otto et al .2006 ) .In the combined BOLDER I and II trials , quetiapine was effective in the treatment of bipolar I and II depression regardless of the severity of baseline anxiety ( Lydiard et al .", "label": "", "metadata": {}, "score": "41.883945"}
{"text": "It is 83 % bound to plasma proteins at therapeutic concentrations .In vitro , quetiapine did not affect the binding of warfarin or diazepam to human serum albumin .", "label": "", "metadata": {}, "score": "42.049"}
{"text": "Changes in these metabolic profiles should be managed as clinically appropriate .Hyperglycemia , in some cases extreme and associated with ketoacidosis or hyperosmolar coma or death , has been reported in patients treated with atypical antipsychotics , including quetiapine .", "label": "", "metadata": {}, "score": "42.142715"}
{"text": "Likewise , failure to statistically separate can not be explained by treatment adherence , as this was similar in the 2 groups .It is important to note that in the current study , benzodiazepine use was slightly lower in the quetiapine XR group ( 10.4 % ) than in the placebo group ( 12.0 % ) .", "label": "", "metadata": {}, "score": "42.22581"}
{"text": "Each of these properties suggests that antipsychotics could represent a new potential alternative for the treatment of fibromyalgia syndrome .To date , most of the published studies on the use of antipsychotics in the treatment of fibromyalgia syndrome have been uncontrolled , either case reports or case series , dealing with olanzapine , quetiapine , ziprasidone , levopromazine and amisulpride .", "label": "", "metadata": {}, "score": "42.316364"}
{"text": "Dose - related Adverse Reactions : Spontaneously elicited adverse reaction data from a study of schizophrenia comparing five fixed doses of quetiapine ( 75 mg , 150 mg , 300 mg , 600 mg , and 750 mg / day ) to placebo were explored for dose - relatedness of adverse reactions .", "label": "", "metadata": {}, "score": "42.41472"}
{"text": "Int Clin Psychopharmacol .2012 Mar;27(2):76 - 90 .Quetiapine has been proposed for depression in bipolar patients but a quantitative analysis is lacking .In the present paper , we review and meta - analyze available data about the short - term and long - term efficacy and tolerability of quetiapine for the depressive phase of bipolar disorder or bipolar depression .", "label": "", "metadata": {}, "score": "42.60163"}
{"text": "0045 ] Exemplary hypnotics / anesthetics include alfaxalone , etomidate , chlordiazepoxide and triazolam .[ 0046 ] Exemplary antivirals include acyclovir , nelfinavir , and virazole .", "label": "", "metadata": {}, "score": "42.62935"}
{"text": "View Article .Papakostas GI , Nelson JC , Kasper S , Moller HJ : A meta - analysis of clinical trials comparing reboxetine , a norepinephrine reuptake inhibitor , with selective serotonin reuptake inhibitors for the treatment of major depressive disorder .", "label": "", "metadata": {}, "score": "42.71745"}
{"text": "Includes quetiapine fumarate tablets and quetiapine fumarate extended - release tablets data .Of the quetiapine treated patients with elevated TSH levels , 1 had simultaneous low free T4 level at end of treatment .", "label": "", "metadata": {}, "score": "42.74012"}
{"text": "Thus , selection bias could distort the comparison of adjunctive lamotrigine and adjunctive quetiapine .Additional potentially confounding differences include having fewer females and fewer patients with BD II , and more patients with BD I and more patients with a history of psychosis in the adjunctive lamotrigine group than the adjunctive quetiapine group .", "label": "", "metadata": {}, "score": "42.823185"}
{"text": "Quetiapine treatment resulted in significant improvements in the symptoms of anxiety in the current analysis among this larger population with bipolar II depression , the majority of whom had mild - to - moderate anxiety at baseline .", "label": "", "metadata": {}, "score": "43.052162"}
{"text": "Safety and effectiveness of quetiapine in pediatric patients less than 18 years of age with bipolar depression have not been established .A clinical trial with quetiapine fumarate extended - release tablets was conducted in children and adolescents ( 10 to 17 years of age ) with bipolar depression , efficacy was not established .", "label": "", "metadata": {}, "score": "43.08338"}
{"text": "28 Patients were taking a mean of 1.7\u00b11.1 other prescription psychotropic drugs ( other mood stabilizers , other antipsychotics , antidepressants , and anxiolytics ) immediately prior to adding lamotrigine or quetiapine .", "label": "", "metadata": {}, "score": "43.17252"}
{"text": "5 ) Chernoloz O , El Mansari M , Blier P Effects of sustained administration of quetiapine alone and in combination with a serotonin reuptake inhibitor on norepinephrine and serotonin transmission .", "label": "", "metadata": {}, "score": "43.4868"}
{"text": "Proportions of patients with at least moderate adverse effects at baseline ( immediately prior to starting combination therapy ) and safety / tolerability endpoint ( last visit taking lamotrigine plus quetiapine ) .", "label": "", "metadata": {}, "score": "43.53351"}
{"text": "Such benefits were significant from the first weeks of treatment onward .Maintenance studies suggested that the combination of quetiapine and mood stabilizers was significantly better than placebo plus mood stabilizers for the prevention of both depressive and manic relapses .", "label": "", "metadata": {}, "score": "43.922127"}
{"text": "In a brief trial , we assessed the effect of clonidine , carbamazepine , dopa therapy , and placebo on manic symptoms and cognitive functions .", "label": "", "metadata": {}, "score": "43.988045"}
{"text": "The pattern of concurrent prescription psychotropic drug administration was similar in the 2 adjunctive groups when considered separately .The mean starting dose of quetiapine was 44.5\u00b136.4 mg / d in the adjunctive quetiapine group , and the mean starting dose of lamotrigine was 18.7\u00b19.9 mg / d in the adjunctive lamotrigine group .", "label": "", "metadata": {}, "score": "44.0159"}
{"text": "This slight tendency to tachycardia in adults may be related to quetiapine 's potential for inducing orthostatic changes [ see Warnings and Precautions ( 5.7 ) ] .", "label": "", "metadata": {}, "score": "44.160416"}
{"text": "The generic name of quetiapine hemifumarate is Seroquel ; it is prescribed for the treatment of schizophrenia , a mental disorder marked by delusions ( false beliefs ) , hallucinations , disrupted thinking , and loss of contact with reality .", "label": "", "metadata": {}, "score": "44.198784"}
{"text": "Among 42 other infants born to pregnant women who used quetiapine during pregnancy , there were no major malformations reported ( one study of 36 women , 6 case reports ) .", "label": "", "metadata": {}, "score": "44.266354"}
{"text": "The effect of treatment with this drug on responses mediated by an alpha 2-agonist have yet to be reported .The authors assessed the effect of a 14-day course of orally administered valproate on the rat 's hypothermic response to clonidine .", "label": "", "metadata": {}, "score": "44.272743"}
{"text": "Quetiapine is not approved for elderly patients with dementia - related psychosis ( 5.1 ) .Suicidal Thoughts and Behaviors .Increased risk of suicidal thoughts and behavior in children , adolescents and young adults taking antidepressants ( 5.2 ) .", "label": "", "metadata": {}, "score": "44.352882"}
{"text": "Concomitant use of strong CYP3A4 inhibitors : Reduce quetiapine dose to one sixth when coadministered with strong CYP3A4 inhibitors ( e.g. , ketoconazole , ritonavir ) ( 2.5 , 7.1 , 12.3 ) .", "label": "", "metadata": {}, "score": "44.544434"}
{"text": "Quetiapine XR ( at doses of 50 , 150 , and 300 mg / d ) previously has demonstrated efficacy in treating depressive symptoms in patients with MDD , as monotherapy 38 , 39 , 41 , 43 and as adjunctive treatment .", "label": "", "metadata": {}, "score": "44.5658"}
{"text": "Quetiapine XR or placebo was administered orally , once daily in the evening .Quetiapine XR was initiated at a dose of 50 mg / d , with the dose increased to 150 mg / d on day 3 .", "label": "", "metadata": {}, "score": "44.583603"}
{"text": "Antipsychotic drugs have been shown to chronically elevate prolactin levels in rodents .Serum measurements in a 1-year toxicity study showed that quetiapine increased median serum prolactin levels a maximum of 32- and 13-fold in male and female rats , respectively .", "label": "", "metadata": {}, "score": "44.653233"}
{"text": "This study evaluated the efficacy and tolerability of quetiapine XR as an adjunct to SSRI / SNRI therapy in patients with GAD with a history of partial or no ( inadequate ) response to SSRI / SNRI treatment either as monotherapy or in combination with a benzodiazepine .", "label": "", "metadata": {}, "score": "44.810677"}
{"text": "Arvanitis LA , Miller BG .Multiple fixed doses of \" Seroquel \" ( quetiapine ) in patients with acute exacerbation of schizophrenia : a comparison with haloperidol and placebo .", "label": "", "metadata": {}, "score": "44.87301"}
{"text": "During the randomized period , anticholinergic medication use was low in both groups : 0.5 % to 1.2 % , quetiapine XR + SSRI / SNRI , and 1.5 % to 1.7 % , placebo + SSRI / SNRI .", "label": "", "metadata": {}, "score": "44.931656"}
{"text": "Switching from Antipsychotics .There are no systematically collected data to specifically address switching patients with schizophrenia from antipsychotics to quetiapine fumarate tablets , or concerning concomitant administration with antipsychotics .", "label": "", "metadata": {}, "score": "45.036926"}
{"text": "D1447C00135 ] ; EMBOLDEN I [ D1447C00001 ] and II [ D1447C00134 ] ) that evaluated the efficacy of quetiapine monotherapy for depressive episodes in patients with bipolar II disorder .", "label": "", "metadata": {}, "score": "45.127594"}
{"text": "Neuropsychopharmacology .Owens MJ , Krulewicz S , Simon JS , et al .Estimates of serotonin and norepinephrine transporter inhibition in depressed patients treated with paroxetine or venlafaxine .", "label": "", "metadata": {}, "score": "45.152927"}
{"text": "There were several limitations of this review .Firstly , the doses of quetiapine were different across the included studies .While a study used a flexible dose with titration , the others applied fixed and multiple doses in several arms .", "label": "", "metadata": {}, "score": "45.32693"}
{"text": "Conversely , more patients in the quetiapine XR + SSRI / SNRI group ( 16.8 % ) experienced a clinically relevant shift ( elevation ) from randomization to treatment end in triglyceride levels than in the placebo + SSRI / SNRI group ( 10.3 % ) .", "label": "", "metadata": {}, "score": "45.363182"}
{"text": "As all studies had low risks of bias , the data of all three trials were included in the analysis .Table 2 .Risk of bias summary of controlled trials of quetiapine in major depressive disorder .", "label": "", "metadata": {}, "score": "45.382996"}
{"text": "Adverse events potentially related to extrapyramidal symptoms were observed in 12.4 % , 8.8 % , and 6.1 % of the quetiapine 300 mg / day , quetiapine 600 mg / day , and placebo groups , respectively .", "label": "", "metadata": {}, "score": "45.460236"}
{"text": "For all of the above analyses , the pattern of findings was similar when the 7 patients who received additional adjunctive antidepressants or aripiprazole were excluded , and when patients with BD I and with BD II / bipolar disorder NOS were considered separately .", "label": "", "metadata": {}, "score": "45.528214"}
{"text": "PubMed View Article .Bortnick B , El - Khalili N , Banov M , Adson D , Datto C , Raines S , Earley W , Eriksson H : Efficacy and tolerability of extended release quetiapine fumarate ( quetiapine XR ) monotherapy in major depressive disorder : a placebo - controlled , randomized study .", "label": "", "metadata": {}, "score": "45.544388"}
{"text": "Decrease quetiapine levels , not previously mentioned .Bosentan .Carbamazepine .Phenytoin .Vulnerable populations will be excluded ( i.e. prisoners , wards of the state , emancipated minors , children , pregnant women ) .", "label": "", "metadata": {}, "score": "45.601646"}
{"text": "All studies included an 8-week , double - blind treatment phase in which patients were randomly assigned to treatment with quetiapine 300 mg / day , quetiapine 600 mg / day , or placebo .", "label": "", "metadata": {}, "score": "45.781055"}
{"text": "Kjelby E , Jorgensen HA , Kroken RA , Loberg EM , Johnsen E : Anti - depressive effectiveness of olanzapine , quetiapine , risperidone and ziprasidone : a pragmatic , randomized trial .", "label": "", "metadata": {}, "score": "45.83642"}
{"text": "Seroquel is the first in a new class of antipsychotic medications .Researchers believe that it works by diminishing the action of dopamine and serotonin , two of the brain 's chief chemical messengers .", "label": "", "metadata": {}, "score": "45.887897"}
{"text": "The discontinuation rate was moderate , and subsequent additional psychotropic mediations were not used in most cases .Aside from a modest rate of discontinuation due to adverse central nervous system effects with adjunctive quetiapine , lamotrigine plus quetiapine combination therapy was generally well tolerated and did not alter body weight or BMI .", "label": "", "metadata": {}, "score": "46.1278"}
{"text": "[ 0033 ] Exemplary anticonvulsants include phenobarbital , phenytoin , primidone , carbamazepine , valproate , felbamate , gabapentin , lamotrigine , topiramate , tiagabine , diazepam ; vigabatrin , oxcarbazepine , zonisamide , and levetiracetam .", "label": "", "metadata": {}, "score": "46.15799"}
{"text": "The majority of patients in this trial taking quetiapine were dosed in a range between 400 mg / day and 800 mg per day .The efficacy of quetiapine in the acute treatment of manic episodes associated with bipolar I disorder in children and adolescents ( 10 to 17 years of age ) was demonstrated in a 3-week , double - blind , placebo - controlled , multicenter trial ( study 4 in Table 20 ) .", "label": "", "metadata": {}, "score": "46.205467"}
{"text": "A recent study included 66 outpatients with bipolar depression resistant to a combination of a mood stabilizer plus at least 1 antidepressant .Patients were randomized to open , adjunctive lamotrigine , inositol , or risperidone for up to 16 weeks .", "label": "", "metadata": {}, "score": "46.33205"}
{"text": "PubMed View Article .Addington DE , Mohamed S , Rosenheck RA , Davis SM , Stroup TS , McEvoy JP , Swartz MS , Lieberman JA : Impact of second - generation antipsychotics and perphenazine on depressive symptoms in a randomized trial of treatment for chronic schizophrenia .", "label": "", "metadata": {}, "score": "46.336708"}
{"text": "2006 ; Leverich et al .2006 ; Vazquez et al .2011 ) .In the current analyses , the rates of treatment - emergent hypomania / mania were similar for the two quetiapine doses and for placebo , indicating that quetiapine poses a minimal risk for affective switching in patients with bipolar II depression .", "label": "", "metadata": {}, "score": "46.33762"}
{"text": "Patients may or may not have received an adequate treatment course of lithium or divalproex prior to randomization .Quetiapine was superior to placebo when added to lithium or divalproex alone in the reduction of YMRS total score .", "label": "", "metadata": {}, "score": "46.36454"}
{"text": "12.3 Pharmacokinetics .Quetiapine fumarate activity is primarily due to the parent drug .The multiple - dose pharmacokinetics of quetiapine are dose - proportional within the proposed clinical dose range , and quetiapine accumulation is predictable upon multiple dosing .", "label": "", "metadata": {}, "score": "46.397884"}
{"text": "CYP3A4 inhibitors : Coadministration of ketoconazole , a potent inhibitor of cytochrome CYP3A4 , resulted in significant increase in quetiapine exposure .The dose of quetiapine should be reduced to one sixth of the original dose if coadministered with a strong CYP3A4 inhibitor [ see Dosage and Administration ( 2.5 ) and Clinical Pharmacology ( 12.3 ) ] .", "label": "", "metadata": {}, "score": "46.43898"}
{"text": "[0099 ] In one embodiment , a quetiapine controlled - release composition is bioequivalent to the tablet formulations commercially available in the United States , for example the reference drug of New Drug Application No . 022047 .", "label": "", "metadata": {}, "score": "46.4755"}
{"text": "One possible explanation is that placebo - treated patients may have taken benzodiazepines because of a lack of symptom improvement .However , benzodiazepine use remained relatively constant over the 8-week randomized period .", "label": "", "metadata": {}, "score": "46.646152"}
{"text": "In addition , Atomoxetine , a relatively pure NRI used for the treatment of ADHD , has shown mixed results when administered in augmentation to depressed subjects .", "label": "", "metadata": {}, "score": "46.7054"}
{"text": "2010 ; Thase et al .2006 ; Young et al .2010 ) .Briefly , the design of each of the four studies encompassed 8 weeks of double - blind treatment whereby patients were randomized to receive quetiapine ( 300 or 600 mg / day ) or placebo .", "label": "", "metadata": {}, "score": "46.737064"}
{"text": "El - Khalili N , Joyce M , Atkinson S , et al .Extended - release quetiapine fumarate ( quetiapine XR ) as adjunctive therapy in major depressive disorder ( MDD ) in patients with an inadequate response to ongoing antidepressant treatment : a multicentre , randomized , double - blind , placebo - controlled study .", "label": "", "metadata": {}, "score": "46.76339"}
{"text": "[ PubMed Citation ] [ Order full text from Infotrieve ] . 2 ) Chang JS , Ha K , Yoon IY , Yoo CS , Yi SH , Her JY , Ha TH , Park T Patterns of cardiorespiratory coordination in young women with recurrent major depressive disorder treated with escitalopram or venlafaxine .", "label": "", "metadata": {}, "score": "46.842045"}
{"text": "However , the proportions of patients meeting the criteria for tachycardia were compared in four 3- to 6-week placebo - controlled clinical trials for the treatment of schizophrenia revealing a 1 % ( 4/399 ) incidence for quetiapine compared to 0.6 % ( 1/156 ) incidence for placebo .", "label": "", "metadata": {}, "score": "46.894203"}
{"text": "The tablet formulation is 100 % bioavailable relative to solution .The bioavailability of quetiapine is marginally affected by administration with food , with C max and AUC values increased by 25 % and 15 % , respectively .", "label": "", "metadata": {}, "score": "46.994247"}
{"text": "5.4 Neuroleptic Malignant Syndrome ( NMS ) .A potentially fatal symptom complex sometimes referred to as Neuroleptic Malignant Syndrome ( NMS ) has been reported in association with administration of antipsychotic drugs , including quetiapine fumarate tablets .", "label": "", "metadata": {}, "score": "47.010075"}
{"text": "[ 0056 ] Exemplary gastrointestinal agents include loperamide and cisapride .[ 0057 ] Exemplary serotonin antagonists include ketanserinand mianserin .[0058 ] Exemplary anesthetics include lidocaine .", "label": "", "metadata": {}, "score": "47.123955"}
{"text": "Quetiapine XR was generally well tolerated and its safety profile was consistent with the known profile of quetiapine .Further studies to evaluate the efficacy of adjunctive quetiapine XR in patients with GAD and an inadequate response to previous treatment should take into consideration the methodological difficulties that may be encountered .", "label": "", "metadata": {}, "score": "47.173275"}
{"text": "In the current study , the primary efficacy variable did not show statistical separation for quetiapine XR compared with placebo .This contrasts with the findings of previous studies conducted with quetiapine XR monotherapy in patients with GAD ( not specified as being treatment - resistant GAD ) that found quetiapine XR to be effective in reducing anxiety symptoms when compared with placebo .", "label": "", "metadata": {}, "score": "47.189224"}
{"text": "[ 0035 ] Exemplary decongestants include pseudoephedrine and phenylephrine .[ 0037 ]Exemplary anti - inflammatory agents include non - steroidal anti - inflammatory drugs such as alicylates , arylalkanoic acids , profens , fenamic acids , pyrazolidine derivatives , oxicams , COX-2 Inhibitors , and sulphonanilides .", "label": "", "metadata": {}, "score": "47.200603"}
{"text": "Specifically , bioequivalence can be determined by an in vivo pharmacokinetic study comparing a pharmacokinetic parameter for the two compositions .A pharmacokinetic parameter for the quetiapine controlled - release composition or the reference drug can be measured in a single or multiple dose bioequivalence study using a replicate or a nonreplicate design .", "label": "", "metadata": {}, "score": "47.20221"}
{"text": "Regarding the response rates of other antidepressants in adults with MDD , the NNTs of fluoxetine and venlafaxine are between 5 and 7 , which are comparable to the NNT of 8 for the quetiapine treatment in this population [ 42 ] .", "label": "", "metadata": {}, "score": "47.229034"}
{"text": "The efficacy and tolerability of once - daily extended - release quetiapine fumarate ( quetiapine XR ) have been evaluated in GAD ; 3 acute monotherapy studies in adults 12 - 14 and 1 in geriatric patients 15 demonstrated that quetiapine XR was effective at significantly reducing anxiety symptoms compared with placebo .", "label": "", "metadata": {}, "score": "47.322655"}
{"text": "In cases of severe extrapyramidal symptoms , anticholinergic medication should be administered .Close medical supervision and monitoring should continue until the patient recovers .Quetiapine fumarate is a psychotropic agent belonging to a chemical class , the dibenzothiazepine derivatives .", "label": "", "metadata": {}, "score": "47.4064"}
{"text": "2012 Jun 23 ; Quetiapine alleviates both positive and negative symptoms as well as certain cognitive impairments in schizophrenia despite a low D(2 ) receptor occupancy and may also be used as monotherapy in bipolar and major depressive disorder .", "label": "", "metadata": {}, "score": "47.44001"}
{"text": "The reasons for quetiapine discontinuation included adverse effects of the medication ( 3 trials : sedation , dizziness , and akathisia in 1 patient each ) , ineffectiveness ( 2 trials ) , and patient choice ( 2 trials ) .", "label": "", "metadata": {}, "score": "47.626667"}
{"text": "Pooled findings from the BOLDER and EMBOLDEN trials showed clear improvements with both doses of quetiapine in overall functioning , individual domains of social and occupational functioning , as well as quality of life ( Gustafsson and Fajutrao 2011 ) .", "label": "", "metadata": {}, "score": "47.69182"}
{"text": "[ 0028 ] Various active agents or combinations thereof can be used in the controlled - release compositions described herein .[ 0029 ] Exemplary antihypertensives include prazosin , nifedipine , trimazosin , amlodipine , and doxazosin mesylate .", "label": "", "metadata": {}, "score": "47.71943"}
{"text": "The nonsignificant differences in this respect have been found in a number of meta - analyses of paroxetine [ 43 ] and duloxetine [ 44 ] and TCAs [ 10 ] for the treatment of MDD .", "label": "", "metadata": {}, "score": "47.796104"}
{"text": "The clastogenic potential of quetiapine was tested in the in vitro chromosomal aberration assay in cultured human lymphocytes and in the in vivo bone marrow micronucleus assay in rats up to 500 mg / kg which is 6 times the maximum recommended human dose on mg / m 2 body surface area .", "label": "", "metadata": {}, "score": "47.807983"}
{"text": "A patient Medication Guide about \" Antidepressant Medicines , Depression and other Serious Mental Illness , and Suicidal Thoughts or Actions \" is available for quetiapine fumarate tablets .", "label": "", "metadata": {}, "score": "47.966248"}
{"text": "2012 ) .Conclusions .These analyses on the largest sample of patients with bipolar II depression studied to date support the efficacy and tolerability of quetiapine 300 and 600 mg / day in treating bipolar II depression .", "label": "", "metadata": {}, "score": "48.048645"}
{"text": "Quetiapine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus .There are limited published data on the use of quetiapine for treatment of schizophrenia and other psychiatric disorders during pregnancy .", "label": "", "metadata": {}, "score": "48.065403"}
{"text": "2012 Jun;37(7):1717 - 28 .Quetiapine is now used in the treatment of unipolar and bipolar disorders , both alone and in combination with other medications .", "label": "", "metadata": {}, "score": "48.20182"}
{"text": "Purdon SE , Malla A , Labelle A , et al .Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol .J Psychiatry Neurosci .", "label": "", "metadata": {}, "score": "48.2078"}
{"text": "Infusion of physostigmine led to a prompt reduction in MHPG release and a marked decline in mood - state measurements and the overall level of thought disorder .", "label": "", "metadata": {}, "score": "48.22225"}
{"text": "Bortnick B , El - Khalili N , Banov M , et al .Efficacy and tolerability of extended release quetiapine fumarate ( quetiapine XR ) monotherapy in major depressive disorder : a placebo - controlled , randomized study .", "label": "", "metadata": {}, "score": "48.237198"}
{"text": "In 59.0 % of trials ( 23/39 ) lamotrigine plus quetiapine combination therapy was continued for 12 weeks without the addition of new medications .In 20.5 % ( 8/39 ) of trials , lamotrigine plus quetiapine combination therapy was continued , but additional psychotropic medication was added after a mean\u00b1SD of 35.0\u00b130.4 days .", "label": "", "metadata": {}, "score": "48.467663"}
{"text": "The adverse event profile in this patient population was qualitatively similar to findings in acute and maintenance studies of quetiapine monotherapy in patients with bipolar I or II disorder ( Bowden et al .", "label": "", "metadata": {}, "score": "48.495224"}
{"text": "We studied the acute effectiveness of lamotrigine plus quetiapine for treatment - resistant syndromal and subsyndromal depressive symptoms in a heterogeneous patient population receiving complex pharmacotherapy for bipolar disorder .", "label": "", "metadata": {}, "score": "48.516403"}
{"text": "For many patients with generalized anxiety disorder ( GAD ) , first - line treatment does not lead to remission .This study investigated the efficacy and tolerability of adjunctive extended - release quetiapine fumarate ( quetiapine XR ) in patients with GAD and an inadequate response to selective serotonin reuptake inhibitors ( SSRIs ) and serotonin - norepinephrine reuptake inhibitors ( SNRIs ) .", "label": "", "metadata": {}, "score": "48.563835"}
{"text": "12.1 Mechanism of Action .The mechanism of action of quetiapine is unknown .However , it has been proposed that the efficacy of quetiapine in schizophrenia and its mood stabilizing properties in bipolar depression and mania are mediated through a combination of dopamine type 2 ( D 2 ) and serotonin type 2 ( 5HT 2 ) antagonism .", "label": "", "metadata": {}, "score": "48.571976"}
{"text": "Expert Opin Pharmacother .2012 Aug;13(11):1653 - 9 .Introduction : Lurasidone is a benzisothiazol derivative , approved by the US Food and Drug Administration for the acute treatment of adults with schizophrenia .", "label": "", "metadata": {}, "score": "48.664963"}
{"text": "Bandelow B , Chouinard G , Bobes J , et al .Extended - release quetiapine fumarate ( quetiapine XR ) : a once - daily monotherapy effective in generalized anxiety disorder .", "label": "", "metadata": {}, "score": "48.728"}
{"text": "The need for continued treatment should be reassessed periodically .If signs and symptoms of tardive dyskinesia appear in a patient on quetiapine , drug discontinuation should be considered .", "label": "", "metadata": {}, "score": "48.755455"}
{"text": "Noradrenergic dysregulation in depression thus is characterized by inefficient hyperreactivity to physiologic stress .\" [ Abstract ] .Grossman F , Potter WZ .Catecholamines in depression : a cumulative study of urinary norepinephrine and its major metabolites in unipolar and bipolar depressed patients versus healthy volunteers at the NIMH .", "label": "", "metadata": {}, "score": "48.77321"}
{"text": "Given these confounders , the relationship between atypical antipsychotic use and hyperglycemia - related adverse reactions is not completely understood .However , epidemiological studies suggest an increased risk of treatment - emergent hyperglycemia - related adverse reactions in patients treated with the atypical antipsychotics .", "label": "", "metadata": {}, "score": "48.85681"}
{"text": "Recent Bipolar Disorder & Norepinephrine Research 1 ) Bj\u00f6rkholm C , Jardemark K , Marcus MM , Malmerfelt A , Nyberg S , Schilstr\u00f6m B , Svensson TH Role of concomitant inhibition of the norepinephrine transporter for the antipsychotic effect of quetiapine .", "label": "", "metadata": {}, "score": "48.89852"}
{"text": "View Article .Chiesa A , Chierzi F , De Ronchi D , Serretti A : Quetiapine for bipolar depression : a systematic review and meta - analysis .", "label": "", "metadata": {}, "score": "48.975525"}
{"text": "The analysis using change from randomization in HAM - A total score according to final prescribed quetiapine XR dose ( 150 mg / d or 300 mg / d ) at week 8 also found no statistically significant difference between quetiapine XR and placebo .", "label": "", "metadata": {}, "score": "48.98569"}
{"text": "Efficacy was established in two maintenance trials in adults .The effectiveness of quetiapine fumarate tablets as monotherapy for the maintenance treatment of bipolar disorder has not been systematically evaluated in controlled clinical trials [ see Clinical Studies ( 14.2 ) ] . 1.3 Special Considerations in Treating Pediatric Schizophrenia and Bipolar I Disorder .", "label": "", "metadata": {}, "score": "49.081444"}
{"text": "Schizophrenia : The incidence of discontinuation due to adverse reactions for quetiapine - treated and placebo - treated patients was 8.2 % and 2.7 % , respectively .", "label": "", "metadata": {}, "score": "49.13309"}
{"text": "No significant differences were observed for other outcome measures , but greater improvements were seen with risperidone vs placebo .The authors concluded that , at low doses , risperidone may be efficacious in the management of symptomatic GAD patients .", "label": "", "metadata": {}, "score": "49.16663"}
{"text": "5.7 Hypotension .Quetiapine may induce orthostatic hypotension associated with dizziness , tachycardia and , in some patients , syncope , especially during the initial dose - titration period , probably reflecting its \u03b1 1 \u00ad-adrenergic antagonist properties .", "label": "", "metadata": {}, "score": "49.36046"}
{"text": "Initially approved for the treatment of adults with schizophrenia , ziprasidone has more recently received supplementary indications for acute manic and mixed episodes and as maintenance therapy for people affected by bipolar disorder .", "label": "", "metadata": {}, "score": "49.430214"}
{"text": "The patient 's behavior did not change with carbamazepine and worsened with levodopa .We suggest that the manic - like syndrome was related to noradrenergic overactivity secondary to the fronto - orbital lesions .", "label": "", "metadata": {}, "score": "49.441574"}
{"text": "However , the effects of serotonin enhancement on cardiovagal tone should be considered .Our results suggest that the pharmacodynamic properties of antidepressants may affect autonomic regulation of women with recurrent MDD even in euthymic state .", "label": "", "metadata": {}, "score": "49.470764"}
{"text": "Am J Psychiatry .McIntyre RS , Brecher M , Paulsson B , et al .Quetiapine or haloperidol as monotherapy for bipolar mania - a 12-week , double - blind , randomised , parallel - group , placebo - controlled trial .", "label": "", "metadata": {}, "score": "49.480957"}
{"text": "Quetiapine fumarate tablets are indicated as monotherapy for the acute treatment of depressive episodes associated with bipolar disorder .Efficacy was established in two 8-week monotherapy trials in adult patients with bipolar I and bipolar II disorder [ see Clinical Studies ( 14.2 ) ] .", "label": "", "metadata": {}, "score": "49.513905"}
{"text": "Emerging evidence indicates that in patients with bipolar disorder , ziprasidone provides valid efficacy and remarkable safety when administered alone for the treatment of manic and mixed episodes .", "label": "", "metadata": {}, "score": "49.63511"}
{"text": "This finding may be due to inhibition of cholesterol biosynthesis by quetiapine .Quetiapine caused a dose - related reduction in plasma cholesterol levels in repeat - dose dog and monkey studies ; however , there was no correlation between plasma cholesterol and the presence of cataracts in individual dogs .", "label": "", "metadata": {}, "score": "49.6454"}
{"text": "The response rate of the quetiapine - treated group in each study was significantly greater than that of the placebo - treated group ( see Figure 2 ) .", "label": "", "metadata": {}, "score": "49.717285"}
{"text": "Timdahl K , Carlsson A , Stening G .An analysis of safety and tolerability data from controlled comparative studies of quetiapine in patients with schizophrenia , focusing on extrapyramidal symptoms .", "label": "", "metadata": {}, "score": "49.75275"}
{"text": "Quetiapine decreased mating and fertility in male Sprague - Dawley rats at oral doses of 50 and 150 mg / kg or approximately 1 and 3 times the maximum human dose ( MRHD ) of 800 mg / day on mg / m 2 body surface area .", "label": "", "metadata": {}, "score": "49.773342"}
{"text": "25 Years to 45 Years .Accepts Healthy Volunteers .Yes .Contacts ICMJE .Contact information is only displayed when the study is recruiting subjects BACKGROUND : Lamotrigine and quetiapine are commonly used in bipolar disorder , but there are no published systematic studies of their use in combination for treatment - resistant bipolar depression .", "label": "", "metadata": {}, "score": "49.788574"}
{"text": "A small number of clinical trials using various dopaminergic and stimulant drugs for the treatment of major depression and bipolar depression have demonstrated some benefit when combined with standard antidepressant drugs .", "label": "", "metadata": {}, "score": "49.845543"}
{"text": "Changes in TSH , thyroxine , and thyroxine clearance consistent with this mechanism were observed in subchronic toxicity studies in rat and mouse and in a 1-year toxicity study in rat ; however , the results of these studies were not definitive .", "label": "", "metadata": {}, "score": "49.867805"}
{"text": "Quetiapine is extensively metabolized by the liver .The major metabolic pathways are sulfoxidation to the sulfoxide metabolite and oxidation to the parent acid metabolite ; both metabolites are pharmacologically inactive .", "label": "", "metadata": {}, "score": "49.92209"}
{"text": "Adverse Reactions Associated with Discontinuation of Treatment in Short - Term , Placebo - Controlled Trials .Schizophrenia : Overall , there was little difference in the incidence of discontinuation due to adverse reactions ( 4 % for quetiapine vs. 3 % for placebo ) in a pool of controlled trials .", "label": "", "metadata": {}, "score": "49.970753"}
{"text": "No patient who developed mood elevation had received additional adjunctive antidepressant medication .One patient developed transient hypomania prior to the addition of aripiprazole .Body weight and BMI .", "label": "", "metadata": {}, "score": "50.00303"}
{"text": "PubMed .Vieta E , Calabrese JR , Goikolea JM , Raines S , Macfadden W : Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid - cycling disease course : a randomized , double - blind , placebo - controlled study .", "label": "", "metadata": {}, "score": "50.08642"}
{"text": "Suppes T , Hirschfeld RM , Vieta E , Raines S , Paulsson B : Quetiapine for the treatment of bipolar II depression : analysis of data from two randomized , double - blind , placebo - controlled studies .", "label": "", "metadata": {}, "score": "50.104248"}
{"text": "The NNT in order to achieve response was calculated according to the formula : 1/(number of placebo responders - number of quetiapine responders ) ; an equivalent formula calculated the NNT to achieve remission .", "label": "", "metadata": {}, "score": "50.187065"}
{"text": "Merideth C , Cutler AJ , She F , et al .Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder : a randomized , placebo - controlled and active - controlled study .", "label": "", "metadata": {}, "score": "50.257454"}
{"text": "[0031 ] Exemplary antianxiety agents include hydroxyzine hydrochloride , lorazepam , buspirone hydrochloride , pazepam , chlordiazepoxide , meprobamate , oxazepam , trifluoperazine hydrochloride , clorazepate dipotassium , and diazepam .", "label": "", "metadata": {}, "score": "50.263832"}
{"text": "Although there are no data to specifically address re - initiation of treatment , it is recommended that when restarting therapy of patients who have been off quetiapine fumarate tablets for more than one week , the initial dosing schedule should be followed .", "label": "", "metadata": {}, "score": "50.266624"}
{"text": "J Clin Psychiatry .Lydiard RB , Rickels K , Herman B , et al .Comparative efficacy of pregabalin and benzodiazepines in treating the psychic and somatic symptoms of generalized anxiety disorder .", "label": "", "metadata": {}, "score": "50.554504"}
{"text": "c Duration of treatment prior to randomization .Study treatment .The mean ( SD ) dose of adjunctive agent ( quetiapine XR or placebo ) was 174.3 ( 49.0 ) mg / d and 190.3 ( 49.6 ) mg / d for quetiapine XR - treated and placebo - treated patients , respectively .", "label": "", "metadata": {}, "score": "50.745502"}
{"text": "In acute bipolar mania ( adjunct ) trials the proportions of patients meeting the same criteria was 0.6 % ( 1/166 ) for quetiapine compared to 0 % ( 0/171 ) incidence for placebo .", "label": "", "metadata": {}, "score": "50.968834"}
{"text": "Discussion .Our review found only three randomized , placebo - controlled trials of quetiapine carried out in adult patients with MDD .All studies had the same study designs .", "label": "", "metadata": {}, "score": "51.05343"}
{"text": "13.1 Carcinogenesis , Mutagenesis , Impairment of Fertility .Carcinogenesis .Carcinogenicity studies were conducted in C57BL mice and Wistar rats .Quetiapine was administered in the diet to mice at doses of 20 , 75 , 250 , and 750 mg / kg and to rats by gavage at doses of 25 , 75 , and 250 mg / kg for two years .", "label": "", "metadata": {}, "score": "51.07092"}
{"text": "Nierenberg AA , Ostacher MJ , Calabrese JR , et al .Treatment - resistant bipolar depression : a STEP - BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine , inositol , or risperidone .", "label": "", "metadata": {}, "score": "51.072662"}
{"text": "The experimental results were presented in Table 9 .Application of the Method to Dosage Forms .The HPLC method developed is sensitive and specific for the quantitative determination of quetiapine fumarate .", "label": "", "metadata": {}, "score": "51.19394"}
{"text": "Mezhebovsky I , Magi K , She F , et al .Double - blind , randomized study of extended release quetiapine fumarate ( quetiapine XR ) monotherapy in older patients with generalized anxiety disorder .", "label": "", "metadata": {}, "score": "51.212288"}
{"text": "Of the approximately 3700 patients in clinical studies with quetiapine , 7 % ( 232 ) were 65 years of age or over .In general , there was no indication of any different tolerability of quetiapine in the elderly compared to younger adults .", "label": "", "metadata": {}, "score": "51.27249"}
{"text": "An initial quetiapine dose of 50 mg / day was subsequently increased in 100-mg increments to achieve a final target dose of 300 or 600 mg / day at day 4 or day 8 , respectively .", "label": "", "metadata": {}, "score": "51.303394"}
{"text": "Baseline demographic and clinical characteristics of the entire sample and each adjunctive group are presented in TABLE 1 .In particular , the adjunctive lamotrigine group had numerically fewer females ( 53.8 % vs 84.6 % ) and BD II patients ( 46.2 % vs 65.4 % ) than the adjunctive quetiapine group .", "label": "", "metadata": {}, "score": "51.303936"}
{"text": "2012 May;138(3):222 - 38 .The treatment of bipolar depression is one of the most challenging issues in contemporary psychiatry .Currently only quetiapine and the olanzapine - fluoxetine combination are officially approved by the FDA against this condition .", "label": "", "metadata": {}, "score": "51.346924"}
{"text": "Steady - state concentrations are expected to be achieved within two days of dosing .Quetiapine is unlikely to interfere with the metabolism of drugs metabolized by cytochrome P450 enzymes .", "label": "", "metadata": {}, "score": "51.48503"}
{"text": "Chemicals and Reagents .Quetiapine fumarate ( 99.92 % ) was gift sample from corpuscle research solutions and lamotrogine ( 99.89 % pure , internal standard was procured from corpuscle research solutions .", "label": "", "metadata": {}, "score": "51.516617"}
{"text": "Controlled -Release Solid Dosage Forms ( with Eudragit )Comprising Sodium Citrate and Quetiapine Fumarate .[ 0118 ] Six controlled - release formulations ( A , B , C , D , E and F ) containing an ionic non - gelling matrix and sodium citrate ( pH modifier ) were prepared .", "label": "", "metadata": {}, "score": "51.58359"}
{"text": "Advise families and caregivers of the need for close observation and communication with the prescriber [ see Warnings and Precautions ( 5.2 ) ] .Quetiapine is not approved for use in pediatric patients under ten years of age [ see Use in Specific Populations ( 8.4 ) ] .", "label": "", "metadata": {}, "score": "51.656895"}
{"text": "6 Combinations of mood stabilizers and atypical antipsychotics are of particular interest , as recent years have brought new options in both therapeutic categories .The mood - stabilizing anticonvulsant lamotrigine represents an important advance in the pharmacotherapy of bipolar disorder .", "label": "", "metadata": {}, "score": "51.71332"}
{"text": "Exclusion : .Allergy to quetiapine , Lipoderm or polyethylene glycol .Currently taking quetiapine .Pregnant , planning to become pregnant or breast feeding .", "label": "", "metadata": {}, "score": "51.722008"}
{"text": "Katzman MA , Vermani M , Jacobs L , et al .Quetiapine as an adjunctive pharmacotherapy for the treatment of non - remitting generalized anxiety disorder : a flexible - dose , open - label pilot trial .", "label": "", "metadata": {}, "score": "51.8054"}
{"text": "Thus , for direct comparison between the controlled - release composition and the brand drug , it is sometimes preferred to determine the pharmacokinetic parameters for the controlled - release composition and the brand drug side - by side in the same pharmacokinetic study .", "label": "", "metadata": {}, "score": "51.84402"}
{"text": "5.3 Cerebrovascular Adverse Reactions , Including Stroke , in Elderly Patients with Dementia - Related Psychosis .In placebo - controlled trials with risperidone , aripiprazole , and olanzapine in elderly subjects with dementia , there was a higher incidence of cerebrovascular adverse reactions ( cerebrovascular accidents and transient ischemic attacks ) including fatalities compared to placebo - treated subjects .", "label": "", "metadata": {}, "score": "51.875916"}
{"text": "Assessments .The primary effectiveness measure was the change in mood status defined by DSM - IV - TR and STEP - BD from baseline ( immediately prior to adding lamotrigine or quetiapine ) to the efficacy endpoint ( last visit taking lamotrigine plus quetiapine combination therapy or time of adding an antidepressant or aripiprazole ) .", "label": "", "metadata": {}, "score": "51.92216"}
{"text": "Katzman MA , Brawman - Mintzer O , Reyes EB , et al .Extended release quetiapine fumarate ( quetiapine XR ) monotherapy as maintenance treatment for generalized anxiety disorder : a long - term , randomized , placebo - controlled trial .", "label": "", "metadata": {}, "score": "52.001274"}
{"text": "The drug is extensively metabolites , principally through CYP3A4 .The drug is having half - life period of approximately 6 hours .Several methods have been reported for the quantitative determination of quetiapine in bulk , and pharmaceutical and biological samples .", "label": "", "metadata": {}, "score": "52.004005"}
{"text": "The duration of prior lamotrigine was numerically more than twice the duration of prior quetiapine ( 517.4 days vs 218.8 days , but with overlapping 95 % CIs ) .", "label": "", "metadata": {}, "score": "52.010777"}
{"text": "PubMed .Goldstein JM , Nyberg S , Brecher M : Preclinical mechanisms for the broad spectrum of antipsychotic , antidepressant and mood stabilizing properties of Seroquel .", "label": "", "metadata": {}, "score": "52.08142"}
{"text": "Biol Psychiatry .Kahn RS , Schulz SC , Palazov VD , et al .Efficacy and tolerability of once - daily extended release quetiapine fumarate in acute schizophrenia : a randomized , double - blind , placebo - controlled study .", "label": "", "metadata": {}, "score": "52.205452"}
{"text": "The norepinephrine elevations in the PTSD group were sustained throughout hospitalization .The only other group to show mean levels in this range was the BP group in the first sample after hospital admission .", "label": "", "metadata": {}, "score": "52.210125"}
{"text": "A rapid , specific , and accurate isocratic HPLC method was developed and validated for the assay of quetiapine fumarate in pharmaceutical dosage forms .The assay involved an isocratic - elution of quetiapine fumarate in Grace C18 column using mobile - phase composition of 0.1 % ortho phosphoric acid with triethyl amine as modifier buffer and acetonitrile in the ratio of 50 : 50 ( v / v ) .", "label": "", "metadata": {}, "score": "52.226753"}
{"text": "9.1 Controlled Substance .9.2 Abuse .Quetiapine has not been systematically studied , in animals or humans , for its potential for abuse , tolerance or physical dependence .", "label": "", "metadata": {}, "score": "52.472717"}
{"text": "13 , 14 Quetiapine is the first atypical antipsychotic agent approved by the FDA for the treatment of acute depression in patients with bipolar I disorder ( BD I ) as well as patients with bipolar II disorder ( BD II ) .", "label": "", "metadata": {}, "score": "52.474586"}
{"text": "5.12 Seizures .During clinical trials , seizures occurred in 0.5 % ( 20/3490 ) of patients treated with quetiapine compared to 0.2 % ( 2/954 ) on placebo and 0.7 % ( 4/527 ) on active control drugs .", "label": "", "metadata": {}, "score": "52.556877"}
{"text": "Schizophrenia .Quetiapine fumarate tablets are indicated for the treatment of schizophrenia .The efficacy of quetiapine fumarate tablets in schizophrenia was established in three 6-week trials in adults and one 6-week trial in adolescents ( 13 to \u00ac17 years ) .", "label": "", "metadata": {}, "score": "52.600754"}
{"text": "Searches were limited to humans and adults only .Additional studies were also searched from the databases of AstraZeneca , the producer of the original quetiapine .", "label": "", "metadata": {}, "score": "52.78383"}
{"text": "Vieta E , Suppes T , Eggens I , et al .Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder ( international trial 126 ) .", "label": "", "metadata": {}, "score": "52.80184"}
{"text": "Changes in CGI - S and GAF from baseline ( immediately prior to lamotrigine plus quetiapine combination therapy ) to efficacy endpoint ( last observation taking lamotrigine plus quetiapine combination therapy or time of adding antidepressant or aripiprazole ) .", "label": "", "metadata": {}, "score": "52.80345"}
{"text": "\" [ Abstract ] .Bhanji NH , Margolese HC , Saint - Laurent M , Chouinard G. Dysphoric mania induced by high - dose mirtazapine : a case for ' norepinephrine syndrome ' ?", "label": "", "metadata": {}, "score": "52.915424"}
{"text": "Only 30%-55 % of MDD patients achieve remission state at the end of acute SSRI or SNRI treatment [ 13 , 14 ] .While these antidepressants presumably affect serotonin and norepinephrine neurotransmitters , several lines of evidence support that dopamine neurotransmitters may also play an important role in the treatment of MDD patients [ 18 , 19 ] .", "label": "", "metadata": {}, "score": "52.936188"}
{"text": "Dose Modifications when used with CYP3A4 Inducers .The dose should be titrated based on the clinical response and tolerability of the individual patient .When the CYP3A4 inducer is discontinued , the dose of quetiapine fumarate tablets should be reduced to the original level within 7 to 14 days [ see Clinical Pharmacology ( 12.3 ) and Drug Interactions ( 7.1 ) ] .", "label": "", "metadata": {}, "score": "52.948376"}
{"text": "By week 8 , significantly higher proportions of patients treated with quetiapine 300 and 600 mg / day had achieved response and remission when compared with placebo .", "label": "", "metadata": {}, "score": "52.96085"}
{"text": "Frye MA , Ketter TA , Kimbrell TA , et al .A placebo - controlled study of lamotrigine and gabapentin mono - therapy in refractory mood disorders .", "label": "", "metadata": {}, "score": "53.06053"}
{"text": "The clinical significance of this finding is unknown .The efficacy of quetiapine in the treatment of schizophrenia in adolescents ( 13 to 17 years of age ) was demonstrated in a 6-week , double - blind , placebo - controlled trial ( study 4 ) .", "label": "", "metadata": {}, "score": "53.11792"}
{"text": "PubMed Central PubMed .Hirschfeld RM , Weisler RH , Raines SR , Macfadden W : Quetiapine in the treatment of anxiety in patients with bipolar I or II depression : a secondary analysis from a randomized , double - blind , placebo - controlled study .", "label": "", "metadata": {}, "score": "53.192543"}
{"text": "Bowden CL , Grunze H , Mullen J , et al .A randomized , double - blind , placebo - controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder .", "label": "", "metadata": {}, "score": "53.195892"}
{"text": "Although there are substantial data regarding the efficacy of lamotrigine monotherapy and quetiapine monotherapy in the management of bipolar disorder , no published study to date has reported on the combination of quetiapine and lamotrigine in the complex patients encountered in clinical settings .", "label": "", "metadata": {}, "score": "53.201096"}
{"text": "Rates of discontinuation because of adverse events were 12.1 % for quetiapine 300 mg / day , 17.9 % for quetiapine 600 mg / day , and 5.1 % for placebo .", "label": "", "metadata": {}, "score": "53.234673"}
{"text": "Suppes T , Vieta E , Liu S , et al .Maintenance treatment for patients with bipolar I disorder : results from a North American study of quetiapine in combination with lithium or divalproex ( trial 127 ) .", "label": "", "metadata": {}, "score": "53.352875"}
{"text": "In acute bipolar mania trials using quetiapine as monotherapy , somnolence was reported in 16 % ( 34/209 ) of patients on quetiapine compared to 4 % of placebo patients .", "label": "", "metadata": {}, "score": "53.528736"}
{"text": "J Clin Psychiatry 1984 Jul;45(7):306 - 9 \" Plasma levels of the major norepinephrine ( NE ) metabolite , 3-methoxy-4-hydroxyphenylglycol ( MHPG ) , were measured in a rapidly cycling bipolar patient and her first - degree relatives .", "label": "", "metadata": {}, "score": "53.560722"}
{"text": "Posttreatment period .This study evaluated the efficacy and tolerability of quetiapine XR as an adjunct to SSRI / SNRI therapy in patients with GAD who demonstrated partial or no ( inadequate ) response to SSRI / SNRI treatment ( alone or in combination with a benzodiazepine ) .", "label": "", "metadata": {}, "score": "53.655865"}
{"text": "Commonly Observed Adverse Reactions in Short - Term , Placebo - Controlled Trials : .Adverse Reactions Occurring at an Incidence of 2 % or More Among Quetiapine Treated Patients in Short - Term , Placebo - Controlled Trials : .", "label": "", "metadata": {}, "score": "53.656815"}
{"text": "When adjusted for weight , the AUC and C max of quetiapine were 41 % and 39 % lower , respectively , in children and adolescents compared to adults .", "label": "", "metadata": {}, "score": "53.8034"}
{"text": "NMS is a rare but very serious condition that can happen in people who take antipsychotic medicines , including quetiapine fumarate tablets .NMS can cause death and must be treated in a hospital .", "label": "", "metadata": {}, "score": "53.85672"}
{"text": "Quetiapine monotherapy demonstrated significant efficacy compared with placebo and was generally well tolerated in the treatment of bipolar II depression .Keywords .Bipolar II depression Efficacy Monotherapy Quetiapine Tolerability .", "label": "", "metadata": {}, "score": "53.976166"}
{"text": "5.9 Leukopenia , Neutropenia and Agranulocytosis .In clinical trial and postmarketing experience , events of leukopenia / neutropenia have been reported temporally related to atypical antipsychotic agents , including quetiapine .", "label": "", "metadata": {}, "score": "54.028694"}
{"text": "5.18 Discontinuation Syndrome .Acute withdrawal symptoms , such as insomnia , nausea , and vomiting have been described after abrupt cessation of atypical antipsychotic drugs , including quetiapine .", "label": "", "metadata": {}, "score": "54.11944"}
{"text": "0065 ] Exemplary ACE inhibitors / antihypertensives include enalaprilic acid and lisinopril .[ 0066 ] Exemplary muscle relaxants include metaxalone .[0067 ] The pH modifier is present in an amount to control the release of the active agent from the composition .", "label": "", "metadata": {}, "score": "54.201324"}
{"text": "Multiple regression analysis showed that pretreatment levels of urinary MHPG correlated with improvement in manic syndrome scores .These data suggest that GABA and norepinephrine may be related to different aspects of the manic state and to its pharmacologic sensitivity .", "label": "", "metadata": {}, "score": "54.28231"}
{"text": "These studies included patients with either bipolar I or II disorder and those with or without a rapid cycling course .Patients randomized to quetiapine were administered fixed doses of either 300 mg or 600 mg once daily .", "label": "", "metadata": {}, "score": "54.34424"}
{"text": "A double - blind controlled trial , published in 1980 , showed that chlorpromazine increased slow - wave sleep and improved pain and mood disturbances .", "label": "", "metadata": {}, "score": "54.379242"}
{"text": "Bauer M , Pretorius HW , Constant EL , et al .Extended - release quetiapine as adjunct to an antidepressant in patients with major depressive disorder : results of a randomized , placebo - controlled , double - blind study .", "label": "", "metadata": {}, "score": "54.48236"}
{"text": "Overall rates of adverse events in the pooled safety population were 73.8 % , 74.3 % , and 67.8 % for the quetiapine 300 mg / day , 600 mg / day , and placebo arms , respectively .", "label": "", "metadata": {}, "score": "54.51456"}
{"text": "Entsuah AR , Huang H , Thase ME : Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine , selective serotonin reuptake inhibitors , or placebo .", "label": "", "metadata": {}, "score": "54.701553"}
{"text": "PubMed View Article .Gibbons RD , Hur K , Brown CH , Davis JM , Mann JJ : Benefits From Antidepressants : Synthesis of 6-Week Patient - Level Outcomes From Double - blind Placebo - Controlled Randomized Trials of Fluoxetine and Venlafaxine .", "label": "", "metadata": {}, "score": "54.73359"}
{"text": "Abstract .Background .Schizophrenia and bipolar depression trials suggest that quetiapine may have an antidepressant effect .Objectives .This meta - analysis aimed to determine the efficacy , acceptability and tolerability of quetiapine treatment for major depressive disorder ( MDD ) .", "label": "", "metadata": {}, "score": "54.775036"}
{"text": "that included a discontinuation phase which evaluated discontinuation symptoms , the aggregated incidence of patients experiencing one or more discontinuation symptoms after abrupt cessation was 12.1 % ( 241/1993 ) for quetiapine fumarate extended - release tablets .", "label": "", "metadata": {}, "score": "54.792763"}
{"text": "Effectiveness and safety of quetiapine fumarate tablets have not been established in pediatric patients less than 13 years of age for schizophrenia or less than 10 years of age for bipolar mania .", "label": "", "metadata": {}, "score": "54.89441"}
{"text": "Tohen M , Vieta E , Calabrese J , et al .Efficacy of olanzapine and olanzapine - fluoxetine combination in the treatment of bipolar I depression .", "label": "", "metadata": {}, "score": "54.94278"}
{"text": "10.1 Human Experience .In clinical trials , survival has been reported in acute overdoses of up to 30 grams of quetiapine .Most patients who overdosed experienced no adverse reactions or recovered fully from the reported reactions .", "label": "", "metadata": {}, "score": "54.958496"}
{"text": "PubMed .J Clin Psychiatry 2010 , 71 ( 2):163 - 74 .PubMed .McIntyre RS , Brecher M , Paulsson B , Huizar K , Mullen J : Quetiapine or haloperidol as monotherapy for bipolar mania - a 12-week , double - blind , randomised , parallel - group , placebo - controlled trial .", "label": "", "metadata": {}, "score": "54.98854"}
{"text": "In a short - term placebo - controlled monotherapy trial in children and adolescent patients with bipolar mania ( 3-week duration ) , the aggregated incidence of extrapyramidal symptoms was 3.6 % ( 7/193 ) or quetiapine and 1.1 % ( 1/90 ) for placebo .", "label": "", "metadata": {}, "score": "55.00544"}
{"text": "PubMed .Weisler RH , Nolen WA , Neijber A , Hellqvist A , Paulsson B : Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder ( trial 144 : a randomized controlled study ) .", "label": "", "metadata": {}, "score": "55.02901"}
{"text": "PubMed View Article .Weisler R , Joyce M , McGill L , Lazarus A , Szamosi J , Eriksson H : Extended release quetiapine fumarate monotherapy for major depressive disorder : results of a double - blind , randomized , placebo - controlled study .", "label": "", "metadata": {}, "score": "55.10037"}
{"text": "View Article .Stewart DE , Wohlreich MM , Mallinckrodt CH , Watkin JG , Kornstein SG : Duloxetine in the treatment of major depressive disorder : comparisons of safety and tolerability in male and female patients .", "label": "", "metadata": {}, "score": "55.191616"}
{"text": "26 They were followed longitudinally with the STEP - BD Clinical Monitoring Form .27 Between July 1 , 2000 , and February 28 , 2006 , we studied outpatients who experienced syndromal or subsyndromal mood symptoms despite treatment with quetiapine or lamotrigine .", "label": "", "metadata": {}, "score": "55.22352"}
{"text": "Int J Neuropsychopharmacol .Khan A , Joyce M , Atkinson S , et al .A randomized , double - blind study of once - daily extended release quetiapine fumarate ( quetiapine XR ) monotherapy in patients with generalized anxiety disorder .", "label": "", "metadata": {}, "score": "55.251835"}
{"text": "Patients and caregivers should be advised that elderly patients with dementia - related psychosis treated with atypical antipsychotic drugs are at increased risk of death compared with placebo .", "label": "", "metadata": {}, "score": "55.255707"}
{"text": "If a patient requires antipsychotic drug treatment after recovery from NMS , the potential reintroduction of drug therapy should be carefully considered .The patient should be carefully monitored since recurrences of NMS have been reported .", "label": "", "metadata": {}, "score": "55.291378"}
{"text": "Patients should be advised to notify their physician if they become pregnant or intend to become pregnant during therapy with quetiapine fumarate tablets .[ see Use in Specific Populations ( 8.1 ) and ( 8.3)].", "label": "", "metadata": {}, "score": "55.335907"}
{"text": "5 , pp . 1113 - 1119 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .Z. Zhou , X. Li , K. Li , et al . , \" Simultaneous determination of clozapine , olanzapine , risperidone and quetiapine in plasma by high - performance liquid chromatography - electrospray ionization mass spectrometry , \" Journal of Chromatography B , vol .", "label": "", "metadata": {}, "score": "55.400948"}
{"text": "Methods .The authors searched such clinical trials carried out between 1991 and February 2012 .Eligibility criteria .The included studies were randomized , placebo - controlled trials of quetiapine monotherapy in adults ( 18 - 65 years old ) with MDD .", "label": "", "metadata": {}, "score": "55.41107"}
{"text": "1.2 Bipolar Disorder .Quetiapine fumarate tablets are indicated for the acute treatment of manic episodes associated with bipolar I disorder , both as monotherapy and as an adjunct to lithium or divalproex .", "label": "", "metadata": {}, "score": "55.49017"}
{"text": "0062 ]Exemplary anti - ulcer agent / H2 antagonists include famotidine .[ 0063 ] Exemplary vasodilators include alprostadil .[ 0064 ] Exemplary platelet inhibitors include prostacyclin .", "label": "", "metadata": {}, "score": "55.537693"}
{"text": "Calabrese JR , Keck PE Jr , Macfadden W , et al .A randomized , double - blind , placebo - controlled trial of quetiapine in the treatment of bipolar I or II depression .", "label": "", "metadata": {}, "score": "55.651367"}
{"text": "J Clin Psychiatry 2005 , 66 ( 1):111 - 21 .PubMed .Calabrese JR , Keck PE Jr , Macfadden W , Minkwitz M , Ketter TA , Weisler RH , Cutler AJ , McCoy R , Wilson E , Mullen J : A randomized , double - blind , placebo - controlled trial of quetiapine in the treatment of bipolar I or II depression .", "label": "", "metadata": {}, "score": "55.664486"}
{"text": "Tollefson GD , Beasley CM Jr , Tamura RN , et al .Blind , controlled , long - term study of the comparative incidence of treatment - emergent tardive dyskinesia with olanzapine or haloperidol .", "label": "", "metadata": {}, "score": "55.666054"}
{"text": "The excipients did not interfere in the analysis .The results showed that this method can be used for rapid determination of quetiapine fumarate in pharmaceutical tablet with precision , accuracy , and specificity .", "label": "", "metadata": {}, "score": "55.710396"}
{"text": "I and II ( Calabrese et al .2005 ; Thase et al .2006 ) .These findings were subsequently confirmed in the similarly designed EMBOLDEN ( Efficacy of Monotherapy Seroquel in BipOLarDepressioN ) I and II trials ( McElroy et al .", "label": "", "metadata": {}, "score": "55.745193"}
{"text": "Limitations .Variety of quetiapine XR doses and the small number of RCTs were key limitations of this meta - analysis .Conclusions .Based on the limited evidence obtained from three RCTs , quetiapine XR is effective for adult patients with MDD .", "label": "", "metadata": {}, "score": "55.832954"}
{"text": "We investigated relationships between indices of catecholamine or GABA system function , pretreatment mania severity and antimanic response to divalproex , lithium , or placebo .", "label": "", "metadata": {}, "score": "55.86661"}
{"text": "Based on the pooled response rates , the NNT of 7.2 indicates that , by average , every 1 in 8 patients with MDD will respond to quetiapine treatment .", "label": "", "metadata": {}, "score": "55.866646"}
{"text": "[ 0040 ] Exemplary cholesterol - reducing agents include statins such as atorvastatin , cerivastatin , fluvastatin , lovastatin , mevastatin , pitavastatin , pravastatin , rosuvastatin , and simvastatin .", "label": "", "metadata": {}, "score": "55.878036"}
{"text": "Thase ME , Macfadden W , Weisler RH , et al .Efficacy of quetiapine monotherapy in bipolar I and II depression : a double - blind , placebo - controlled study ( the BOLDER II study ) .", "label": "", "metadata": {}, "score": "55.886536"}
{"text": "Such monitoring should include daily observation by families and caregivers .Prescriptions for quetiapine fumarate tablets should be written for the smallest quantity of tablets consistent with good patient management , in order to reduce the risk of overdose .", "label": "", "metadata": {}, "score": "56.016937"}
{"text": "Patients with dysphoric mania , recognized by Kraepelin to have poor prognoses , have been reported to respond poorly to lithium carbonate but may be among those who respond to carbamazepine .", "label": "", "metadata": {}, "score": "56.026455"}
{"text": "PubMed View Article .Barbui C , Furukawa TA , Cipriani A : Effectiveness of paroxetine in the treatment of acute major depression in adults : a systematic re - examination of published and unpublished data from randomized trials .", "label": "", "metadata": {}, "score": "56.06656"}
{"text": "A total of 1,497 participants in three RCTs were included .All trials examined the quetiapine extended - release ( XR ) .The overall response and remission rates were significantly greater in the quetiapine - treated group with RRs ( 95%CIs ) of 1.44 ( 1.26 , 1.64 ) and 1.37 ( 1.12 , 1.68 ) , respectively .", "label": "", "metadata": {}, "score": "56.081825"}
{"text": "The results obtained from intermediate precision ( interday ) also indicated a good method precision .All the data were within the acceptance criteria .Table 5 : Intraday and interday precision and accuracy of HPLC assay of quetiapine fumarate .", "label": "", "metadata": {}, "score": "56.10884"}
{"text": "2008 ; Thase et al .2008 ) .Confirming the antidepressant efficacy observed on the MADRS scale , both doses of quetiapine were associated with significantly greater improvements in HAM - D total score from week 1 through week 8 .", "label": "", "metadata": {}, "score": "56.141075"}
{"text": "\" [ Abstract ] .Rudorfer MV , Ross RJ , Linnoila M , Sherer MA , Potter WZ .Exaggerated orthostatic responsivity of plasma norepinephrine in depression .", "label": "", "metadata": {}, "score": "56.162193"}
{"text": "13.2 Animal Toxicology and/or Pharmacology .Quetiapine caused a dose - related increase in pigment deposition in thyroid gland in rat toxicity studies which were 4 weeks in duration or longer and in a mouse 2-year carcinogenicity study .", "label": "", "metadata": {}, "score": "56.17202"}
{"text": "Treatment outcome , however , was not related exclusively to the reduction of noradrenergic indexes by lithium carbonate since reductions were similar in both responders and nonresponders .", "label": "", "metadata": {}, "score": "56.372925"}
{"text": "Neurophysiological recordings suggest a common deficit in a central neuronal sensory gating mechanism which regulates sensitivity to repeated auditory stimuli .Dopamine and norepinephrine are hypothesized to have major roles in these illnesses , but their role in aberrant sensory processing has not yet been proved .", "label": "", "metadata": {}, "score": "56.46383"}
{"text": "PubMed View Article .Bech P , Cialdella P : Citalopram in depression - meta - analysis of intended and unintended effects .Int Clin Psychopharmacol 1992 , 6 ( Suppl 5 ) : 45 - 54 .", "label": "", "metadata": {}, "score": "56.493946"}
{"text": "29 Lamotrigine monotherapy is well tolerated , aside from the risk of a rash that is usually benign , but can be serious .30 Quetiapine monotherapy may yield adverse effects such as sedation and weight gain .", "label": "", "metadata": {}, "score": "56.517757"}
{"text": "Safety and tolerability of lamotrigine for bipolar disorder .Drug Saf .Adler CM , Fleck DE , Brecher M , et al .Safety and tolerability of quetiapine in the treatment of acute mania in bipolar disorder .", "label": "", "metadata": {}, "score": "56.569427"}
{"text": "In particular , the noradrenergic action seemed to be related to the motor activity , attention , and arousal .[ PubMed Citation ] [ Order full text from Infotrieve ] Validation of Quetiapine Fumarate in Pharmaceutical Dosage by Reverse - Phase HPLC with Internal Standard Method .", "label": "", "metadata": {}, "score": "56.57788"}
{"text": "Lohoff FW , Etemad B , Mandos LA , et al .Ziprasidone treatment of refractory generalized anxiety disorder : a placebo - controlled , double - blind study .", "label": "", "metadata": {}, "score": "56.586834"}
{"text": "Consideration should be given to a slower rate of dose titration and a lower target dose in the elderly and in patients who are debilitated or who have a predisposition to hypotensive reactions [ see Clinical Pharmacology ( 12.3 ) ] .", "label": "", "metadata": {}, "score": "56.664078"}
{"text": "View Article .Thase ME , Entsuah AR , Rudolph RL : Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors .Br J Psychiatry 2001 , 178 : 234 - 241 .", "label": "", "metadata": {}, "score": "56.765076"}
{"text": "Absolute values of 5-HIAA and tryptamine were similar for both groups , during the baseline and again with carbidopa .These results after carbidopa are compatible with a central catecholaminergic deficit in bipolar depressives and the use of urinary MHPG as an index of CNS catecholamine function .", "label": "", "metadata": {}, "score": "56.82022"}
{"text": "PubMed .Young AH , McElroy SL , Olausson B , Paulsson B : A randomised , placebo - controlled 52-week trial of continued quetiapine treatment in recently depressed patients with bipolar I and bipolar II disorder .", "label": "", "metadata": {}, "score": "56.83735"}
{"text": "The dosage of quetiapine XR ranged from 50 to 300 mg / day .Table 1 shows the main characteristics of included studies .Table 1 .", "label": "", "metadata": {}, "score": "56.892982"}
{"text": "Higher cortisol levels were found to predict depressed mood 3 days after blood sampling , higher urinary dopamine predicted a manic mood 3 days after blood sampling , urinary norepinephrine was associated with severity of current mood and prolactin was lower with concurrent depressed mood .", "label": "", "metadata": {}, "score": "56.913284"}
{"text": "Sachs G , Chengappa KN , Suppes T , et al .Quetiapine with lithium or divalproex for the treatment of bipolar mania : a randomized , double - blind , placebo - controlled study .", "label": "", "metadata": {}, "score": "56.971924"}
{"text": "This finding extends data suggesting that unmedicated unipolar and bipolar depressed patients have a ' hyperresponsive ' noradrenergic system and provides a framework which ties together plasma and urinary findings .", "label": "", "metadata": {}, "score": "57.065334"}
{"text": "If you suddenly stop taking quetiapine fumarate tablets , you may have side effects such as trouble sleeping or trouble staying asleep ( insomnia ) , nausea , and vomiting .", "label": "", "metadata": {}, "score": "57.080597"}
{"text": "Bauer M , Tharmanathan P , Volz HP , Moeller HJ , Freemantle N : The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression : a meta - analysis .", "label": "", "metadata": {}, "score": "57.08194"}
{"text": "Adverse events included dry mouth , somnolence , sedation , headache , and dizziness .CONCLUSIONS : In patients with GAD and an inadequate response to SSRI / SNRIs , adjunctive quetiapine XR did not show a statistically significant effect for the primary endpoint at week 8 , although some secondary endpoints were statistically significant vs placebo .", "label": "", "metadata": {}, "score": "57.109665"}
{"text": "Active Comparator : Seroquel \u00ae .Seroquel \u00ae ( Quetiapine Fumarate )Tablets 25 mg of M / s AstraZeneca Pharmaceuticals LP , USA .Intervention : Drug : Quetiapine Fumarate .", "label": "", "metadata": {}, "score": "57.148697"}
{"text": "PubMed .Cutler AJ , Montgomery SA , Feifel D , Lazarus A , Astrom M , Brecher M : Extended release quetiapine fumarate monotherapy in major depressive disorder : a placebo- and duloxetine - controlled study .", "label": "", "metadata": {}, "score": "57.150436"}
{"text": "Conclusion .A rapid sensitive and specific method for the determination of quetiapine fumarate in the pharmaceutical formulations has been developed using lamotrogine as the internal standard .", "label": "", "metadata": {}, "score": "57.17153"}
{"text": "Increases in weight have been observed in clinical trials .Patients receiving quetiapine should receive regular monitoring of weight .The mean change in body weight in the schizophrenia trial was 2 kg in the quetiapine group and -0.4 kg in the placebo group and in the bipolar mania trial it was 1.7 kg in the quetiapine group and 0.4 kg in the placebo group .", "label": "", "metadata": {}, "score": "57.22328"}
{"text": "Thase ME , Macfadden W , Weisler RH , Chang W , Paulsson B , Khan A , Calabrese JR : Efficacy of quetiapine monotherapy in bipolar I and II depression : a double - blind , placebo - controlled study ( the BOLDER II study ) .", "label": "", "metadata": {}, "score": "57.312485"}
{"text": "Atypical antipsychotic drugs have been associated with metabolic changes that include hyperglycemia / diabetes mellitus , dyslipidemia , and body weight gain .While all of the drugs in the class have been shown to produce some metabolic changes , each drug has its own specific risk profile .", "label": "", "metadata": {}, "score": "57.321995"}
{"text": "However , topical and rectal formulations have been produced in compounding pharmacies .There is no data available suggesting that topical or rectal formulations provide serum levels similar to oral medication .", "label": "", "metadata": {}, "score": "57.401077"}
{"text": "Yatham LN , Paulsson B , Mullen J , et al .Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania .", "label": "", "metadata": {}, "score": "57.473232"}
{"text": "PubMed View Article .Sanford M , Keating GM : Quetiapine : a review of its use in the management of bipolar depression .CNS Drugs 2012 , 26 ( 5 ) : 435 - 460 .", "label": "", "metadata": {}, "score": "57.482925"}
{"text": "Ahlfors UG , Baastrup PC , Dencker SJ , et al .Flupenthixol decanoate in recurrent manic - depressive illness .A comparison with lithium .", "label": "", "metadata": {}, "score": "57.519146"}
{"text": "He is a Lead Investigator for EMBOLDEN Study ( AstraZeneca ) , BCI Neuroplasticity study , and Aripiprazole Mania Study .Also , he is an investigator which initiated studies from AZ , Eli Lilly , Wyeth .", "label": "", "metadata": {}, "score": "57.562096"}
{"text": "Thus , understanding molecular influences on PFC function through basic research in animals is essential to rational drug development .In this review , we discuss the molecular signaling events initiated by norepinephrine and dopamine that strengthen working memory function mediated by the dorsolateral PFC under optimal conditions , and weaken working memory function during uncontrollable stress .", "label": "", "metadata": {}, "score": "57.608196"}
{"text": "Horacek J , Bubenikova - Valesova V , Kopecek M , Palenicek T , Dockery C , Mohr P , Hoschl C : Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia .", "label": "", "metadata": {}, "score": "57.62365"}
{"text": "The pooled discontinuation rate due to adverse event was greater in the quetiapine group with an RR ( 95%CI ) of 2.90 ( 1.87 , 4.48 ) .", "label": "", "metadata": {}, "score": "57.638206"}
{"text": "[ 0060 ] Exemplary dopaminergic agents include L - DOPA .[ 0061 ] Exemplary anti - Alzheimer agents include zcetylcholinesterase inhibitors such as donepezil , galantamine , and rivastigmine ; and NMDA antagonists such as memantine .", "label": "", "metadata": {}, "score": "57.63882"}
{"text": "[0048 ] Exemplary vitamins / nutritional agents include retinol and vitamin E. .[ 0049 ] Exemplary emetics include apomorphine .[ 0050 ] Exemplary diuretics include chlorthalidone and spironolactone .", "label": "", "metadata": {}, "score": "57.657345"}
{"text": "The spectrum of quetiapine fumarate extracted from the tablets was matching with that of standard quetiapine fumarate showing the purity of peak of quetiapine fumarate in the tablets .", "label": "", "metadata": {}, "score": "57.676575"}
{"text": "The primary endpoint in both studies was the change from baseline in MADRS score at week 8 .In both studies , quetiapine was superior to placebo in reduction of MADRS score .", "label": "", "metadata": {}, "score": "57.7378"}
{"text": "Currently prescribed or taken with in the last 7 days , medications which have a known interaction with quetiapine or compound the risk of adverse events associated with quetiapine : .", "label": "", "metadata": {}, "score": "57.73933"}
{"text": "Patients repeatedly or severely nonadherent were discontinued at the investigator 's discretion .Concomitant treatment .Chloral hydrate ( 1 g ) , zaleplon ( 20 mg ) , zolpidem tartrate ( 10 mg ) , or zopiclone ( 7.5 mg ) were permitted twice weekly for insomnia up to day 14 ( except before study assessments ) .", "label": "", "metadata": {}, "score": "57.85733"}
{"text": "\" [ Abstract ] .Bakchine S , Lacomblez L , Benoit N , Parisot D , Chain F , Lhermitte F. Manic - like state after bilateral orbitofrontal and right temporoparietal injury : efficacy of clonidine .", "label": "", "metadata": {}, "score": "57.888065"}
{"text": "9 The World Federation of Societies of Biological Psychiatry also includes pregabalin as a first - line option .5 However , for many patients with GAD , initial pharmacotherapy does not lead to remission , 2 and the concept of \" refractory \" or \" treatment - resistant \" GAD has emerged .", "label": "", "metadata": {}, "score": "57.928864"}
{"text": "Breast - feeding or plans to breast - feed .Quetiapine can pass into your breast milk .You and your healthcare provider should decide if you will take quetiapine fumarate tablets or breast - feed .", "label": "", "metadata": {}, "score": "57.970566"}
{"text": "Patient disposition is shown in Figure 1 .A total of 776 ( 35.2 % ) patients with bipolar II depression were included in the ITT population ( 283 , 289 , and 204 patients received quetiapine 300 mg / day , quetiapine 600 mg / day , or placebo , respectively ) .", "label": "", "metadata": {}, "score": "58.002975"}
{"text": "Additional problems with such drugs include that multiple dosing a day often adversely affects patient compliance with the treatment .Accordingly , the present invention provides a controlled - release composition as described below .", "label": "", "metadata": {}, "score": "58.056786"}
{"text": "View Article .Storosum JG , Elferink AJ , van Zwieten BJ , van den Brink W , Gersons BP , van Strik R , Broekmans AW : Short - term efficacy of tricyclic antidepressants revisited : a meta - analytic study .", "label": "", "metadata": {}, "score": "58.104473"}
{"text": "In comparison , the effect sizes in the bipolar I population were also moderate but numerically higher ( 0.58 for quetiapine 300 mg / day and 0.64 for quetiapine 600 mg / day ) .", "label": "", "metadata": {}, "score": "58.125793"}
{"text": "None of the patients who developed mood elevation had received additional adjunctive antidepressant medications to that point .The pattern of improvement was similar in the 2 adjunctive groups when considered separately .", "label": "", "metadata": {}, "score": "58.12752"}
{"text": "Mixed manics met Research Diagnostic Criteria for primary manic episodes and also met criteria for major depressive episodes except for duration .The norepinephrine metabolite methoxyhydroxy phenthylene glycol ( MHPG ) was higher in cerebrospinal fluid from mixed manic than from agitated depressed patients , consistent with differences previously reported between the overall samples of depressed and manic patients .", "label": "", "metadata": {}, "score": "58.16013"}
{"text": "To compare the 24-h cortisol secretion profiles of normal control subjects and patients with bipolar disorder who were in the depressive , manic and euthymic phases of the disorder .", "label": "", "metadata": {}, "score": "58.166256"}
{"text": "Weisler R , Joyce M , McGill L , et al .Extended release quetiapine fumarate monotherapy for major depressive disorder : results of a double - blind , randomized , placebo - controlled study .", "label": "", "metadata": {}, "score": "58.18451"}
{"text": "2013 ) .The analysis was based on 8-week studies and gives an insight into the short - term safety and tolerability of quetiapine in this population .", "label": "", "metadata": {}, "score": "58.208866"}
{"text": "PubMed View Article .Furukawa TA , McGuire H , Barbui C : Meta - analysis of effects and side effects of low dosage tricyclic antidepressants in depression : systematic review .", "label": "", "metadata": {}, "score": "58.224827"}
{"text": "PubMed .Lydiard RB , Culpepper L , Schioler H , Gustafsson U , Paulsson B : Quetiapine monotherapy as treatment for anxiety symptoms in patients with bipolar depression : a pooled analysis of results from 2 double - blind , randomized , placebo - controlled studies .", "label": "", "metadata": {}, "score": "58.290077"}
{"text": "The decision to prescribe atypical antipsychotic medication will depend upon the physician 's assessment of the chronicity and severity of the patient 's symptoms [ see Indications and Usage ( 1.3 ) ] .", "label": "", "metadata": {}, "score": "58.298927"}
{"text": "On average , patients were stabilized for 15 weeks .In the randomization phase , patients continued treatment with lithium or divalproex and were randomized to receive either quetiapine ( administered twice daily totaling 400 mg / day to 800 mg / day ) or placebo .", "label": "", "metadata": {}, "score": "58.34879"}
{"text": "Recommended Dosing .The recommended initial dose , titration , dose range and maximum quetiapine fumarate tablets dose for each approved indication is displayed in Table 1 .", "label": "", "metadata": {}, "score": "58.38555"}
{"text": "Observational studies suggest that , similar to atypical antipsychotic drugs , treatment with conventional antipsychotic drugs may increase mortality .The extent to which the findings of increased mortality in observational studies may be attributed to the antipsychotic drug as opposed to some characteristic(s ) of the patients is not clear .", "label": "", "metadata": {}, "score": "58.387413"}
{"text": "Examples of successful translation from animals to humans include guanfacine for the treatment of ADHD and related PFC disorders , and prazosin for the treatment of PTSD .", "label": "", "metadata": {}, "score": "58.451958"}
{"text": "PubMed .Mallinckrodt CH , Prakash A , Andorn AC , Watkin JG , Wohlreich MM : Duloxetine for the treatment of major depressive disorder : a closer look at efficacy and safety data across the approved dose range .", "label": "", "metadata": {}, "score": "58.465454"}
{"text": "WARNINGS AND PRECAUTIONS .Cerebrovascular Adverse Reactions : Increased incidence of cerebrovascular adverse events ( e.g. , stroke , transient ischemic attack ) has been seen in elderly patients with dementia - related psychoses treated with atypical antipsychotic drugs ( 5.3 ) .", "label": "", "metadata": {}, "score": "58.5339"}
{"text": "5.6 Tardive Dyskinesia .A syndrome of potentially irreversible , involuntary , dyskinetic movements may develop in patients treated with antipsychotic drugs , including quetiapine .", "label": "", "metadata": {}, "score": "58.62741"}
{"text": "PubMed View Article .Beasley CM Jr , Nilsson ME , Koke SC , Gonzales JS : Efficacy , adverse events , and treatment discontinuations in fluoxetine clinical studies of major depression : a meta - analysis of the 20-mg / day dose .", "label": "", "metadata": {}, "score": "58.631943"}
{"text": "Levels in CSF of homovanillic acid and 5-hydroxyindoleacetic acid did not correlate with severity or with change during lithium carbonate treatment .Responders ( about 70 % of the patients ) did not differ from nonresponders in pretreatment mania ratings or neurotransmitter measures .", "label": "", "metadata": {}, "score": "58.686207"}
{"text": "Across all analyses , the lower dose was as effective as the higher dose in patients with bipolar II disorder and tended to be associated with lower reports of adverse events .", "label": "", "metadata": {}, "score": "58.720413"}
{"text": "Cutler AJ , Montgomery SA , Feifel D , et al .Extended release quetiapine fumarate monotherapy in major depressive disorder : a placebo- and duloxetine- controlled study .", "label": "", "metadata": {}, "score": "58.721535"}
{"text": "Expert opinion : Lurasidone 's simplicity of use and favorable metabolic profile are distinct advantages relative to several other agents ( e.g. , olanzapine ) .", "label": "", "metadata": {}, "score": "58.75164"}
{"text": "PubMed .Cruz N , Sanchez - Moreno J , Torres F , Goikolea JM , Valenti M , Vieta E : Efficacy of modern antipsychotics in placebo - controlled trials in bipolar depression : a meta - analysis .", "label": "", "metadata": {}, "score": "58.770523"}
{"text": "Two different stock solutions of quetiapine fumarate working standard and lamotrogine ( internal standard ) were prepared by dissolving accurately weighed 10 mg of drug in 10 mL of acetonitrile , so that final concentration is 1 mg/1 mL. The prepared stock solution is stored in 4 \u00b0 C protected from light .", "label": "", "metadata": {}, "score": "58.880753"}
{"text": "PubMed View Article .Pre - publication history .Copyright .\u00a9 Maneeton et al . ; licensee BioMed Central Ltd. 2012 .This article is published under license to BioMed Central Ltd. Extended - release quetiapine fumarate ( quetiapine XR ) as adjunctive therapy in patients with generalized anxiety disorder and a history of inadequate treatment response : A randomized , double - blind study .", "label": "", "metadata": {}, "score": "59.025997"}
{"text": "Patients who develop symptoms of hyperglycemia during treatment with atypical antipsychotics should undergo fasting blood glucose testing .In some cases , hyperglycemia has resolved when the atypical antipsychotic was discontinued ; however , some patients required continuation of anti - diabetic treatment despite discontinuation of the suspect drug .", "label": "", "metadata": {}, "score": "59.03251"}
{"text": "Entsuah AR , Rudolph RL , Chitra R : Effectiveness of venlafaxine treatment in a broad spectrum of depressed patients : a meta - analysis .", "label": "", "metadata": {}, "score": "59.11042"}
{"text": "One example of the active agent is quetiapine or quetiapine fumarate .Quetiapine fumarate has an aqueous solubility of 3.29 mg / ml at 25 \u00b0 C. , specifically at a pH of about 7 .", "label": "", "metadata": {}, "score": "59.115833"}
{"text": "0044 ] Exemplary antibiotics include aminoglycosides , ansamycins , cephalosporins , glycopeptides , macrolides , and penicillins ; and antifungal include econazole , terconazole , fluconazole , voriconazole , and griseofulvin .", "label": "", "metadata": {}, "score": "59.15252"}
{"text": "PubMed .Thase ME , Jonas A , Khan A , Bowden CL , Wu X , McQuade RD , Carson WH , Marcus RN , Owen R : Aripiprazole monotherapy in nonpsychotic bipolar I depression : results of 2 randomized , placebo - controlled studies .", "label": "", "metadata": {}, "score": "59.190926"}
{"text": "There were differences in absolute risk of suicidality across the different indications , with the highest incidence in MDD .The risk differences ( drug vs. placebo ) , however , were relatively stable within age strata and across indications .", "label": "", "metadata": {}, "score": "59.239693"}
{"text": "The mean change in fasting glucose from baseline was 3.2 mg / dL and mean change in 2 hour glucose from baseline was -1.8 mg / dL for quetiapine .", "label": "", "metadata": {}, "score": "59.414112"}
{"text": "Conditions that lower the seizure threshold may be more prevalent in a population of 65 years or older .5.13 Hypothyroidism .Adults : Clinical trials with quetiapine demonstrated dose - related decreases in thyroid hormone levels .", "label": "", "metadata": {}, "score": "59.415123"}
{"text": "Up to 31 % of MDD patients may have insomnia [ 48 ] .In addition , insomnia is a common adverse effect of many antidepressants , e.g. , SSRIs [ 49 ] and SNRIs [ 50 ] .", "label": "", "metadata": {}, "score": "59.49573"}
{"text": "Liebowitz M , Lam RW , Lepola U , Datto C , Sweitzer D , Eriksson H : Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder : a randomized , placebo - controlled trial .", "label": "", "metadata": {}, "score": "59.542297"}
{"text": "Medication treatment for both pediatric schizophrenia and bipolar I disorder is indicated as part of a total treatment program that often includes psychological , educational and social interventions .", "label": "", "metadata": {}, "score": "59.625572"}
{"text": "PubMed View Article .Furukawa T , McGuire H , Barbui C : Low dosage tricyclic antidepressants for depression .Cochrane Database Syst Rev 2003 , ( 3 ) :", "label": "", "metadata": {}, "score": "59.690506"}
{"text": "In bipolar depression trials , somnolence was reported in 57 % ( 398/698 ) of patients on quetiapine compared to 15 % ( 51/347 ) of placebo patients .", "label": "", "metadata": {}, "score": "59.729828"}
{"text": "( 2C ) and 5-HT(2C ) receptor subtypes .It has demonstrated efficacy in fixed - dose studies across a variable dose range ( i.e. , 40 - 160 mg ) , with a recommended starting dose of 40 mg and a maximum recommended dose of 80 mg .", "label": "", "metadata": {}, "score": "59.798912"}
{"text": "Dysphoric mania with atypical features may be induced by mirtazapine , providing support for a common hypothesis such as ' central norepinephrine hyperactivity ' as the basis for development of mania with mirtazapine .", "label": "", "metadata": {}, "score": "59.8631"}
{"text": "In general , reported signs and symptoms were those resulting from an exaggeration of the drug 's known pharmacological effects , i.e. , drowsiness and sedation , tachycardia and hypotension .", "label": "", "metadata": {}, "score": "59.870705"}
{"text": "Antipsychotics .Vaughan Williams Class IA , IB , IC , III antiarrhythmics .Anti - infective agents ( excluding topical agents , oral penicillins , oral cephalosporins ) .", "label": "", "metadata": {}, "score": "59.88571"}
{"text": "PubMed .Mallinckrodt CH , Watkin JG , Liu C , Wohlreich MM , Raskin J : Duloxetine in the treatment of Major Depressive Disorder : a comparison of efficacy in patients with and without melancholic features .", "label": "", "metadata": {}, "score": "59.92357"}
{"text": "The only adverse event to increase in frequency was dry mouth ( absolute increase of 2.9 % ) .At the safety / tolerability endpoint , 2/39 ( 5.1 % ) patients developed syndromal and 2/39 ( 5.1 % ) developed subsyndromal mood elevation .", "label": "", "metadata": {}, "score": "59.93705"}
{"text": "Severity of the core manic syndrome , anxiety , and hostility correlated with 24-hour urinary excretion of epinephrine relative to its metabolites , but only weakly with norepinephrine .", "label": "", "metadata": {}, "score": "59.9707"}
{"text": "The proportions of patients who continued combination therapy with or without adding additional subsequent psychotropic medication(s ) were assessed .Information about the time of and reason(s ) for discontinuing combination therapy and adding subsequent psychotropic medication(s ) was recorded .", "label": "", "metadata": {}, "score": "60.012726"}
{"text": "Specificity was determined from blank ( Figure 5 ) , zero blank ( Figure 6 ) , and sample containing both internal standard and drug ( Figure 7 ) .", "label": "", "metadata": {}, "score": "60.02137"}
{"text": "Adjunct therapy is defined as the simultaneous initiation or subsequent administration of quetiapine with lithium or divalproex .The efficacy of quetiapine in the acute treatment of bipolar mania was established in 2 placebo - controlled trials .", "label": "", "metadata": {}, "score": "60.0524"}
{"text": "In the mania adjunct studies , where quetiapine was added to lithium or divalproex , 12 % ( 24/196 ) of quetiapine treated patients compared to 7 % ( 15/203 ) of placebo - treated patients had elevated TSH levels .", "label": "", "metadata": {}, "score": "60.312218"}
{"text": "Studies of similar phenomena in animals show comparable effects of catecholamines on sensory processing , both behaviorally and at the single neuron level .In this study , gating of auditory evoked potentials ( EPs ) during treatment of both illnesses was compared with plasma dopamine and norepinephrine metabolites .", "label": "", "metadata": {}, "score": "60.354607"}
{"text": "10 , 11 Benzodiazepines may be used for short - term ( 2 to 4 weeks ) therapy , 4 , 7 second - line treatment , 6 or treatment - resistant cases .", "label": "", "metadata": {}, "score": "60.35556"}
{"text": "Quetiapine fumarate tablets of 200 mg and 300 mg strength from two different manufacturers were evaluated for the amount of quetiapine fumarate .The amount of quetiapine fumarate in tablet 1 is 98.49 \u00b1 0.36 and tablet 2 is 98.59 \u00b1 0.35 ( Table 10 ) .", "label": "", "metadata": {}, "score": "60.44378"}
{"text": "The present controlled - release composition can provide for an increased duration of the active agent action , permitting for example , once - daily or twice - daily dosing .", "label": "", "metadata": {}, "score": "60.479786"}
{"text": "In these studies , no additional benefit was seen with the 600 mg dose .For the 300 mg dose group , statistically significant improvements over placebo were seen in overall quality of life and satisfaction related to various areas of functioning , as measured using the Q - LES - Q(SF ) .", "label": "", "metadata": {}, "score": "60.502872"}
{"text": "In other embodiments , an in vivo pharmacokinetic study is performed only for a particular strength of the active agent controlled - release composition of the present invention which is an equivalent strength to the reference listed drug product for the brand .", "label": "", "metadata": {}, "score": "60.52525"}
{"text": "17 In contrast to antidepressants , 18 atypical antipsychotics do not appear to increase the risk of treatment - emergent affective switch .Among the atypical antipsychotics , quetiapine is of particular interest .", "label": "", "metadata": {}, "score": "60.546516"}
{"text": "Study eligible criteria , participants and interventions .Eligible studies were randomized , placebo - controlled trials of quetiapine monotherapy carried out in adults with MDD and presenting endpoint outcomes relevant to : i ) depression severity , ii ) response rate , iii ) overall discontinuation rate , or iv ) discontinuation rate due to adverse events .", "label": "", "metadata": {}, "score": "60.63605"}
{"text": "PubMed View Article .Arroll B , Elley CR , Fishman T , Goodyear - Smith FA , Kenealy T , Blashki G , Kerse N , Macgillivray S : Antidepressants versus placebo for depression in primary care .", "label": "", "metadata": {}, "score": "60.64243"}
{"text": "The rate of anticholinergic medication use to treat emergent EPS for placebo and the five fixed doses was : 14 % ; 11 % ; 10 % ; 8 % ; 12 % and 11 % .", "label": "", "metadata": {}, "score": "60.709995"}
{"text": "Neonates exposed to antipsychotic drugs ( including quetiapine ) , during the third trimester of pregnancy are at risk for extrapyramidal and/or withdrawal symptoms following delivery .", "label": "", "metadata": {}, "score": "60.774307"}
{"text": "Patients with schizophrenia - related depressions also excreted reduced levels of MHPG when compared with patients with unipolar nonendogenous depressions .Moreover , levels of urinary epinephrine and metanephrine were significantly lower in patients with schizophrenia - related depressions .", "label": "", "metadata": {}, "score": "60.90354"}
{"text": "Lancet 2009 , 373 ( 9665 ) : 746 - 758 .PubMed View Article .Nutt DJ : The role of dopamine and norepinephrine in depression and antidepressant treatment .", "label": "", "metadata": {}, "score": "60.926697"}
{"text": "Bipolar I disorder , manic or mixed episodes Adults The efficacy of quetiapine in the acute treatment of manic episodes was established in 3 placebo - controlled trials in patients who met DSM - IV criteria for bipolar I disorder with manic episodes .", "label": "", "metadata": {}, "score": "60.950336"}
{"text": "SNRI Duloxetine Mean dose b Treatment duration ( days ) c Venlafaxine Mean dose b Treatment duration ( days ) c .a All patients in the MITT population received an SSRI / SNRI ; one patient received escitalopram and venlafaxine prior to and at randomization .", "label": "", "metadata": {}, "score": "61.021324"}
{"text": "At the safety / tolerability endpoint , the mean dose of each drug was lower in the group that used it adjunctively .Effectiveness .Change in mood status .", "label": "", "metadata": {}, "score": "61.026394"}
{"text": "At week 1 , concomitant sleep medication was used by 10.0 % and 12.5 % of patients in the quetiapine XR and placebo + SSRI / SNRI groups , respectively ; this level of use remained consistent throughout the randomized period .", "label": "", "metadata": {}, "score": "61.085335"}
{"text": "Slow changes in mood , motor activity , sleep , and urinary norepinephrine levels during the course of each depressed and manic episode are reported , as well as rapid alterations in many variables at the time of mood switch .", "label": "", "metadata": {}, "score": "61.092316"}
{"text": "The management of NMS should include : 1 ) immediate discontinuation of antipsychotic drugs and other drugs not essential to concurrent therapy ; 2 ) intensive symptomatic treatment and medical monitoring ; and 3 ) treatment of any concomitant serious medical problems for which specific treatments are available .", "label": "", "metadata": {}, "score": "61.137653"}
{"text": "0105 ] In some embodiments a single dose pharmacokinetic study is performed under non - fasted or fasted conditions .[ 0106 ]In other embodiments , the single dose pharmacokinetic study is conducted between the controlled - release composition and the reference listed drug using the strength specified by the FDA in APPROVED DRUG PRODUCTS WITH THERAPEUTIC EQUIVALENCE EVALUATIONS ( ORANGE BOOK ) .", "label": "", "metadata": {}, "score": "61.170074"}
{"text": "Bowden CL , Calabrese JR , Sachs G , et al .A placebo - controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder .", "label": "", "metadata": {}, "score": "61.181953"}
{"text": "Neither clinical studies nor epidemiologic studies conducted to date have shown an association between chronic administration of this class of drugs and tumorigenesis in humans , but the available evidence is too limited to be conclusive [ see Nonclinical Toxicology ( 13.1 ) ] .", "label": "", "metadata": {}, "score": "61.18974"}
{"text": "Before you take quetiapine fumarate tablets , tell your healthcare provider if you have or have had : . diabetes or high blood sugar in you or your family .", "label": "", "metadata": {}, "score": "61.194153"}
{"text": "Although average weight gain was only about 1 kg greater in the two groups receiving quetiapine , the proportions of patients in both arms gaining at least 7 % body weight was higher in both quetiapine arms ( Table 4 ) .", "label": "", "metadata": {}, "score": "61.31391"}
{"text": "Similarly , a meta - analysis of 7 RCTs found that the response rates of bupropion and SSRIs treatment in MDD patients were 62 and 63 % , respectively , compared with 51 % for placebo [ 40 ] .", "label": "", "metadata": {}, "score": "61.40587"}
{"text": "Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder : a randomized , placebo - controlled trial .Depress Anxiety .", "label": "", "metadata": {}, "score": "61.437183"}
{"text": "581 - 585 , 2007 .View at Publisher \u00b7 View at Google Scholar .J. Sachse , J. K\u00f6ller , S. H\u00e4rtter , and C. Hiemke , \" Automated analysis of quetiapine and other antipsychotic drugs in human blood by high performance - liquid chromatography with column - switching and spectrophotometric detection , \" Journal of Chromatography B , vol .", "label": "", "metadata": {}, "score": "61.470444"}
{"text": "Commonly Observed Adverse Reactions in Short - Term , Placebo - Controlled Trials .Adverse events that were potentially dose - related with higher frequency in the 800 mg group compared to the 400 mg group included dizziness ( 8 % vs. 15 % ) , dry mouth ( 4 % vs. 10 % ) , and tachycardia ( 6 % vs. 11 % ) .", "label": "", "metadata": {}, "score": "61.606384"}
{"text": "Mean increases in heart rate were 12.8 bpm and 13.4 bpm for quetiapine 400 mg and 600 mg groups , respectively , compared to a decrease of 1.7 bpm in the placebo group [ see Warnings and Precautions ( 5.7 ) ] .", "label": "", "metadata": {}, "score": "61.723526"}
{"text": "Do not use quetiapine fumarate tablets for a condition for which it was not prescribed .Do not give quetiapine fumarate tablets to other people , even if they have the same symptoms you have .", "label": "", "metadata": {}, "score": "61.80928"}
{"text": "Changes in body weight and body mass index ( BMI ) from baseline to the safety / tolerability endpoint ( the last visit at which the patient was taking lamotrigine plus quetiapine ) also were assessed .", "label": "", "metadata": {}, "score": "61.821213"}
{"text": "Sustained administration of hQuet for 2 and 14 days , respectively , significantly enhanced the firing rate of norepinephrine ( NE ) neurons by blocking the cell body ? ?", "label": "", "metadata": {}, "score": "61.916176"}
{"text": "Eight of the patients had mixed states : concurrent manic and depressive syndromes .There were no differences between mixed and pure manic patients with respect to catecholamine or metabolite excretion or precursor / product ratios , but mixed manic patients tended to have higher excretion of norepinephrine and had increased variance with respect to catecholamine measures .", "label": "", "metadata": {}, "score": "62.015366"}
{"text": "Patient population .Only patients with bipolar II disorder were included in the current analysis .Current antipsychotic , antidepressant , and mood - stabilizing medications were discontinued in a washout period of at least 5 to 28 days .", "label": "", "metadata": {}, "score": "62.07586"}
{"text": "PubMed .Calabrese JR , Huffman RF , White RL , Edwards S , Thompson TR , Ascher JA , Monaghan ET , Leadbetter RA : Lamotrigine in the acute treatment of bipolar depression : results of five double - blind , placebo - controlled clinical trials .", "label": "", "metadata": {}, "score": "62.109386"}
{"text": "It is generally believed ( though not established in controlled trials ) that treating such an episode with an antidepressant alone may increase the likelihood of precipitation of a mixed / manic episode in patients at risk for bipolar disorder .", "label": "", "metadata": {}, "score": "62.1099"}
{"text": "Papakostas GI , Fava M : A metaanalysis of clinical trials comparing moclobemide with selective serotonin reuptake inhibitors for the treatment of major depressive disorder .", "label": "", "metadata": {}, "score": "62.163174"}
{"text": "Conclusions .Based on the limited evidence obtained from three RCTs , quetiapine XR is effective for adult patients with MDD .The high dropout rate due to adverse events suggests that some MDD patients may not be able to tolerate quetiapine XR .", "label": "", "metadata": {}, "score": "62.187744"}
{"text": "Similarly , the cited frequencies can not be compared with figures obtained from other clinical investigations involving different treatments , uses , and investigators .The cited figures , however , do provide the prescribing physician with some basis for estimating the relative contribution of drug and nondrug factors to the side effect incidence in the population studied .", "label": "", "metadata": {}, "score": "62.25943"}
{"text": "The problem of the placebo response in clinical trials for psychiatric disorders : culprits , possible remedies , and a novel study design approach .Psychother Psychosom .", "label": "", "metadata": {}, "score": "62.272842"}
{"text": "One case , involving an estimated overdose of 9600 mg , was associated with hypokalemia and first degree heart block .In postmarketing experience , there were cases reported of QT prolongation with overdose .", "label": "", "metadata": {}, "score": "62.27513"}
{"text": "Thus , similar neurophysiological deficits in the two psychoses are associated with different biochemical abnormalities , which may explain similarities in acute symptoms and differences in other aspects of the illnesses , such as their response to treatment .", "label": "", "metadata": {}, "score": "62.331802"}
{"text": "Intervention ICMJE .Drug : Quetiapine Fumarate Tablets 25 mg .25 mg tablet once a day .Other Name : Test Product .Drug : Quetiapine Fumarate .", "label": "", "metadata": {}, "score": "62.409233"}
{"text": "View Article .Brecht S , Kajdasz D , Ball S , Thase ME : Clinical impact of duloxetine treatment on sleep in patients with major depressive disorder .", "label": "", "metadata": {}, "score": "62.61973"}
{"text": "146 - 154 , 2010 .View at Google Scholar .V. G. Prasanth , S. C. Eapan , S. V. Kutti , and T. S. Jyothi , \" Development and validation of Quetiapine fumarate in pure and pharmaceutical formulation by UV - Spectrophotometric method , \" Der Pharmacia Sinica , vol .", "label": "", "metadata": {}, "score": "62.638382"}
{"text": "and second - generation antipsychotics have shown analgesic properties both in an experimental setting and in humans , although most of the available evidence for the treatment of human pain concerns older antipsychotics and involves clinical trials performed several decades ago .", "label": "", "metadata": {}, "score": "62.65824"}
{"text": "The effect sizes in the bipolar I population in the four trials were 0.58 for quetiapine 300 mg / day and 0.64 for quetiapine 600 mg / day ( Figure 3 ) .", "label": "", "metadata": {}, "score": "62.66442"}
{"text": "4545 - 4550 , 2009 .M. A. Saracino , L. Mercolini , G. Flotta , L. J. Albers , R. Merli , and M. A. Raggi , \" Simultaneous determination of fluvoxamine isomers and quetiapine in human plasma by means of high - performance liquid chromatography , \" Journal of Chromatography B , vol .", "label": "", "metadata": {}, "score": "62.717644"}
{"text": "024- 031 , 2010 .View at Google Scholar .S. R. Dhaneshwar , N. G. Patre , and M. V. Mahadik , \" Stability - indicating HPTLC method for quantitation of quetiapine fumarate in the pharmaceutical dosage form , \" Acta Chromatographica , vol .", "label": "", "metadata": {}, "score": "62.90547"}
{"text": "2003 Dec;36 Suppl 3:215 - 21 .\" The efficacy resulting from adjunctive use of supraphysiological doses of levothyroxine has emerged as a promising approach to therapy and prophylaxis for refractory mood disorders .", "label": "", "metadata": {}, "score": "62.929962"}
{"text": "Take quetiapine fumarate tablets exactly as your healthcare provider tells you to take it .Do not change the dose yourself .Take quetiapine fumarate tablets by mouth , with or without food .", "label": "", "metadata": {}, "score": "62.93474"}
{"text": "Of these trials , 2 were monotherapy ( 12 weeks ) and 1 was adjunct therapy ( 3 weeks ) to either lithium or divalproex .", "label": "", "metadata": {}, "score": "62.974823"}
{"text": "2005 ; Weisler et al .2011 ) .However , patients with bipolar II disorder are thought to be more sensitive to side effects than bipolar I disorder patients .", "label": "", "metadata": {}, "score": "62.993866"}
{"text": "Symptoms such as these may be associated with an increased risk for suicidal thinking and behavior and indicate a need for very close monitoring and possibly changes in the medication [ s ee Warnings and Precautions ( 5.2 ) ] .", "label": "", "metadata": {}, "score": "63.063118"}
{"text": "Tignol J , Stoker MJ , Dunbar GC : Paroxetine in the treatment of melancholia and severe depression .Int Clin Psychopharmacol 1992 , 7 ( 2 ) : 91 - 94 .", "label": "", "metadata": {}, "score": "63.18253"}
{"text": "The chromatographic separation of quetiapine fumarate ( drug ) and lamotrogine ( ISTD ) was carried out using GRACE Genesis C18 column ( 50 \u00d7 4.6 mm ID , 3 \u03bc m ) .", "label": "", "metadata": {}, "score": "63.191616"}
{"text": "Cardiovascular monitoring should commence immediately and should include continuous electrocardiographic monitoring to detect possible arrhythmias .If antiarrhythmic therapy is administered , disopyramide , procainamide and quinidine carry a theoretical hazard of additive QT - prolonging effects when administered in patients with acute overdosage of quetiapine .", "label": "", "metadata": {}, "score": "63.213486"}
{"text": "\" [ Abstract ] .Deleon - Jones F , Maas JW , Dekirmenjian H , Sanchez J. Diagnostic subgroups of affective disorders and their urinary excretion of catecholamine metabolities .", "label": "", "metadata": {}, "score": "63.215023"}
{"text": "Data analysis was performed on paced rhythms and VTs induced by norepinephrine ( NE ) .Endocardial and epicardial origins of paced beats were successfully predicted in 72 % and 86 % of cases , respectively , during left ventricular pacing .", "label": "", "metadata": {}, "score": "63.261578"}
{"text": "2008 ) .Overall , there were changes in some glucose and lipid parameters and increases in weight with quetiapine , which were consistent with previous observations ( Calabrese et al .", "label": "", "metadata": {}, "score": "63.36464"}
{"text": "The continuation phase of the EMBOLDEN studies included 231 patients with bipolar II depression who received quetiapine for 26 to 52 weeks and is one of the largest bipolar II patient populations studied in a continuation phase trial ( Young et al .", "label": "", "metadata": {}, "score": "63.44405"}
{"text": "The improvements during quetiapine treatment were observed at week 1 and were sustained up to week 8 .Significant improvements in 9 and 8 of the 10 MADRS individual items were apparent with quetiapine 300 and 600 mg / day , respectively , indicating the efficacy of quetiapine over a broad range of depressive symptoms .", "label": "", "metadata": {}, "score": "63.51703"}
{"text": "Whether antipsychotic drug products differ in their potential to cause tardive dyskinesia is unknown .The risk of developing tardive dyskinesia and the likelihood that it will become irreversible are believed to increase as the duration of treatment and the total cumulative dose of antipsychotic drugs administered to the patient increase .", "label": "", "metadata": {}, "score": "63.541138"}
{"text": "Drug - related effects included decreases in matings and in matings resulting in pregnancy , and an increase in the interval to mate .An increase in irregular estrus cycles was observed at doses of 10 and 50 mg / kg , or approximately 0.1 and 1 times the MRHD of 800 mg / day on mg / m 2 body surface area .", "label": "", "metadata": {}, "score": "63.724426"}
{"text": "Rickels K , Rynn M , Iyengar M , et al .Remission of generalized anxiety disorder : a review of the paroxetine clinical trials database .", "label": "", "metadata": {}, "score": "63.770813"}
{"text": "Serotonin reuptake which constitutes the cornerstone in unipolar depression treatment does not seem to play a significant role for bipolar depression .Our exhaustive review is compatible with a complex model with multiple levels of interaction between the major neurotransmitter systems without a single target being either necessary or sufficient to elicit the antidepressant effect in bipolar depression .", "label": "", "metadata": {}, "score": "63.90522"}
{"text": "16In all 5 studies the overall tolerability and safety results among quetiapine XR - treated patients were consistent with the known profile of quetiapine .", "label": "", "metadata": {}, "score": "63.940144"}
{"text": "Adults : During clinical trials with quetiapine , the incidence of shifts in prolactin levels to a clinically significant value occurred in 3.6 % ( 158/4416 ) of patients treated with quetiapine compared to 2.6 % ( 51/1968 ) on placebo .", "label": "", "metadata": {}, "score": "63.970856"}
{"text": "Moreover , lurasidone 's efficacy in bipolar depression is awaited to determine whether this agent can be considered as a treatment alternative for depressive symptoms in adults with bipolar disorder .", "label": "", "metadata": {}, "score": "64.01486"}
{"text": "2011 Dec;17(6):723 - 32 .Even though noradrenaline has been recognized as one of the key neurotransmitters in the pathophysiology of major depression ( MD ) , noradrenergic compounds have been less extensively utilized in clinical practice , compared to selective serotonin reuptake inhibitors ( SSRIs ) .", "label": "", "metadata": {}, "score": "64.03606"}
{"text": "These symptoms usually get better 1 week after you start having them .General information about the safe and effective use of quetiapine fumarate tablets .", "label": "", "metadata": {}, "score": "64.03621"}
{"text": "Quetiapine fumarate tablets may cause serious side effects , including : . 1 risk of death in the elderly with dementia .Medicines like quetiapine fumarate tablets can increase the risk of death in elderly people who have memory loss ( dementia ) .", "label": "", "metadata": {}, "score": "64.08364"}
{"text": "The incidence of the individual adverse events ( i.e. , insomnia , nausea , headache , diarrhea , vomiting , dizziness and irritability ) did not exceed 5.3 % in any treatment group and usually resolved after 1 week post - discontinuation .", "label": "", "metadata": {}, "score": "64.088356"}
{"text": "Treatment .Following placebo run - in , patients were randomized ( 1:1 ratio using a computer - based system to generate the randomization list ) to quetiapine XR + SSRI / SNRI or placebo + SSRI / SNRI for 8 weeks .", "label": "", "metadata": {}, "score": "64.14459"}
{"text": "World J Biol Psychiatry 2010 , 11 ( 2):81 - 109 .PubMed .Gustafsson U , Fajutrao L : Effect of quetiapine on functioning and quality of life in bipolar depression [ abstract].", "label": "", "metadata": {}, "score": "64.18195"}
{"text": "8.4 Pediatric Use .In general , the adverse reactions observed in children and adolescents during the clinical trials were similar to those in the adult population with few exceptions .", "label": "", "metadata": {}, "score": "64.251854"}
{"text": "Adjunctive lamotrigine .CGI - S : Clinical Global Impression - Severity ; CI : 95 % confidence interval ; GAF : Global Assessment of Functioning .", "label": "", "metadata": {}, "score": "64.31285"}
{"text": "357 - 362 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .R. Mandrioli , S. Fanali , A. Ferranti , and M. A. Raggi , \" HPLC analysis of the novel antipsychotic drug quetiapine in human plasma , \" Journal of Pharmaceutical and Biomedical Analysis , vol .", "label": "", "metadata": {}, "score": "64.39914"}
{"text": "J Clin Psychiatr 2005 , 66 ( 8) : 974 - 981 .View Article .Machado M , Iskedjian M , Ruiz I , Einarson TR : Remission , dropouts , and adverse drug reaction rates in major depressive disorder : a meta - analysis of head - to - head trials .", "label": "", "metadata": {}, "score": "64.41745"}
{"text": "Vomiting .Sexual dysfunction .TABLE 4 .Weight and BMI at baseline ( immediately prior to starting combination therapy ) and safety/ tolerability endpoint ( last visit taking lamotrigine plus quetiapine ) .", "label": "", "metadata": {}, "score": "64.42761"}
{"text": "5.16 Body Temperature Regulation .Although not reported with quetiapine , disruption of the body 's ability to reduce core body temperature has been attributed to antipsychotic agents .", "label": "", "metadata": {}, "score": "64.44853"}
{"text": "Due to the balance of its efficacy benefit and risk of side effects , as the overall discontinuation rate shown , the acceptability of this agent is not more than placebo .", "label": "", "metadata": {}, "score": "64.60059"}
{"text": "Due to the balance of its efficacy benefit and risk of side effects , as the overall discontinuation rate shown , the acceptability of this agent is not more than placebo .", "label": "", "metadata": {}, "score": "64.60059"}
{"text": "Other Name : Seroquel \u00ae .Study Arm ( s ) .Experimental : Quetiapine Fumarate Tablets 25 mg .Quetiapine Fumarate Tablets 25 mg of M / s Ipca Laboratories Limited , India .", "label": "", "metadata": {}, "score": "64.62188"}
{"text": "Short - term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24 ; there was a reduction with antidepressants compared to placebo in adults aged 65 and older .", "label": "", "metadata": {}, "score": "64.6511"}
{"text": "5.1 Increased Mortality in Elderly Patients with Dementia - Related Psychosis .Elderly patients with dementia - related psychosis treated with antipsychotic drugs are at an increased risk of death .", "label": "", "metadata": {}, "score": "64.65689"}
{"text": "The comparable design of the BOLDER and EMBOLDEN trials facilitated a pooling of the data for patients with bipolar II depression data to increase the power of the statistical analyses .", "label": "", "metadata": {}, "score": "64.682144"}
{"text": "At week 8 , significant reductions in the HAM - A psychic cluster score were seen with quetiapine XR compared with placebo .The anxiolytic effect of quetiapine XR may be translated through the psychic cluster items ( anxious mood , tension , fears , insomnia , intellectual difficulties , depressed mood , and behavior at interview ) .", "label": "", "metadata": {}, "score": "64.79727"}
{"text": "1 Patients with GAD experience impaired functioning , decreased work productivity , and increased healthcare utilization .Published guidelines recommend selective serotonin reuptake inhibitors ( SSRIs ) or serotonin - norepinephrine reuptake inhibitors ( SNRIs ) as first - line treatment for GAD .", "label": "", "metadata": {}, "score": "64.801346"}
{"text": "The enhancement of NE and 5-HT transmission by hQuet may contribute to its antidepressant action in mood disorders .[ PubMed Citation ] [ Order full text from Infotrieve ] .", "label": "", "metadata": {}, "score": "64.84384"}
{"text": "Furthermore , even with multiple administrations of such a drug per day , the blood or plasma concentrations of the active ingredient may still vary with time , i.e. , at certain time points between administrations there are higher concentrations of the active ingredient than at other times .", "label": "", "metadata": {}, "score": "64.90986"}
{"text": "There was a tendency for the pretreatment MHPG excretion to be low in the patients who went on to show a clear - cut antidepressant response to lithium compared to those who were unequivocal non - responders .", "label": "", "metadata": {}, "score": "65.04731"}
{"text": "In the exploratory analysis of the relationship between MADRS total score at baseline and end of treatment , there was an indication that the difference between placebo and both quetiapine doses at end of treatment increased as baseline score increased ( Table 2 ; Figure 4 ) .", "label": "", "metadata": {}, "score": "65.14192"}
{"text": "Nursing Mothers .Quetiapine was excreted into human milk .Because of the potential for serious adverse reactions in nursing infants from quetiapine , a decision should be made whether to discontinue nursing or to discontinue the drug , taking into account the importance of the drug to the mother 's health .", "label": "", "metadata": {}, "score": "65.14327"}
{"text": "Participants .Participants had syndromal or subsyndromal depressive symptoms , as defined in the DSM - IV - TR or STEP - BD , respectively .", "label": "", "metadata": {}, "score": "65.1463"}
{"text": "A total of 320/409 ( 78.2 % ) patients completed the study : 152/209 quetiapine XR - treated and 168/200 placebo - treated patients .Treatment groups were generally well matched with respect to demographic and clinical characteristics at randomization and the SSRI or SNRI used ( TABLE 1 ) .", "label": "", "metadata": {}, "score": "65.14631"}
{"text": "Controlled trials are currently underway to evaluate lurasidone 's efficacy in bipolar depression as well as its procognitive effects in individuals with schizophrenia .Lurasidone is administered once a day with ?", "label": "", "metadata": {}, "score": "65.336876"}
{"text": "Previous meta - analyses found that the remission rates of TCAs , SSRIs , and SNRIs were 44.1 , 37.7 and 31 - 55 % respectively [ 41 ] .", "label": "", "metadata": {}, "score": "65.3939"}
{"text": "Finally , plasma DOPEG levels did not differ in uni or bipolar patients .The present data provides further evidence for a reduced CNS noradrenergic transmission in major depression .", "label": "", "metadata": {}, "score": "65.42316"}
{"text": "Numerically greater decreases in mean weight and BMI were seen in the adjunctive lamotrigine group than in the adjunctive quetiapine group ( mean weight change , 2.7 vs 1.2 lbs ; mean BMI change , 0.44 vs 0.22 kg / m 2 ) .", "label": "", "metadata": {}, "score": "65.55927"}
{"text": "Ketter TA , Nasrallah HA , Fagiolini A .Mood stabilizers and atypical antipsychotics : bimodal treatments for bipolar disorder .Psychopharmacol Bull .Kupfer DJ , Frank E , Grochocinski VJ , et al .", "label": "", "metadata": {}, "score": "65.56375"}
{"text": "Your healthcare provider should check blood pressure in children and adolescents before starting quetiapine fumarate tablets and during therapy .low white blood cell count . cataracts .", "label": "", "metadata": {}, "score": "65.8226"}
{"text": "Lurasidone is not known to adversely affect body composition , anthropometrics , metabolic and/or electrocardiographic parameters .Although prolactin elevation might be observed , prolactin - related adverse events are rarely reported .", "label": "", "metadata": {}, "score": "65.85585"}
{"text": "[0109 ] The controlled - release compositions may be characterized by dissolution properties .In one embodiment , the controlled - release compositions as described herein may exhibit an in vitro dissolution profile substantially corresponding to the pattern for a brand drug or reference listed drug when tested in a particular dissolution medium .", "label": "", "metadata": {}, "score": "65.87861"}
{"text": "Chronic treatment with valproate decreases the hypothermic response to clonidine .Pharmacol Biochem Behav 1993 May;45(1):247 - 9 \" Treatment with lithium ( the prototype of an antimanic agent ) attenuates responsiveness to the alpha 2-agonist clonidine in animal models .", "label": "", "metadata": {}, "score": "65.917984"}
{"text": "[ s ee Warnings and Precautions ( 5.15)].As with other medications , patients should be advised to notify their physicians if they are taking , or plan to take , any prescription or over - the - counter drugs .", "label": "", "metadata": {}, "score": "65.927536"}
{"text": "The final blend for Formulations B and C were compressed into tablets on beta press using 0.36''\u00d70.74 ' ' modified capsule tooling .[0120 ] Formulation CE - A was prepared by wet granulating wherein the wet granulation components include purified water .", "label": "", "metadata": {}, "score": "65.95373"}
{"text": "During acute illness , they have an additional transient hypersensitivity to stimuli , manifested as smaller EPs , which seems to be mediated by dopamine .", "label": "", "metadata": {}, "score": "65.958206"}
{"text": "In addition to the measure of efficacy , the number needed to treat ( NNT ) , the number of patients who must receive a particular therapy for one to benefit , was also calculated .", "label": "", "metadata": {}, "score": "66.06654"}
{"text": "2007 ) .There has been a paucity of evidence regarding the treatment of bipolar II depression , and , in consequence , there are few consensus recommendations for the management of these patients ( Swartz and Thase 2011 ) .", "label": "", "metadata": {}, "score": "66.17613"}
{"text": "Talk to your child 's healthcare provider for more information .It is not known if quetiapine fumarate tablets are safe and effective in children under 10 years of age .", "label": "", "metadata": {}, "score": "66.19441"}
{"text": "The relative risk ( 95 % CI ) for suicidal behavior / ideation and possible suicidal behavior / ideation for quetiapine XR + SSRI / SNRI vs placebo + SSRI / SNRI treatment was .96", "label": "", "metadata": {}, "score": "66.3"}
{"text": "It is unknown whether the suicidality risk extends to longer - term use , i.e. , beyond several months .However , there is substantial evidence from placebo - controlled maintenance trials in adults with depression that the use of antidepressants can delay the recurrence of depression .", "label": "", "metadata": {}, "score": "66.315994"}
{"text": "Over the course of a typical 10-\u00adweek controlled trial , the rate of death in drug - treated patients was about 4.5 % , compared to a rate of about 2.6 % in the placebo group .", "label": "", "metadata": {}, "score": "66.401184"}
{"text": "Safety and tolerability .Adverse events .The overall incidence of AEs was 73.7 % and 60.0 % in the quetiapine XR + SSRI / SNRI and placebo + SSRI / SNRI groups , respectively .", "label": "", "metadata": {}, "score": "66.49663"}
{"text": "Among subgroups , bipolar and unipolar endogenous depression patients had much higher abnormal rates for the DST ( 59 % and 48 % , respectively ) than nonendogenous cases ( 8 % ) .", "label": "", "metadata": {}, "score": "66.523476"}
{"text": "Baldwin DS , Anderson IM , Nutt DJ , et al .Evidence - based guidelines for the pharmacological treatment of anxiety disorders : recommendations from the British Association for Psychopharmacology .", "label": "", "metadata": {}, "score": "66.581726"}
{"text": "-adrenergic receptors on NE terminals .Sustained administration of hQuet for 2 and 14 days , respectively , significantly inhibited the firing rate of 5-HT , whether it was given alone or with a 5-HT reuptake inhibitor , because of the blockade of excitatory ? ?", "label": "", "metadata": {}, "score": "66.59913"}
{"text": "The patterns of the above findings were similar in the 2 adjunctive groups when considered separately .Exclusion of these 8 trials from the analysis of effectiveness did not alter the pattern of the results .", "label": "", "metadata": {}, "score": "66.662476"}
{"text": "Anticholinergics for extrapyramidal symptoms ( EPS ) were permitted except for prophylactic use .Efficacy evaluations .The primary efficacy endpoint was change from randomization to week 8 in HAM - A total score .", "label": "", "metadata": {}, "score": "66.73013"}
{"text": "These data are consistent with findings that have shown abnormal , perhaps excessive , central noradrenergic activity in patients with mania , but not with those suggesting deficits in serotoninergic function .", "label": "", "metadata": {}, "score": "66.75545"}
{"text": "This receptor supersensitivity is not related to an increased amount or enhanced intrinsic activity of G - proteins .The new finding provides functional support to the involvement of alpha(2)-adrenoceptors in the pathogenesis of mood disorders .", "label": "", "metadata": {}, "score": "66.817604"}
{"text": "Compared with controls , no statistically significant differences were found in mean levels of NE , 5-HT , or DA in any brain area of bipolar subjects .", "label": "", "metadata": {}, "score": "66.8802"}
{"text": "PubMed .Young AH , McElroy SL , Bauer M , Philips N , Chang W , Olausson B , Paulsson B , Brecher M : A double - blind , placebo - controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression ( EMBOLDEN I ) .", "label": "", "metadata": {}, "score": "66.901855"}
{"text": "The development of cataracts was observed in association with quetiapine treatment in chronic dog studies [ see Nonclinical Toxicology ( 13.2 ) ] .Lens changes have also been observed in adults , children and adolescents during long - term quetiapine treatment , but a causal relationship to quetiapine use has not been established .", "label": "", "metadata": {}, "score": "66.909515"}
{"text": "83 - 93 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .S. Hillaert , L. Snoeck , and W. Van den Bossche , \" Optimization and validation of a capillary zone electrophoretic method for the simultaneous analysis of four atypical antipsychotics , \" Journal of Chromatography A , vol .", "label": "", "metadata": {}, "score": "66.92342"}
{"text": "Enhancing the technology of clinical trials and the trials model to evaluate newly developed , targeted antidepressants .Neuropsychopharmacology .Brawman - Mintzer O , Knapp RG , Nietert PJ .", "label": "", "metadata": {}, "score": "66.94685"}
{"text": "Somnolence was a commonly reported adverse event reported in patients treated with quetiapine especially during the 3 to 5 day period of initial dose - titration .", "label": "", "metadata": {}, "score": "66.95667"}
{"text": "Among bipolar depressed patients , those with autonomous episodes had elevated excretion of O - methylated catecholamine metabolites and of epinephrine , while those with environment - sensitive episodes had normal excretion of catecholamines and metabolites .", "label": "", "metadata": {}, "score": "67.01899"}
{"text": "In these studies , the incidence of the individual adverse reactions ( akathisia , extrapyramidal disorder , tremor , dyskinesia , dystonia , restlessness , muscle contractions involuntary , psychomotor hyperactivity and muscle rigidity ) were generally low and did not exceed 4 % in any treatment group .", "label": "", "metadata": {}, "score": "67.023636"}
{"text": "PubMed .Seroquel Prescribing Information : Prescribing information .Wilmington , DE : AstraZeneca Pharmaceuticals LP ; 2012 .Simon GE , Bauer MS , Ludman EJ , Operskalski BH , Unutzer J : Mood symptoms , functional impairment , and disability in people with bipolar disorder : specific effects of mania and depression .", "label": "", "metadata": {}, "score": "67.02869"}
{"text": "For example , at week 1 , significant differences between quetiapine XR and placebo were seen for HAM - A total , HAM - A psychic and somatic cluster scores , and CGI - S total score .", "label": "", "metadata": {}, "score": "67.04187"}
{"text": "There also was a 25 % reduction in cholesterol content of the outer cortex of the lens observed in a special study in quetiapine treated female dogs .", "label": "", "metadata": {}, "score": "67.05466"}
{"text": "Data acquisitions were done using LC - solution software .The mobile phase consists of 50 : 50 ( v / v ) of acetonitrile and 0.1 % orthophosphoric acid with added tri - ethyl amine as modifier , operated on isocratic mode .", "label": "", "metadata": {}, "score": "67.15988"}
{"text": "PubMed .Fiedorowicz JG , Endicott J , Leon AC , Solomon DA , Keller MB , Coryell WH : Subthreshold hypomanic symptoms in progression from unipolar major depression to bipolar disorder .", "label": "", "metadata": {}, "score": "67.23645"}
{"text": "The patients in the current study had an inadequate response to prior treatment and so , compared with treatment - na\u00efve or -responsive patients , may have a reduced capacity for symptom improvement , and any benefits experienced by these patients may not be captured by HAM - A score change .", "label": "", "metadata": {}, "score": "67.25594"}
{"text": "Patients unable to tolerate the higher dose returned to 150 mg / d at any time at the investigator 's discretion .Patients continued to receive the same SSRI or SNRI at the same dose as at enrollment throughout the study .", "label": "", "metadata": {}, "score": "67.31009"}
{"text": "FIGURE 1 : Study design a Enrollment was a maximum of 28 days prior to placebo run - in period .CGI - S : Clinical Global Impression - Severity of illness ; SNRI : serotonin - norepinephrine reuptake inhibitor ; SSRI : selective serotonin reuptake inhibitor .", "label": "", "metadata": {}, "score": "67.33549"}
{"text": "We performed a complete and systematic review to identify agents with definite positive or negative results concerning efficacy followed by a second systematic review to identify the pharmacodynamic properties of these agents .", "label": "", "metadata": {}, "score": "67.411835"}
{"text": "49 - 57 , 1992 .View at Google Scholar .P. C. Davis , O. Bravo , M. Gehrke , and C. T. Azumaya , \" Development and validation of an LC - MS / MS method for the determination of quetiapine and four related metabolites in human plasma , \" Journal of Pharmaceutical and Biomedical Analysis , vol .", "label": "", "metadata": {}, "score": "67.46388"}
{"text": "Table 6 : Short - term , long - term , and autosampler stability of quetiapine fumarate .Stress Testing .The stress studies involved heat , acid , light ( UV ) , oxidation , and alkaline conditions .", "label": "", "metadata": {}, "score": "67.475815"}
{"text": "While these symptoms can occur at low doses , they occur more frequently and with greater severity with high potency and at higher doses of first generation antipsychotic drugs .", "label": "", "metadata": {}, "score": "67.502945"}
{"text": "Sample Preparation .Commercially available tablets of quetiapine fumarate are taken from two different brands and tested for assay .Twenty tablets of each brand are taken and crushed to powder .", "label": "", "metadata": {}, "score": "67.578415"}
{"text": "The relationship of epinephrine levels among diagnostic groups was sustained throughout hospitalization .It appears likely that the main underlying mechanisms for elevations of both hormones are psychological , but further work will be required to establish the exact nature of these mechanisms . \" [ Abstract ] .", "label": "", "metadata": {}, "score": "67.628494"}
{"text": "You may not have any symptoms , so your healthcare provider may decide to check your cholesterol and triglycerides during your treatment with quetiapine fumarate tablets . increase in weight ( weight gain ) .", "label": "", "metadata": {}, "score": "67.74665"}
{"text": "Benzodiazepines and alcohol may be counterproductive .Although dopaminergic agonists sometimes stimulate creativity , their doing so may inappropriately disinhibit behaviour .Dopamine antagonists may suppress creative motivation ; lithium and anticonvulsant mood stabilizers may do so less .", "label": "", "metadata": {}, "score": "67.85109"}
{"text": "Tardive dyskinesia may not go away , even if you stop taking quetiapine fumarate tablets .Tardive dyskinesia may also start after you stop taking quetiapine fumarate tablets .", "label": "", "metadata": {}, "score": "67.86766"}
{"text": "Logistic regression ( with score at randomization as covariate and treatment included as a fixed effect ) was used to compare quetiapine XR with placebo for categorical variables including HAM - A response , HAM - A remission , and CGI - I. A robustness analysis for the primary efficacy variable using an ANCOVA model on the PP analysis population also was performed .", "label": "", "metadata": {}, "score": "67.98019"}
{"text": "Quetiapine fumarate tablets may affect the way other medicines work , and other medicines may affect how quetiapine fumarate tablets work .Tell your healthcare provider if you are having a urine drug screen because quetiapine fumarate tablets may affect your test results .", "label": "", "metadata": {}, "score": "67.98609"}
{"text": "CNS Spectr .Khan A , Khan S , Brown WA .Are placebo controls necessary to test new antidepressants and anxiolytics ?Int J Neuropsychopharmacol .", "label": "", "metadata": {}, "score": "68.04884"}
{"text": "Montgomery SA , Sheehan DV , Meoni P , et al .Characterization of the longitudinal course of improvement in generalized anxiety disorder during long - term treatment with venlafaxine XR .", "label": "", "metadata": {}, "score": "68.20067"}
{"text": "Adults : Data from one 6-week clinical trial of schizophrenia comparing five fixed doses of quetiapine ( 75 , 150 , 300 , 600 , 750 mg / day ) provided evidence for the lack of treatment - emergent extrapyramidal symptoms ( EPS ) and dose - relatedness for EPS associated with quetiapine treatment .", "label": "", "metadata": {}, "score": "68.26178"}
{"text": "Histamine H2 receptors are also antagonized , as are postsynaptic serotonin 5-HT2 and 5-HT3 receptors , leading to serotonergic activity primarily via 5-HT1A receptors .", "label": "", "metadata": {}, "score": "68.3316"}
{"text": "J Clin Psychiatry .Calabrese JR , Bowden CL , Sachs G , et al .A placebo - controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder .", "label": "", "metadata": {}, "score": "68.34096"}
{"text": "FIGURE 3B shows the MMRM analysis of mean change in HAM - A total score from randomization at each time point .With the adjustment of each of these effects , at week 8 quetiapine XR + SSRI / SNRI did not demonstrate a statistically significant difference from placebo in HAM - A total score change from randomization .", "label": "", "metadata": {}, "score": "68.3716"}
{"text": "The pooled analyses of placebo - controlled trials in adults with MDD or other psychiatric disorders included a total of 295 short - term trials ( median duration of 2 months ) of 11 antidepressant drugs in over 77,000 patients .", "label": "", "metadata": {}, "score": "68.40503"}
{"text": "Similar to a previous meta - analysis , the acceptability in this review was derived from the overall discontinuation rate [ 17 ] .The tolerability , frequently defined as a measure of antidepressant side effects [ 36 ] , was drawn from the discontinuation rate due to adverse events .", "label": "", "metadata": {}, "score": "68.408554"}
{"text": "Table 4 : Results and regression analysis of linearity data of quetiapine fumarate .Accuracy and Precision .Accuracy and precision calculated for the QC samples during the intra- and interday run are given in Table 5 .", "label": "", "metadata": {}, "score": "68.542046"}
{"text": "A correlation was found between plasma MHPG and mood states , with exceedingly high levels during mania and hypomania .Levels were significantly decreased by ECT or combined lithium and chlorpromazine administration .", "label": "", "metadata": {}, "score": "68.56137"}
{"text": "11 However , these differences were not statistically significant , perhaps due to limited statistical power related to the small sample size .The newer atypical antipsychotics provide some advantages over the older typical antipsychotics , as they may relieve 12 - 14 rather than exacerbate 15 depressive symptoms .", "label": "", "metadata": {}, "score": "68.60577"}
{"text": "Application of multivariate discriminant function analysis to data on urinary catecholamines and metabolites .Arch Gen Psychiatry 1978 Dec;35(12):1436 - 9 \" The previous article in this series reported on the differences in urinary excretion of 3-methoxy-4-hydroxyphenylglycol ( MHPG ) in patients with various clinically defined subtypes of depressive disorders .", "label": "", "metadata": {}, "score": "68.609924"}
{"text": "Official Title ICMJE .A Randomized , Open Label , Two - Treatment , Two - Period , Two - Sequence , Crossover , Single Dose , Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg With Seroquel \u00ae 25 mg in Normal , Healthy , Adult , Human Subjects , Under Fed Condition .", "label": "", "metadata": {}, "score": "68.610855"}
{"text": "Alternately , a four - period , replicate design crossover study may also be used .Single doses of the test composition and reference drug are administered and blood or plasma levels of the active agent are measured over time .", "label": "", "metadata": {}, "score": "68.68762"}
{"text": "\" [ Abstract ] .Cervantes P , Gelber S , Kin FN , Nair VN , Schwartz G. Circadian secretion of cortisol in bipolar disorder .", "label": "", "metadata": {}, "score": "68.84132"}
{"text": "Swann AC , Secunda S , Davis JM , Robins E , Hanin I , Koslow SH , Maas JW .CSF monoamine metabolites in mania .", "label": "", "metadata": {}, "score": "68.86623"}
{"text": "Other safety parameters comprised weight , clinical laboratory parameters using fasting and nonfasting samples , physical examination , and vital signs .Statistical analyses .Data for patients with a diagnosis of bipolar II depression in the BOLDER I and II and EMBOLDEN I and II studies were pooled in order to enhance the precision of the statistical analyses .", "label": "", "metadata": {}, "score": "68.88332"}
{"text": "Although its pathophysiology is not yet fully understood , it is known that both genetic and environmental factors are involved in its development .Fibromyalgia shares a high degree of co - morbidity with other conditions , including chronic headache , temporomandibular disorder , irritable bowel syndrome , major depression , anxiety disorders and chronic fatigue syndrome .", "label": "", "metadata": {}, "score": "69.00365"}
{"text": "Simpson GM , Angus JWS .A rating scale for extrapyramidal side effects .Acta Psychiatr Scand Suppl .Barnes TR .A rating scale for drug - induced akathisia .", "label": "", "metadata": {}, "score": "69.019356"}
{"text": "Effect sizes for these differences were large between women receiving venlafaxine and healthy controls .We found a positive association between cardiorespiratory decoupling and venlafaxine dose .", "label": "", "metadata": {}, "score": "69.024765"}
{"text": "By reducing the peripheral component of end - products of these amines in urine , a more accurate assessment of central nervous system ( CNS ) amine metabolism is provided .", "label": "", "metadata": {}, "score": "69.19583"}
{"text": "There is no known treatment for established cases of tardive dyskinesia , although the syndrome may remit , partially or completely , if antipsychotic treatment is withdrawn .", "label": "", "metadata": {}, "score": "69.20598"}
{"text": "Post RM .Time course of clinical effects of carbamazepine : implications for mechanisms of action .J Clin Psychiatry 1988 Apr;49 Suppl:35 - 48 \" The relatively acute time course of antimanic efficacy may be related to the above - mentioned mechanisms or to other effects related to systems postulated to be altered in the manic syndrome .", "label": "", "metadata": {}, "score": "69.230576"}
{"text": "Approximately one - fifth of patients discontinued therapy ( 20.5 % ) or required subsequent additional pharmacotherapy ( 20.5 % ) .Only 10.3 % discontinued due to adverse effects , and there was no significant change in mean body weight .", "label": "", "metadata": {}, "score": "69.237946"}
{"text": "Elderly patients with dementia - related psychosis treated with antipsychotic drugs are at an increased risk of death [ see Warnings and Precautions ( 5.1 ) ] .", "label": "", "metadata": {}, "score": "69.338425"}
{"text": "342 - 348 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .R. H. Pullen , K. M. Palermo , and M. A. Curtis , \" Determination of an antipsychotic agent ( ICI 204,636 ) and its 7-hydroxy metabolite in human plasma by high - performance liquid chromatography and gas chromatography - mass spectrometry , \" Journal of chromatography , vol .", "label": "", "metadata": {}, "score": "69.34167"}
{"text": "2011 ; Swartz and Thase 2011 ) .Further studies are required to establish the relative therapeutic position of these agents in the bipolar II disorder treatment armamentarium , with long - term trials being essential .", "label": "", "metadata": {}, "score": "69.39554"}
{"text": "100 - 113 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .B. Barrett , M. Holcapek , J. Huclov\u00e1 et al . , \" Validated HPLC - MS / MS method for determination of quetiapine in human plasma , \" Journal of Pharmaceutical and Biomedical Analysis , vol .", "label": "", "metadata": {}, "score": "69.41008"}
{"text": "They reported higher rates of comorbid anxiety in bipolar II disorder compared with bipolar I disorder and higher rates of anxiety disorders , eating disorders , substance use , suicide , and borderline personality comorbidity in bipolar II disorder than for unipolar disorder ( Angst et al .", "label": "", "metadata": {}, "score": "69.509186"}
{"text": "Finally , NE treatment resulted in a progressive decrease in the pluripotent marker Oct4 and an increase in the neuronal growth cone marker , growth - associated - protein 43 ( GAP-43 ) .", "label": "", "metadata": {}, "score": "69.60596"}
{"text": "The authors present data indicating that a subgroup of depressed patients who excrete less than normal quantities of MHPG may be identified by the application of explicit clinical criteria .", "label": "", "metadata": {}, "score": "69.747375"}
{"text": "The ratio of free over conjugated DOPEG was not statistically different in the two groups .The reduction of plasma DOPEG levels in the depressed patients did not appear to be related to the duration of drug - free period and was similar in males and females .", "label": "", "metadata": {}, "score": "69.88083"}
{"text": "The mean change from randomization in MADRS total score was -2.8 and -1.8 at week 4 , and -3.4 and -2.5 at week 8 with quetiapine XR + SSRI / SNRI and placebo + SSRI / SNRI , respectively .", "label": "", "metadata": {}, "score": "69.88104"}
{"text": "The controlled - release composition is substantially free of a gelling or swellable excipient and does not contain a functional coating or a lipophilic component .", "label": "", "metadata": {}, "score": "69.91396"}
{"text": "6 , pp .52 - 58 , 2011 .View at Google Scholar .K. Basavaiah , N. Rajendra Prasad , P. J. Ramesh , and K. B. Vinay , \" Sensitive and selective extraction - free spectrophotometric determination of quetiapine fumarate in pharmaceuticals using two sulphonthalein dyes , \" Journal of Pre - Clinical and Chemical Research , vol .", "label": "", "metadata": {}, "score": "69.989334"}
{"text": "However , when adjusted for dose and weight , AUC and C max of the parent compound were 41 % and 39 % lower , respectively , in children and adolescents than in adults .", "label": "", "metadata": {}, "score": "69.99242"}
{"text": "The receptor - independent [ ( 35)S]GTPgammaS binding stimulation by mastoparan and the G - protein density were also examined .The alpha(2A)-adrenoceptor - mediated stimulation of [ ( 35)S]GTPgammaS binding with the agonist UK14304 displayed a 4.6-fold greater sensitivity in suicide victims than in controls , without changes in the maximal stimulation .", "label": "", "metadata": {}, "score": "70.013535"}
{"text": "Therefore , the cross - trial comparisons of the response and remission rates of quetiapine with those of other antidepressants may not be justified .Absolute risk reduction ( ARR ) is the difference between the control group 's event rate and the experimental group 's event rate .", "label": "", "metadata": {}, "score": "70.03008"}
{"text": "\" [ Abstract ] .Scatton B , Loo H , Dennis T , Benkelfat C , Gay C , Poirier - Littre MF .Decrease in plasma levels of 3,4-dihydroxyphenylethyleneglycol in major depression .", "label": "", "metadata": {}, "score": "70.205"}
{"text": "Swann AC , Stokes PE , Secunda SK , Maas JW , Bowden CL , Berman N , Koslow SH .Depressive mania versus agitated depression : biogenic amine and hypothalamic - pituitary - adrenocortical function .", "label": "", "metadata": {}, "score": "70.21006"}
{"text": "\" [ Abstract ] .Swann AC , Secunda SK , Koslow SH , Katz MM , Bowden CL , Maas JW , Davis JM , Robins E. Mania : sympathoadrenal function and clinical state .", "label": "", "metadata": {}, "score": "70.219086"}
{"text": "235 - 243 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. Hasselstr\u00f8m and K. Linnet , \" Fully automated on - line quantification of quetiapine in human serum by solid phase extraction and liquid chromatography , \" Journal of Chromatography B , vol .", "label": "", "metadata": {}, "score": "70.26968"}
{"text": "Rosenbaum JF , Fava M , Hoog SL , et al .Selective serotonin reuptake inhibitor discontinuation syndrome : a randomized clinical trial .Biol Psychiatry .", "label": "", "metadata": {}, "score": "70.30473"}
{"text": "[0052 ] Exemplary cardiotonics include digoxin and digitoxin .[ 0053 ] Exemplary androgens include 17-methyltestosterone and testosterone .[0054 ] Exemplary corticoids include desoxycorticosterone .", "label": "", "metadata": {}, "score": "70.35678"}
{"text": "For pediatric schizophrenia , symptom profiles can be variable , and for bipolar I disorder , patients may have variable patterns of periodicity of manic or mixed symptoms .", "label": "", "metadata": {}, "score": "70.38292"}
{"text": "Moreover , sub - threshold bipolar II disorder has been estimated to affect up to 6.7 % of the general population ( Angst et al .", "label": "", "metadata": {}, "score": "70.457565"}
{"text": "18 to 24 .5 additional cases .Decreases Compared to Placebo .25 to 64 .1 fewer case .6 fewer cases .No suicides occurred in any of the pediatric trials .", "label": "", "metadata": {}, "score": "70.48027"}
{"text": "5.8 Increases in Blood Pressure ( Children and Adolescents ) .In the 26-week open - label clinical trial , one child with a reported history of hypertension experienced a hypertensive crisis .", "label": "", "metadata": {}, "score": "70.50633"}
{"text": "In certain conditions such alkaline conditions certain degraded peaks were observed accompanied with a reduction in the number of theoretical plates and increasing tailing and all these peaks were well resolved from drug and internal standard peaks ( Tables 7 and 8 ) .", "label": "", "metadata": {}, "score": "70.66263"}
{"text": "PubMed .Vazquez G , Tondo L , Baldessarini RJ : Comparison of antidepressant responses in patients with bipolar vs. unipolar depression : a meta - analytic review .", "label": "", "metadata": {}, "score": "70.671074"}
{"text": "Pigment deposition was shown to be irreversible in rats .The identity of the pigment could not be determined , but was found to be co - localized with quetiapine in thyroid gland follicular epithelial cells .", "label": "", "metadata": {}, "score": "70.713844"}
{"text": "Among the altered genes , an increase in the expression level of two neurite - outgrowth promoting genes , neural cell adhesion molecule L1 and laminin , was confirmed by RT - PCR .", "label": "", "metadata": {}, "score": "70.78991"}
{"text": "Clinical manifestations of NMS are hyperpyrexia , muscle rigidity , altered mental status , and evidence of autonomic instability ( irregular pulse or blood pressure , tachycardia , diaphoresis , and cardiac dysrhythmia ) .", "label": "", "metadata": {}, "score": "70.950294"}
{"text": "[ 0080 ] The present controlled - release compositions can be prepared by various conventional mixing , commination and fabrication techniques readily apparent to those skilled in the art of drug formulations .", "label": "", "metadata": {}, "score": "71.10272"}
{"text": "When starting treatment , patients with diabetes or risk factors for diabetes should undergo blood glucose testing before and during treatment ( Seroquel Prescribing Information 2012 ) .", "label": "", "metadata": {}, "score": "71.14975"}
{"text": "Subjects with clinically acceptable findings as determined by haemogram , biochemistry , serology ( HIV , Hepatitis B and Hepatitis C ) , urinalysis , 12 lead ECG and chest X - ray ( chest X - ray if required ) .", "label": "", "metadata": {}, "score": "71.17579"}
{"text": "PubMed .Swartz HA , Thase ME : Pharmacotherapy for the treatment of acute bipolar II depression : current evidence .J Clin Psychiatry 2011 , 72 ( 3):356 - 66 .", "label": "", "metadata": {}, "score": "71.21949"}
{"text": "[ PubMed Citation ] [ Order full text from Infotrieve ] .13 ) Jerrell JM , McIntyre RS , Tripathi A Childhood treatment with psychotropic medication and development of comorbid medical conditions in adolescent - onset bipolar disorder .", "label": "", "metadata": {}, "score": "71.26601"}
{"text": "However , in unipolar depressed patients , most studies in non - elderly populations consistently report elevated concentrations of plasma NE , at least following an orthostatic challenge .", "label": "", "metadata": {}, "score": "71.31691"}
{"text": "Creativity depends on goal - driven approach motivation from midbrain dopaminergic systems .Fear - driven avoidance motivation is of less aid to creativity .When serotonin and norepinephrine lower motivation and flexible behaviour , they can inhibit creativity .", "label": "", "metadata": {}, "score": "71.38342"}
{"text": "The relevance of this increased incidence of prolactin - mediated mammary gland tumors in rats to human risk is unknown [ see Warnings and Precautions ( 5.14 ) ] .", "label": "", "metadata": {}, "score": "71.42099"}
{"text": "Triglycerides ( mg / dL ) b .Prolactin ( ng / mL ) .Randomization Change .Weight , kg .a Numbers of patients include only those who were assessed .", "label": "", "metadata": {}, "score": "71.431435"}
{"text": "He has received grant / research support from Agency for Healthcare Research and Quality , Eli Lilly , Forest Laboratories , GlaxoSmithKline , National Institute of Mental Health , Otsuka , and Sepracor .", "label": "", "metadata": {}, "score": "71.47281"}
{"text": "Caution should be exercised in the interpretation of positive urine drug screen results for these drugs , and confirmation by alternative analytical technique ( e.g. , chromatographic methods ) should be considered .", "label": "", "metadata": {}, "score": "71.49692"}
{"text": "Bandelow B , Zohar J , Hollander E , et al ; WFSBP Task Force on Treatment Guidelines for Anxiety .Obsessive - Compulsive and Post - Traumatic Stress Disorders .", "label": "", "metadata": {}, "score": "71.517685"}
{"text": "The mean change MADRS and HAM - D scores of the quetiapine - treated group in each study were higher than that of the placebo - treated group ( see Figures 4 and 5 ) .", "label": "", "metadata": {}, "score": "71.5468"}
{"text": "Specificity is also observed in the degradation study of the drug .None of the degraded products must interfere with the quantification of the drug .", "label": "", "metadata": {}, "score": "71.583954"}
{"text": "Papakostas GI , Charles D , Fava M : Are typical starting doses of the selective serotonin reuptake inhibitors sub - optimal ?A meta - analysis of randomized , double - blind , placebo - controlled , dose - finding studies in major depressive disorder .", "label": "", "metadata": {}, "score": "71.679"}
{"text": "In 7/39 trials ( 17.9 % ) , patients attained recovered status , defined as 8 consecutive weeks euthymic .At the efficacy endpoint , 1/39 ( 2.6 % ) patient developed syndromal and 2/39 ( 5.1 % ) developed subsyndromal mood elevation .", "label": "", "metadata": {}, "score": "71.845474"}
{"text": "Stopping an antidepressant medicine suddenly can cause other symptoms .Antidepressants are medicines used to treat depression and other illnesses .It is important to discuss all the risks of treating depression and also the risks of not treating it .", "label": "", "metadata": {}, "score": "71.90733"}
{"text": "9 ) Sacchetti E , Galluzzo A , Valsecchi P Oral ziprasidone in the treatment of patients with bipolar disorders : a critical review .Expert Rev Clin Pharmacol .", "label": "", "metadata": {}, "score": "71.96396"}
{"text": "Calabrese JR , Bowden CL , Sachs GS , et al .Lamictal 602 Study Group .A double - blind placebo - controlled study of lamotrigine monotherapy in outpatients with bipolar I depression .", "label": "", "metadata": {}, "score": "71.98105"}
{"text": "This drug is rapidly absorbed after oral administration with peak plasma concentration attained within 1.50 hrs .Bioavailability of tablet formulation is 100 % relative to an oral solution , which may be marginally affected by food .", "label": "", "metadata": {}, "score": "72.01732"}
{"text": "All relevant randomized - controlled trials ( RCTs ) and clinical - controlled trials ( CCTs ) were included .Searches .Similarly , these search strategies were used in the rest of databases .", "label": "", "metadata": {}, "score": "72.07855"}
{"text": "Using Diagnostic and Statistical Manual of Mental Disorders , Fourth Edition ( DSM - IV ) criteria , the reported lifetime prevalence of bipolar II disorder ( 1.0 % ) is similar to the estimate for bipolar I disorder ( 1.1 % ) ( Merikangas et al .", "label": "", "metadata": {}, "score": "72.13081"}
{"text": "Based on response and tolerability , may be administered three times daily .Bipolar Mania- Adults Monotherapy or as an adjunct to lithium or divalproex .", "label": "", "metadata": {}, "score": "72.132866"}
{"text": "0079 ] Dosage forms can be combination dosage forms having both immediate - release and controlled - release characteristics , such as , for example , a combination of immediate - release pellets and controlled - release pellets .", "label": "", "metadata": {}, "score": "72.16344"}
{"text": "Long - standing hyperprolactinemia when associated with hypogonadism may lead to decreased bone density in both female and male subjects .Tissue culture experiments indicate that approximately one - third of human breast cancers are prolactin dependent in vitro , a factor of potential importance if the prescription of these drugs is considered in a patient with previously detected breast cancer .", "label": "", "metadata": {}, "score": "72.16939"}
{"text": "PubMed .Br J Psychiatry 2006 , 189 : 20 - 5 .PubMed .Perugi G , Angst J , Azorin JM , Bowden C , Vieta E , Young AH : The bipolar - borderline personality disorders connection in major depressive patients .", "label": "", "metadata": {}, "score": "72.21637"}
{"text": "[ 0088 ] \" Bioavailability \" can be characterized by one or more pharmacokinetic parameters .Release forms may also be characterized by their pharmacokinetic parameters .", "label": "", "metadata": {}, "score": "72.31023"}
{"text": "257 - 262 , 2004 .View at Google Scholar . H. Kirchherr and W. N. K\u00fchn - Velten , \" Quantitative determination of forty - eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry : a multi - level , single - sample approach , \" Journal of Chromatography B , vol .", "label": "", "metadata": {}, "score": "72.32126"}
{"text": "PubMed Central PubMed .Am J Psychiatry 2006 , 163 ( 2):232 - 9 . PubMed .Li CT , Bai YM , Huang YL , Chen YS , Chen TJ , Cheng JY , Su TP : Association between antidepressant resistance in unipolar depression and subsequent bipolar disorder : cohort study .", "label": "", "metadata": {}, "score": "72.48758"}
{"text": "In these situations , the single enantiomers , i.e. , optically active forms can be obtained by asymmetric synthesis , synthesis from optically pure precursors , or by resolution of the racemates .", "label": "", "metadata": {}, "score": "72.54772"}
{"text": "Supine plasma NE levels were significantly lower in bipolar patients than in either unipolar depressives or normal volunteers .Following the orthostatic challenge , the fractional NE increase in both patient groups -- particularly the bipolar group -- was greatly exaggerated , exceeding that in the controls by approximately 100 % .", "label": "", "metadata": {}, "score": "72.606636"}
{"text": "0070 ] The controlled - release matrix may further optionally comprise an additional pharmaceutically acceptable excipient , lubricant , or glidant .The additional pharmaceutically acceptable excipient , lubricant , or glidant can be any of those known in the pharmaceutical art .", "label": "", "metadata": {}, "score": "72.61361"}
{"text": "In addition , the controlled - release composition does not contain a functional coating or a lipophilic component .[ 0005 ] These and other embodiments , advantages and features of the present invention become clear when detailed description and examples are provided in subsequent sections .", "label": "", "metadata": {}, "score": "72.61657"}
{"text": "Angst J , Cui L , Swendsen J , Rothen S , Cravchik A , Kessler RC , Merikangas KR : Major depressive disorder with subthreshold bipolarity in the National Comorbidity Survey Replication .", "label": "", "metadata": {}, "score": "72.670334"}
{"text": "Quetiapine fumarate tablets can cause serious side effects , including : .See \" What is the most important information I should know about quetiapine fumarate tablets ? \" stroke that can lead to death can happen in elderly people with dementia who take medicines like quetiapine fumarate tablets .", "label": "", "metadata": {}, "score": "72.7003"}
{"text": "\" [ Abstract ] .Goodnick PJ , Dominguez RA , DeVane CL , Bowden CL .Bupropion slow - release response in depression : diagnosis and biochemistry .", "label": "", "metadata": {}, "score": "72.728195"}
{"text": "Notably many of the limbic system structures where thyroid hormone receptors are prevalent have been implicated in the pathogenesis of mood disorders .The influence of the thyroid system on neurotransmitters ( particularly serotonin and norepinephrine ) , which putatively play a major role in the regulation of mood and behavior , may contribute to the mechanisms of mood modulation .", "label": "", "metadata": {}, "score": "72.730835"}
{"text": "The 14-day regimen of hQuet enhanced the tonic activation of postsynaptic ? ? -but not ? ?-adrenergic receptors in the hippocampus .", "label": "", "metadata": {}, "score": "72.83144"}
{"text": "12 - 14 Patients in the current study had already received treatment ( SSRI / SNRI ) for their anxiety ; therefore , it might be expected that on study entry some improvement in symptoms would have already occurred .", "label": "", "metadata": {}, "score": "72.833435"}
{"text": "Data from these active treatment groups have been reported previously ( McElroy et al .2010 ; Young et al .2010 ) .A continuation phase of 26 to 52 weeks ' duration also formed the design of the EMBOLDEN studies , the results for which have been reported previously ( Young et al .", "label": "", "metadata": {}, "score": "72.86191"}
{"text": "Larger controlled studies of longer duration are needed to confirm these preliminary observations .This study has noteworthy strengths and limitations .The sample was derived from a heterogeneous cohort of bipolar disorder patients with diverse comorbidities and medication regimens , suggesting more generalizability than might be inferred from controlled trials with restrictive inclusion and exclusion criteria .", "label": "", "metadata": {}, "score": "72.94141"}
{"text": "We searched MEDLINE , EMBASE , CINHL , PsycINFO and Cochrane Controlled Trials Register databases in February 2012 .According to MEDLINE search , the first publication of the ICI 204,636 ( the drug code of quetiapine ) was in 1991 .", "label": "", "metadata": {}, "score": "72.95484"}
{"text": "This Medication Guide summarizes the most important information about quetiapine fumarate tablets .If you would like more information , talk with your healthcare provider .", "label": "", "metadata": {}, "score": "72.971214"}
{"text": "No deaths or SAEs occurred during the study .TABLE 3 .Constipation .Nausea .Nasopharyngitis . a MedDRA preferred term .No AEs potentially related to suicidality were reported and no incidences of suicidal behavior / ideation ( Columbia Classification codes 1 , 2 , 3 , 4 ) were reported in either treatment group .", "label": "", "metadata": {}, "score": "73.162865"}
{"text": "However , the magnitude of change in HAM - A total score seen here for the placebo group ( -9.61 ) was unexpectedly high when compared with those seen in other placebo - controlled adjunct studies .", "label": "", "metadata": {}, "score": "73.17378"}
{"text": "[ 0119 ] Formulations A , B , C , D , E , F , G , H , and I were individually prepared by wet granulating wherein the wet granulation components include isopropyl alcohol .", "label": "", "metadata": {}, "score": "73.20919"}
{"text": "Several instruments were used for assessing psychiatric signs and symptoms in these studies , among them the Brief Psychiatric Rating Scale ( BPRS ) , a multi - item inventory of general psychopathology traditionally used to evaluate the effects of drug treatment in schizophrenia .", "label": "", "metadata": {}, "score": "73.25316"}
{"text": "AEs potentially related to somnolence ( MedDRA preferred terms : lethargy , sedation , sluggishness , and somnolence ) were reported by 35.9 % and 14.5 % of patients in the quetiapine XR + SSRI / SNRI and placebo + SSRI / SNRI groups , respectively .", "label": "", "metadata": {}, "score": "73.28656"}
{"text": "Number needed to treat ( NNT ) was calculated using the formula 1/([proportion of quetiapine XR - treated patients with positive response ] - [ proportion of placebo - treated patients with positive response ] ) .", "label": "", "metadata": {}, "score": "73.29564"}
{"text": "8.6 Renal Impairment . 8.7Hepatic Impairment .Since quetiapine is extensively metabolized by the liver , higher plasma levels are expected in patients with hepatic impairment .", "label": "", "metadata": {}, "score": "73.36769"}
{"text": "[0008 ] The present controlled - release composition does not contain a functional coating .As used herein , the term \" functional coating \" denotes a coating that modifies the release properties of the total formulation , for example , a sustained - release coating .", "label": "", "metadata": {}, "score": "73.41322"}
{"text": "Maintenance Treatment as an Adjunct to Lithium or Divalproex .The trials included patients whose most recent episode was manic , depressed , or mixed , with or without psychotic features .", "label": "", "metadata": {}, "score": "73.436005"}
{"text": "Antidepressants increased the risk of suicidal thoughts and behavior in children , adolescents , and young adults in short - term studies .These studies did not show an increase in the risk of suicidal thoughts and behavior with antidepressant use in patients over age 24 ; there was a reduction in risk with antidepressant use in patients aged 65 and older [ see Warnings and Precautions ( 5.2 ) ] .", "label": "", "metadata": {}, "score": "73.45018"}
{"text": "PubMed Central PubMed .Angst J , Gamma A , Azorin JM , Bowden CL , Perugi G , Vieta E , Young AH : Evidence - based efforts to re - define bipolar disorders .", "label": "", "metadata": {}, "score": "73.52994"}
{"text": "Three additional formulations ( G , H , and J ) were prepared with an ionic non - gelling matrix and no pH modifier .A comparative example containing a gelling matrix material ( CE - A ) was also prepared .", "label": "", "metadata": {}, "score": "73.60864"}
{"text": "\" [ Abstract ] .Garfinkel PE , Warsh JJ , Stancer HC , Godse DD .CNS monoamine metabolism in bipolar affective disorder .Evaluation using a peripheral decarboxylase inhibitor .", "label": "", "metadata": {}, "score": "73.63018"}
{"text": "Quetiapine fumarate is a white to off - white powder which is insoluble in water .Inactive ingredients are microcrystalline cellulose , colloidal silicon dioxide , silicon dioxide , crospovidone , anhydrous citric acid , polysorbate 80 , magnesium stearate , lactose monohydrate , hypromellose , polyethylene glycol and titanium dioxide .", "label": "", "metadata": {}, "score": "73.64465"}
{"text": "J Clin Psychiatry .Keck PE Jr , McElroy SL , Strakowski SM , et al .Compliance with maintenance treatment in bipolar disorder .Psychopharmacol Bull .", "label": "", "metadata": {}, "score": "73.65057"}
{"text": "KEYWORDS : clinical trial , phase 3 , anxiety disorders , sustained - release preparations , antipsychotics , treatment efficacy .Generalized anxiety disorder ( GAD ) is a chronic condition with low recovery rates and a high likelihood of recurrence .", "label": "", "metadata": {}, "score": "73.66223"}
{"text": "The primary endpoint in these studies was time to recurrence of a mood event ( manic , mixed or depressed episode ) .( Figure 1 and Figure 2 ) .", "label": "", "metadata": {}, "score": "73.693756"}
{"text": "CORRESPONDENCE : Arifulla Khan , MD Department of Psychiatry and Behavioral Sciences Duke Medical Hospital Northwest Clinical Research Center 1951 152nd Place NE , Suite 200 Bellevue , WA 98007 USA E - MAIL : akhan@nwcrc.net Given a suggested decrease in noradrenergic transmission in depression , and an antidepressant induced increase in norepinephrine ( NE ) level , a possible role for NE in mediating alterations in neuronal morphology and plasticity was examined .", "label": "", "metadata": {}, "score": "73.70705"}
{"text": "CONCLUSIONS : This fixed - dose study indicates that there may be specific benefits for bupropion SR in atypical and bipolar depression , and that these benefits may be related also to plasma levels and biochemical changes in catecholamines .", "label": "", "metadata": {}, "score": "73.82686"}
{"text": "Remission rate , response rates , overall discontinuation rates , and discontinuation due to adverse events were also reported in all studies .Risk of bias within studies .", "label": "", "metadata": {}, "score": "73.85108"}
{"text": "Thus , the proportions of patients with syndromal and subsyndromal depression decreased from 79.5 % to 30.8 % ( from 31/39 to 12/39 ) and from 20.5 % to 15.4 % ( from 8/39 to 6/39 ) , respectively .", "label": "", "metadata": {}, "score": "73.87076"}
{"text": "Magalhaes PV , Dean OM , Bush AI , Copolov DL , Malhi GS , Kohlmann K , Jeavons S , Schapkaitz I , Anderson - Hunt M , Berk M : N - acetyl cysteine add - on treatment for bipolar II disorder : a subgroup analysis of a randomized placebo - controlled trial .", "label": "", "metadata": {}, "score": "73.954285"}
{"text": "227 - 233 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . L. Mercolini , M. Grillo , C. Bartoletti , G. Boncompagni , and M. A. Raggi , \" Simultaneous analysis of classical neuroleptics , atypical antipsychotics and their metabolites in human plasma , \" Analytical and Bioanalytical Chemistry , vol .", "label": "", "metadata": {}, "score": "73.98622"}
{"text": "Eight subjects , including those in our study , were identified as having developed mirtazapine - induced mania with atypical features , consisting of dysphoria , irritability , insomnia , psychomotor agitation and abnormal gait .", "label": "", "metadata": {}, "score": "74.13727"}
{"text": "The diagnostic evaluation of patients with this syndrome is complicated .In arriving at a diagnosis , it is important to exclude cases where the clinical presentation includes both serious medical illness ( e.g. , pneumonia , systemic infection , etc . ) and untreated or inadequately treated extrapyramidal signs and symptoms ( EPS ) .", "label": "", "metadata": {}, "score": "74.23471"}
{"text": "The NNT value calculated using the end of treatment response data for quetiapine XR was 20.8 .Health - related quality of life .There was no statistically significant difference between treatment groups in change from randomization to week 8 in Q - LES - Q percent maximum total score ( TABLE 2 ) .", "label": "", "metadata": {}, "score": "74.28535"}
{"text": "Clinical outcome measures were the Hamilton Depression Rating Scale ( HDRS ) and Beck Depression Inventory ( BDI ) .Biological parameters included plasma HVA and 3-methoxy-4-hydroxyphenyl - glycol ( MHPG ) , as well as a final measurement of plasma bupropion and its metabolites .", "label": "", "metadata": {}, "score": "74.37019"}
{"text": "2011 ) .While the debilitating effects of bipolar I disorder are well established , the burden imposed by bipolar II disorder is gaining increasing recognition ( Benazzi 2007 ; MacQueen and Young 2001 ; Valtonen et al .", "label": "", "metadata": {}, "score": "74.37847"}
{"text": "12 )Johansson J , Landgren M , Fernell E , Vumma R , \u00c5hlin A , Bjerkenstedt L , Venizelos N Altered tryptophan and alanine transport in fibroblasts from boys with attention - deficit / hyperactivity disorder ( ADHD ) : an in vitro study .", "label": "", "metadata": {}, "score": "74.38465"}
{"text": "During the posttreatment period , a modified 18-item treatment discontinuation signs and symptoms ( TDSS ) scale was used .This scale was a hybrid of the 43-item discontinuation emergent signs and symptoms scale 27 and the 17-item discontinuation scale 28 and included additional AEs of vomiting , nausea , and trouble sleeping , insomnia .", "label": "", "metadata": {}, "score": "74.44533"}
{"text": "Dosage adjustment is therefore not needed in these patients [ see Use in Specific Populations ( 8.6)].In two of the 8 hepatically impaired patients , AUC and C max were 3 times higher than those observed typically in healthy subjects .", "label": "", "metadata": {}, "score": "74.46614"}
{"text": "Columbia Classification Algorithm of Suicide Assessment ( C - CASA ) : classification of suicidal events in the FDA 's pediatric suicidal risk analysis of antidepressants .", "label": "", "metadata": {}, "score": "74.48319"}
{"text": "[0007 ] The present controlled - release composition is substantially free of a gelling or swelling excipient .The term \" excipient \" denotes any inert or slightly active substance which is used in preparing the composition as a vehicle or medium of administration for the active agent .", "label": "", "metadata": {}, "score": "74.53248"}
{"text": "Any conclusion on the potential of ziprasidone as an antidepressant should be postponed because of insufficient evidence .[ PubMed Citation ] [ Order full text from Infotrieve ] .", "label": "", "metadata": {}, "score": "74.53362"}
{"text": "0093 ] In another embodiment , bioequivalence is determined according to the European Medicines Agency ( EMEA ) document \" Note for Guidance on the Investigation of Bioavailability and Bioequivalence \" , issued Jul. 26 , 2001 , available from EMEA .", "label": "", "metadata": {}, "score": "74.534"}
{"text": "Dilsaver SC , Chen YW , Swann AC , et al .Suicidality , panic disorder and psychosis in bipolar depression , depressive - mania and pure - mania .", "label": "", "metadata": {}, "score": "74.53438"}
{"text": "This latter result may be explained by the relatively low power of the subanalyses in each of the trials , where the predominant number of patients had bipolar I rather than bipolar II depression .", "label": "", "metadata": {}, "score": "74.60996"}
{"text": "It is available in tablets form in dosage level of 25 mg , 50 mg , 100 mg , 200 mg , 300 mg , and 400 mg .", "label": "", "metadata": {}, "score": "74.63219"}
{"text": "[Abstract ] .Gonzalez - Maeso J , Rodriguez - Puertas R , Meana JJ , Garcia - Sevilla JA , Guimon J. Neurotransmitter receptor - mediated activation of G - proteins in brains of suicide victims with mood disorders : selective supersensitivity of alpha(2A)-adrenoceptors .", "label": "", "metadata": {}, "score": "74.63567"}
{"text": "Patients with an established diagnosis of diabetes mellitus who are started on atypical antipsychotics should be monitored regularly for worsening of glucose control .Patients with risk factors for diabetes mellitus ( e.g. , obesity , family history of diabetes ) who are starting treatment with atypical antipsychotics should undergo fasting blood glucose testing at the beginning of treatment and periodically during treatment .", "label": "", "metadata": {}, "score": "74.71017"}
{"text": "4 The past decade has seen important advances in the pharmacotherapy of bipolar disorder , 5 yet monotherapies often are inadequate , particularly for depressive symptoms .", "label": "", "metadata": {}, "score": "74.854324"}
{"text": "Studies with any duration of treatment for single or recurrent major depressive episodes diagnosed by any set of criteria were included .No language restriction was applied .", "label": "", "metadata": {}, "score": "74.86258"}
{"text": "6.1 Clinical Study Experience .Because clinical studies are conducted under widely varying conditions , adverse reaction rates observed in the clinical studies of a drug can not be directly compared to rates in the clinical studies of another drug and may not reflect the rates observed in practice .", "label": "", "metadata": {}, "score": "74.92106"}
{"text": "Patients should be advised of the risk of somnolence or sedation ( which may lead to falls ) , especially during the period of initial dose titration .", "label": "", "metadata": {}, "score": "74.98308"}
{"text": "The controlled - release composition of claim 1 , wherein the active agent has a solubility of greater than or equal to about 2 . 0 mg / ml in an aqueous medium at room temperature .", "label": "", "metadata": {}, "score": "75.051315"}
{"text": "PubMed Central PubMed .Gao K , Tolliver BK , Kemp DE , Verduin ML , Ganocy SJ , Bilali S , Brady KT , Shim SS , Findling RL , Calabrese JR : Differential interactions between comorbid anxiety disorders and substance use disorder in rapid cycling bipolar I or II disorder .", "label": "", "metadata": {}, "score": "75.11104"}
{"text": "The incidences of AEs potentially related to EPS ( MedDRA preferred terms : akathisia , psychomotor hyperactivity , restlessness , and tremor ) were 3.8 % and 2.0 % in the quetiapine XR + SSRI / SNRI and placebo + SSRI / SNRI groups , respectively .", "label": "", "metadata": {}, "score": "75.12172"}
{"text": "Severity of mania was evaluated using the Manic Syndrome , Behavior and Ideation and Mania Rating Scale scores from the SADS - C. Multiple regression analysis showed that pretreatment plasma GABA was related to severity of manic symptoms .", "label": "", "metadata": {}, "score": "75.134735"}
{"text": "PubMed .Wiebe N , Vandermeer B , Platt RW , Klassen TP , Moher D , Barrowman NJ : A systematic review identifies a lack of standardization in methods for handling missing variance data .", "label": "", "metadata": {}, "score": "75.19214"}
{"text": "Exemplary pH modifiers include sodium citrate , citric acid , and the like .As used herein , the organic acids do not include any fatty acids .", "label": "", "metadata": {}, "score": "75.21713"}
{"text": "Arch Gen Psychiatry 1978 Dec;35(12):1427 - 33 \" The urinary excretion of 3-methoxy-4-hydroxyphenylglycol ( MHPG ) and other catecholamine metabolites was measured in a series of 63 patients with various clinically defined subtypes of depressive disorders .", "label": "", "metadata": {}, "score": "75.237335"}
{"text": "PubMed .Suppes T , Dennehy EB : Evidence - based long - term treatment of bipolar II disorder .J Clin Psychiatry 2002 , 63 ( Suppl 10):29 - 33 .", "label": "", "metadata": {}, "score": "75.23909"}
{"text": "\" [ Abstract ] .Bauer M , London ED , Silverman DH , Rasgon N , Kirchheiner J , Whybrow PC .Thyroid , brain and mood modulation in affective disorder : insights from molecular research and functional brain imaging .", "label": "", "metadata": {}, "score": "75.32358"}
{"text": "The pH modifier is a pharmaceutically acceptable organic acid , or an alkali metal or alkaline earth metal salt thereof .[ 0087 ] For active agents that are intended to be absorbed into the bloodstream , bioavailability data for a given formulation may provide an estimate of the relative fraction of the administered dose that is absorbed into the systemic circulation .", "label": "", "metadata": {}, "score": "75.374435"}
{"text": "Specificity .Figure 7 : Typical chromatogram containing internal standard and drug .A less than 20 % interference of the peak area at the retention time of the drug in the blank sample and zero blank samples are taken as acceptance criteria for the analyte .", "label": "", "metadata": {}, "score": "75.46297"}
{"text": "PubMed .Judd LL , Akiskal HS , Schettler PJ , Coryell W , Endicott J , Maser JD , Solomon DA , Leon AC , Keller MB : A prospective investigation of the natural history of the long - term weekly symptomatic status of bipolar II disorder .", "label": "", "metadata": {}, "score": "75.48811"}
{"text": "The non - invasively imaged activation sequence correlated well with invasively measured counterparts , with a correlation coefficient of 0.72 and a relative error of 0.30 averaged over all paced beats and NE - induced PVCs and VT beats .", "label": "", "metadata": {}, "score": "75.54378"}
{"text": "Claims : .The controlled - release composition of claim 1 , wherein the ionic non - gelling matrix polymer is selected from the group consisting of a methacrylic acid - methyl methacrylate co - polymer , a methacrylic acid - ethyl acrylate co - polymer , methacrylic acid - methyl acrylate - methyl methacrylate , and a combination thereof .", "label": "", "metadata": {}, "score": "75.56371"}
{"text": "Early timing ( phase - advance ) in manic - depressives compared with normal subjects .Arch Gen Psychiatry 1980 Mar;37(3):257 - 63 \" Twenty - four - hour ( circadian ) rhythms in urinary 3-methoxy-4-hydroxyphenylglycol ( MHPG ) excretion , motor activity , and oral temperature were studied in 14 normal subjects and ten manic - depressive patients .", "label": "", "metadata": {}, "score": "75.61604"}
{"text": "The controlled - release composition of claim 1 , wherein the pH modifier is sodium citrate .The controlled - release composition of claim 1 , wherein the pH modifier is present in the matrix in an amount from about 2 to about 50 wt % based on the total weight of the composition .", "label": "", "metadata": {}, "score": "75.63143"}
{"text": "\" [ Abstract ] .Joyce PR , Fergusson DM , Woollard G , Abbott RM , Horwood LJ , Upton J. Urinary catecholamines and plasma hormones predict mood state in rapid cycling bipolar affective disorder .", "label": "", "metadata": {}, "score": "75.67294"}
{"text": "Relationships between environmental sensitivity of affective episodes and neurotransmitter function therefore appear to be related to the type of episode .\" [ Abstract ] .", "label": "", "metadata": {}, "score": "75.70159"}
{"text": "The runtime of the method is 5 mins .The developed method was applied to directly and easily analyse of the pharmaceutical tablet preparations .The percentage recoveries were near 100 % for given methods .", "label": "", "metadata": {}, "score": "75.70291"}
{"text": "Increased cortical NE turnover , however , may be a more important component in the pathophysiology of bipolar disorder . \" [ Abstract ] [ Note that no information on the mood state of the subjects is given . ]", "label": "", "metadata": {}, "score": "75.71945"}
{"text": "In one embodiment , the pH modifier can maintain the pH of the matrix internal environment such that the matrix remains in a pH range where the ionic non - gelling matrix polymer is insoluble .", "label": "", "metadata": {}, "score": "75.721054"}
{"text": "An important consideration is its post hoc nature .Furthermore , the generalizability of the findings should be considered in the context of the inclusion and exclusion criteria of the BOLDER and EMBOLDEN trials .", "label": "", "metadata": {}, "score": "75.84425"}
{"text": "5.17 Dysphagia .Esophageal dysmotility and aspiration have been associated with antipsychotic drug use .Aspiration pneumonia is a common cause of morbidity and mortality in elderly patients , in particular those with advanced Alzheimer 's dementia .", "label": "", "metadata": {}, "score": "75.85755"}
{"text": "[ PubMed Citation ] [ Order full text from Infotrieve ] . 7 ) Howland RH The use of dopaminergic and stimulant drugs for the treatment of depression .", "label": "", "metadata": {}, "score": "75.86221"}
{"text": "2007 ) .The current pooled analysis extends these observations by demonstrating significant decreases in MADRS total score at week 8 with both quetiapine doses both in patients with bipolar II depression who have rapid cycling and in those with less frequent episodes .", "label": "", "metadata": {}, "score": "75.952995"}
{"text": "Few papers substantively address this important but fraught topic .Antidepressants ( ADs ) that inhibit fear - driven motivation , such as selective serotonin reuptake inhibitors , sometimes inhibit goal - oriented motivation as well .", "label": "", "metadata": {}, "score": "75.9554"}
{"text": "Upon administration , these high molecular weight polymers swell to form a gel creating a barrier to slow down the release of the active agent bound in the gel matrices .", "label": "", "metadata": {}, "score": "76.02742"}
{"text": "Of 1,497 participants , 64.3 % were female .All participants were outpatients with MDD , single or recurrent episode .None of them had treatment - resistant depression .", "label": "", "metadata": {}, "score": "76.07102"}
{"text": "Excretion was positively correlated with cortisol level at 17 hr after dexamethasone administration in 32 depressive inpatients , especially in the unipolar subgroup .A trend toward negative correlation , though not statistically significant , was found in bipolar depression between cortisol levels at 17 hr after dexamethasone administration and urinary MHPG X SO4 excretion .", "label": "", "metadata": {}, "score": "76.07191"}
{"text": "PubMed .Merikangas KR , Akiskal HS , Angst J , Greenberg PE , Hirschfeld RM , Petukhova M , Kessler RC : Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication .", "label": "", "metadata": {}, "score": "76.07382"}
{"text": "View Article .Amit BH , Weizman A : Antidepressant treatment for acute bipolar depression : an update .Depress Res Treat 2012 , 2012 : 684725 .", "label": "", "metadata": {}, "score": "76.08328"}
{"text": "17 ) Valent\u00ed M , Pacchiarotti I , Rosa AR , Bonn\u00edn CM , Popovic D , Nivoli AM , Murru A , Grande I , Colom F , Vieta E Bipolar mixed episodes and antidepressants : a cohort study of bipolar I disorder patients .", "label": "", "metadata": {}, "score": "76.1328"}
{"text": "RECENT MAJOR CHANGES .Warnings and Precautions , Cerebrovascular Adverse Reactions , Including Stroke , in Elderly Patients with Dementia - Related Psychosis ( 5.3 ) ---------------------4/2013 .", "label": "", "metadata": {}, "score": "76.30812"}
{"text": "Nevertheless , the 14-day regimen of hQuet enhanced the tonic activation of postsynaptic 5-HT(1A ) receptors in the hippocampus .This increase in 5-HT transmission was attributable to the attenuated inhibitory function of the ? ?", "label": "", "metadata": {}, "score": "76.30994"}
{"text": "2011 Oct;26(7):451 - 9 .[ PubMed Citation ] [ Order full text from Infotrieve ] .14 ) Fountoulakis KN , Kelsoe JR , Akiskal H Receptor targets for antidepressant therapy in bipolar disorder : an overview .", "label": "", "metadata": {}, "score": "76.345"}
{"text": "9 - 16 , 2003 .View at Google Scholar . K.-Y Li , Y.-G Zhou , H.-Y Ren , F. Wang , B.-K Zhang , and H.-D Li , \" Ultra - performance liquid chromatography - tandem mass spectrometry for the determination of atypical antipsychotics and some metabolites in in vitro samples , \" Journal of Chromatography B , vol .", "label": "", "metadata": {}, "score": "76.35311"}
{"text": "Angst J , Gamma A , Bowden CL , Azorin JM , Perugi G , Vieta E , Young AH : Diagnostic criteria for bipolarity based on an international sample of 5,635 patients with DSM - IV major depressive episodes .", "label": "", "metadata": {}, "score": "76.39816"}
{"text": "Zhou DF , Shen YC , Shu LN , Lo HC .Dexamethasone suppression test and urinary MHPG X SO4 determination in depressive disorders .Biol Psychiatry 1987 Jul;22(7):883 - 91 \" The Dexamethasone Suppression Test ( DST ) was performed in 64 depressed inpatients , in 48 schizophrenics , and in 20 normal controls .", "label": "", "metadata": {}, "score": "76.47374"}
{"text": "Am J Psychiatry .Pollack MH .Refractory generalized anxiety disorder .J Clin Psychiatry .Wittchen HU .Generalized anxiety disorder : prevalence burden , and cost to society .", "label": "", "metadata": {}, "score": "76.50598"}
{"text": "Findings from a series of depressed patients whose biochemical data had not been used to derive this equation confirmed these differences in D - type scores among subtypes of depressions .", "label": "", "metadata": {}, "score": "76.554306"}
{"text": "Rosa AR , Reinares M , Michalak EE , Bonnin CM , Sole B , Franco C , Comes M , Torrent C , Kapczinski F , Vieta E : Functional impairment and disability across mood states in bipolar disorder .", "label": "", "metadata": {}, "score": "76.56122"}
{"text": "Moreover , cell survival was enhanced in the presence of NE , while proliferation was inhibited .The above effects suggest a role for NE in cell differentiation .", "label": "", "metadata": {}, "score": "76.59692"}
{"text": "\" [ Abstract ] .Swann AC , Koslow SH , Katz MM , Maas JW , Javaid J , Secunda SK , Robins E. Lithium carbonate treatment of mania .", "label": "", "metadata": {}, "score": "76.62373"}
{"text": "Metabolic Changes : Atypical antipsychotics have been associated with metabolic changes .These metabolic changes include hyperglycemia , dyslipidemia , and weight gain ( 5.5 ) .", "label": "", "metadata": {}, "score": "76.639465"}
{"text": "However , depressed patients diagnosed as having primary affective disorder and bipolar illness excreted significantly less MHPG than did the healthy comparison group .\" [ Abstract ] .", "label": "", "metadata": {}, "score": "76.65987"}
{"text": "The incidence and severity of adverse events ( AEs ) , and AEs leading to withdrawal were recorded throughout the study .Serious AEs ( SAEs ) were recorded until 30 days after the last dose of study medication .", "label": "", "metadata": {}, "score": "76.66986"}
{"text": "Levels of 5-HIAA and HVA did not differ between the manic patients and the comparison male subjects , but they were elevated in the female manic patients .", "label": "", "metadata": {}, "score": "76.67085"}
{"text": "Elderly patients should be started on quetiapine fumarate tablets 50 mg / day and the dose can be increased in increments of 50 mg / day depending on the clinical response and tolerability of the individual patient .", "label": "", "metadata": {}, "score": "76.75226"}
{"text": "The receptor - independent activation of G - proteins was similar in both groups .Immunoreactive densities of G(alphai1/2)- , G(alphai3)- , G(alphao)- , and G(alphas)-proteins did not differ between suicide victims and controls .", "label": "", "metadata": {}, "score": "76.80435"}
{"text": "The retention times of internal standard and the drug are 1.45 \u00b1 0.05 and 3.6 \u00b1 0.05 , respectively .The column is a 50 \u00d7 4.6 mm C18 column with the particle size of 3 \u00b5 m. Quetiapine fumarate is tested for the stress conditions like photostability , acid stability , alkaline , oxidation , and thermal conditions for the 24 Hrs .", "label": "", "metadata": {}, "score": "76.85705"}
{"text": "History of malignancy or other serious diseases .Refusal to abstain from food for at least ten ( 10.00 ) hours prior to study drug administration and for at least four ( 04.00 ) hours post - dose , in each study period .", "label": "", "metadata": {}, "score": "76.87788"}
{"text": "3 ) Bielau H , Brisch R , Bernard - Mittelstaedt J , Dobrowolny H , Gos T , Baumann B , Mawrin C , Bernstein HG , Bogerts B , Steiner J Immunohistochemical evidence for impaired nitric oxide signaling of the locus coeruleus in bipolar disorder .", "label": "", "metadata": {}, "score": "76.887215"}
{"text": "Possible risk factors for leukopenia / neutropenia include preexisting low white cell count ( WBC ) and history of drug induced leukopenia / neutropenia .Patients with neutropenia should be carefully monitored for fever or other symptoms or signs of infection and treated promptly if such symptoms or signs occur .", "label": "", "metadata": {}, "score": "76.92819"}
{"text": "4 , pp .898 - 904 , 2009 .View at Google Scholar \u00b7 View at Scopus .K. Basavaiah , N. Rajendra Prasad , P. J. Ramesh , and K. B. Vinay , \" Sensitive ultraviolet spectrophotometric determination of quetiapine fumarate in pharmaceuticals , \" Thai Journal of Pharmaceutical Sciences , vol .", "label": "", "metadata": {}, "score": "76.96395"}
{"text": "This study ( Palladium , D1441L00016 ) was funded by AstraZeneca Pharmaceuticals .The authors thank Jocelyn Woodcock , MPhil , from Complete Medical Communications , who provided medical writing support funded by AstraZeneca .", "label": "", "metadata": {}, "score": "77.05389"}
{"text": "Swann AC , Petty F , Bowden CL , Dilsaver SC , Calabrese JR , Morris DD .Mania : gender , transmitter function , and response to treatment .", "label": "", "metadata": {}, "score": "77.09822"}
{"text": "2012 Jun 12;1459:91 - 9 .Nitric oxide ( NO ) is an important messenger in brain signaling and influences the balance of monoaminergic and glutamatergic neurotransmission .", "label": "", "metadata": {}, "score": "77.28146"}
{"text": "The pH modifier is present in an amount to control the release of the active agent from the composition .Preferably , the pH modifier is a pharmaceutically acceptable organic acid , or an alkali metal or alkaline earth metal salt thereof .", "label": "", "metadata": {}, "score": "77.292915"}
{"text": "Arch Gen Psychiatry 1987 Apr;44(4):345 - 54 \" Treatment of manic patients with lithium carbonate was associated with significant decreases in cerebrospinal fluid ( CSF ) 3-methoxy-4-hydroxyphenylglycol ( MHPG ) and urinary norepinephrine excretion .", "label": "", "metadata": {}, "score": "77.34479"}
{"text": "When the active agent is a compound , then salts , solvates ( including hydrates ) , esters , and prodrugs of the compound are contemplated herein .", "label": "", "metadata": {}, "score": "77.36452"}
{"text": "These effects continued to be observed at 3 times the MRHD even after a two - week period without treatment .The no - effect dose for impaired mating and fertility in male rats was 25 mg / kg , or 0.3 times the MRHD dose on mg / m 2 body surface area .", "label": "", "metadata": {}, "score": "77.37227"}
{"text": "He is an Honorary Consultant WLMHT ( NHS ) .He was paid for lectures and advisory boards for all major pharmaceutical companies with drugs used in affective and related disorders .", "label": "", "metadata": {}, "score": "77.44537"}
{"text": "Dr. Thase has equity holdings in MedAvante and receives royalty income from American Psychiatric Publishing , Guilford Publications , Herald House , and W.W. Norton .", "label": "", "metadata": {}, "score": "77.466705"}
{"text": "Post RM , Rubinow DR , Uhde TW , Roy - Byrne PP , Linnoila M , Rosoff A , Cowdry R. Dysphoric mania .Clinical and biological correlates .", "label": "", "metadata": {}, "score": "77.47159"}
{"text": "Orthostatic hypotension , dizziness , and syncope may lead to falls .The risk of orthostatic hypotension and syncope may be minimized by limiting the initial dose to 25 mg twice daily [ s ee Dosage and Administration ( 2.2 ) ] .", "label": "", "metadata": {}, "score": "77.479904"}
{"text": "In one embodiment , the controlled - release composition contains less than 5 wt % of a gelling or swelling excipient .In another embodiment , the controlled - release composition contains less than 3 wt % of a gelling or swelling excipient .", "label": "", "metadata": {}, "score": "77.48597"}
{"text": "Antidepressant medicines have other side effects .Talk to the healthcare provider about the side effects of the medicine prescribed for you or your family member .", "label": "", "metadata": {}, "score": "77.50041"}
{"text": "Urban Gustafsson is a former employee of AstraZeneca .Willie Earley is a former employee of AstraZeneca Pharmaceuticals LP .Authors ' contributions .AY , JC , SM , TS , and MT made substantial contributions to the acquisition of data and interpretation of data ; UG , MB , and WE contributed to the analysis and interpretation of data .", "label": "", "metadata": {}, "score": "77.52247"}
{"text": "Bipolar I Mania : The incidence of discontinuation due to adverse reactions for quetiapine - treated and placebo - treated patients was 11.4 % and 4.4 % , respectively .", "label": "", "metadata": {}, "score": "77.5522"}
{"text": "MHPG correlated positively with age , age of onset , rating of anxiety and psychosis and , most importantly , with systolic blood pressure .These data support the concept of biological heterogeneity among individuals with major depressive disorders .", "label": "", "metadata": {}, "score": "77.60148"}
{"text": "Patients should be given the opportunity to discuss the contents of the Medication Guide and to obtain answers to any questions they may have .The complete text of the Medication Guide is reprinted at the end of this document .", "label": "", "metadata": {}, "score": "77.61032"}
{"text": "Kane JM , Smith JM .Tardive dyskinesia : prevalence and risk factors , 1959 to 1979 .Arch Gen Psychiatry .Altshuler LL , Suppes T , Black DO , et al .", "label": "", "metadata": {}, "score": "77.68805"}
{"text": "Abstract ] .Schildkraut JJ , Orsulak PJ , LaBrie RA , Schatzberg AF , Gudeman JE , Cole JO , Rohde WA .Toward a biochemical classification of depressive disorders .", "label": "", "metadata": {}, "score": "77.70122"}
{"text": "The baseline symptom severity scores indicated a patient population with moderate to severe depression without mania symptoms .Primary efficacy outcome : Montgomery - \u00c5sberg depression rating scale total score .", "label": "", "metadata": {}, "score": "77.74286"}
{"text": "Liver function tests less than 1.5 times the upper limit of normal .Estimated creatinine clearance ( estimated by Cockcroft Gault formulation ) greater than 60 mL / min .", "label": "", "metadata": {}, "score": "77.75589"}
{"text": "Some patients with TSH increases needed replacement thyroid treatment .In eight patients , where TBG was measured , levels of TBG were unchanged .Table 8 shows the incidence of these shifts in short - term placebo - controlled clinical trials .", "label": "", "metadata": {}, "score": "77.75844"}
{"text": "REFERENCES .Judd LL , Akiskal HS , Schettler PJ , et al .The long - term natural history of the weekly symptomatic status of bipolar I disorder .", "label": "", "metadata": {}, "score": "77.82477"}
{"text": "The total number of Nissl - stained LC neurons showed no changes between major depressive disorder patients , bipolar patients and controls .A reduced relative amount of NO in the LC of bipolar patients is likely a result of a compensation for increased glutamatergic activity .", "label": "", "metadata": {}, "score": "77.90684"}
{"text": "Non - smokers and non - alcoholics .For female subject is child bearing potential practicing acceptable method of birth control for the duration of the study as judged by Investigator such as Condom , Foams , Jellies , Diaphragm , Intrauterine device and Abstinence .", "label": "", "metadata": {}, "score": "77.91667"}
{"text": "Patients who are diagnosed with diabetes , those with risk factors for diabetes , or those that develop these symptoms during treatment should have their blood glucose monitored at the beginning of and periodically during treatment [ s ee Warnings and Precautions ( 5.5 ) ] .", "label": "", "metadata": {}, "score": "78.01673"}
{"text": "0081 ] Processes such as direct compression , wet granulation in a high shear mixer , fluid bed granulation , roller compaction , extrusion / spheronization , and fluid bed pellet layering can be employed in manufacturing a solid dosage form .", "label": "", "metadata": {}, "score": "78.06001"}
{"text": "Unlike the case before treatment , urinary MHPG excretion was higher during treatment in nonresponders than in responders and correlated with several indexes of symptom severity .", "label": "", "metadata": {}, "score": "78.092155"}
{"text": "Dose Modifications in Hepatically Impaired Patients .Patients with hepatic impairment should be started on 25 mg / day .The dose should be increased daily in increments of 25 mg / day to 50 mg / day to an effective dose , depending on the clinical response and tolerability of the patient . 2.5", "label": "", "metadata": {}, "score": "78.09829"}
{"text": "Analyses of safety variables were performed on the pooled safety population ( i.e. , patients who received at least one dose of the study medication ) and were presented descriptively .", "label": "", "metadata": {}, "score": "78.11169"}
{"text": "Monitor glucose regularly in patients with diabetes or at risk for diabetes .Dyslipidemia : Undesirable alterations have been observed in patients treated with atypical antipsychotics .", "label": "", "metadata": {}, "score": "78.1824"}
{"text": "This is a randomized , open Label , two - treatment , two - period , two - sequence , crossover , single dose pivotal study .", "label": "", "metadata": {}, "score": "78.20587"}
{"text": "Table 2 Drug - Placebo Difference in Number of Cases of Suicidality per 1000 Patients Treated .Age Range .Drug - Placebo Difference in Number of Cases of Suicidality per 1000 Patients Treated .", "label": "", "metadata": {}, "score": "78.2295"}
{"text": "PubMed .Keck PE , Perlis RH , Otto MW , Carpenter D , Ross R , Docherty JP : The expert consensus guideline series : treatment of bipolar disorder .", "label": "", "metadata": {}, "score": "78.27457"}
{"text": "The calibration curves were constructed with eight concentrations ranging from 2.01 to 50.20 \u00b5 g / mL. The peak area ratio of the drug to the internal standard was evaluated by linearity graph .", "label": "", "metadata": {}, "score": "78.30379"}
{"text": "The authors searched such clinical trials carried out between 1991 and February 2012 .Data sources .MEDLINE , EMBASE , CINHL , PsycINFO and Cochrane Controlled Trials Register were searched in February 2012 .", "label": "", "metadata": {}, "score": "78.345825"}
{"text": "12/143,460 , filed on Jun. 20 , 2008 and entitled \" Controlled - Release Formulations , Method of Manufacture , and Use thereof \" , the content of which is hereby incorporated by reference in its entirety .", "label": "", "metadata": {}, "score": "78.3471"}
{"text": "11 )Han C , Pogwizd SM , Killingsworth CR , He B Noninvasive reconstruction of the three - dimensional ventricular activation sequence during pacing and ventricular tachycardia in the canine heart .", "label": "", "metadata": {}, "score": "78.35837"}
{"text": "J Clin Psychiatry .Hamilton M .The assessment of anxiety states by rating .Br J Med Psychol .Guy W .Clinical Global Impressions .", "label": "", "metadata": {}, "score": "78.38701"}
{"text": "Although bipolar disorder is characterized by recurrent episodes of both depression and mood elevation , depressive symptoms are far more pervasive and treatment resistant than the symptoms of mood elevation .", "label": "", "metadata": {}, "score": "78.393585"}
{"text": "Distance between perpendicular dropped from peak maximum to the leading edge of the peak at 1/20 of peak height .References .S. B. Bagade , S. P. Narkhede , D. S. Nikam , and C. K. Sachde , \" Development and validation of UV - Spectrophotometric method for determination of Quetiapine fumarate in two different dose tablets , \" International Journal of ChemTech Research , vol .", "label": "", "metadata": {}, "score": "78.41768"}
{"text": "7 , 8 Moreover , limited data suggest that lamotrigine monotherapy yields some benefit in acute bipolar depression , 9 , 10 although to date , lamotrigine lacks an FDA indication for acute bipolar depression .", "label": "", "metadata": {}, "score": "78.47829"}
{"text": "Swann AC , Berman N , Frazer A , Koslow SH , Secunda S. Lithium distribution in mania : plasma and red blood cell lithium , clinical state , and monoamine metabolites during lithium treatment .", "label": "", "metadata": {}, "score": "78.51847"}
{"text": "PubMed Central PubMed .MacQueen GM , Young LT : Bipolar II disorder : symptoms , course , and response to treatment .Psychiatr Serv 2001 , 52 ( 3):358 - 61 .", "label": "", "metadata": {}, "score": "78.57329"}
{"text": "The controlled - release composition of claim 1 , wherein the first aqueous fluid has a pH equal to or less than about 4 . 5 , and the second aqueous fluid has a pH greater than about 4 .", "label": "", "metadata": {}, "score": "78.58447"}
{"text": "Among patients with bipolar II disorder , the risk of suicide , comorbidity , and role impairment is generally comparable with that of bipolar I disorder ( Angst et al .", "label": "", "metadata": {}, "score": "78.5966"}
{"text": "Diagnosis , ( % )Bipolar disorder I Bipolar disorder II Bipolar disorder NOS .Comorbid mental disorder ( % ) .History of alcohol or substance abuse ( % ) .", "label": "", "metadata": {}, "score": "78.65713"}
{"text": "Patients should have their lipid profile monitored at the beginning of and periodically during treatment [ s ee Warnings and Precautions ( 5.5)].", "label": "", "metadata": {}, "score": "78.65936"}
{"text": "We postulate that the slow behavioral and biological changes preceding switches in this patient are an important manifestation of the cyclic process in manic - depressive illness . \" [ Abstract ] .", "label": "", "metadata": {}, "score": "78.67011"}
{"text": "10.2 Management of Overdosage .In case of acute overdosage , establish and maintain an airway and ensure adequate oxygenation and ventilation .Gastric lavage ( after intubation , if patient is unconscious ) and administration of activated charcoal together with a laxative should be considered .", "label": "", "metadata": {}, "score": "78.69097"}
{"text": "Risk of bias in individual studies .Two reviewers ( NM and BM ) rated the internal validity ( quality ) of each eligible randomized trial .", "label": "", "metadata": {}, "score": "78.7248"}
{"text": "[0092 ] In one embodiment , bioequivalence is any definition thereof as promulgated by the U.S. Food and Drug Administration or any successor agency thereof .", "label": "", "metadata": {}, "score": "78.77726"}
{"text": "- is surgically sterile ( bilateral tubal ligation , bilateral oophorectomy or hysterectomy has been performed on the subject ) .Exclusion Criteria : .Known history of hypersensitivity to Quetiapine , or related drugs .", "label": "", "metadata": {}, "score": "78.80443"}
{"text": "To control the overall type I error rate at .05 , 29 a sequential stepwise procedure was used , starting with the primary efficacy variable followed by the Q - LES - Q percent maximum score ; both nominal and adjusted P values were presented .", "label": "", "metadata": {}, "score": "78.862465"}
{"text": "Weight Gain : Gain in body weight has been observed ; clinical monitoring of weight is recommended .Hypotension : Use with caution in patients with known cardiovascular or cerebrovascular disease ( 5.7 ) .", "label": "", "metadata": {}, "score": "78.877464"}
{"text": "The drug peaks obtained from all stress conditions were found to be homogeneous and pure .Hence this method is specific .Robustness Study .Robustness is the measure of method capacity to remain unaffected by deliberate small changes in the chromatographic conditions .", "label": "", "metadata": {}, "score": "78.87832"}
{"text": "2011 Mar;13(2):145 - 54 .[ PubMed Citation ] [ Order full text from Infotrieve ] .18 ) Adida M , Jollant F , Clark L , Besnier N , Guillaume S , Kaladjian A , Mazzola - Pomietto P , Jeanningros R , Goodwin GM , Azorin JM , Courtet P Trait - related decision - making impairment in the three phases of bipolar disorder .", "label": "", "metadata": {}, "score": "78.88138"}
{"text": "Suicide .Psychiatry Res 1980 Oct;3(2):225 - 36 \" Suicidality scores from the Schedule for Affective Disorders and Schizophrenia on 21 unipolar and 12 bipolar depressives were correlated with monoamine metabolites in the cerebrospinal fluid using multiple regression analyses .", "label": "", "metadata": {}, "score": "78.897064"}
{"text": "Theses studies confirm that thyroid hormones are active in modulating metabolic function in the mature adult brain , and provide intriging neuroanatomic clues that may guide future research .", "label": "", "metadata": {}, "score": "78.91501"}
{"text": "The prevalence of bipolar II disorder in clinical practice may well be underestimated .Temporally , depression usually precedes hypomania ( Berk et al .2007 ) .", "label": "", "metadata": {}, "score": "78.92375"}
{"text": "Table 2 .Relationship between MADRS total score at baseline and of treatment ( ITT ) ( ANCOVA with baseline score as covariate and treatment as fixed effect ) .", "label": "", "metadata": {}, "score": "78.93805"}
{"text": "[ 0072 ] In one embodiment , the soluble , non - gelling pharmaceutically acceptable excipient comprises a pharmaceutically acceptable sugar polyol , monosaccharide , or disaccharide .", "label": "", "metadata": {}, "score": "78.97684"}
{"text": "PubMed View Article .Breslau N , Roth T , Rosenthal L , Andreski P : Sleep disturbance and psychiatric disorders : a longitudinal epidemiological study of young adults .", "label": "", "metadata": {}, "score": "78.99629"}
{"text": "Future studies may clarify the potential role of glial cells in the context of the described nNOS deficit .[ PubMed Citation ] [ Order full text from Infotrieve ] .", "label": "", "metadata": {}, "score": "79.03969"}
{"text": "For example AUC 0 -t is the area under the curve of plasma concentration versus time from time 0 to time t. [ 0090 ] In some embodiments , the controlled - release composition is bioequivalent to a Reference drug . \" Reference drug \" means an active pharmaceutical ingredient product as described in the U.S. Federal Food and Drug Administration 's ( FDA )", "label": "", "metadata": {}, "score": "79.21942"}
{"text": "2011 ; Suppes and Dennehy 2002 ; Valtonen et al .2005 ) .The authors of the BRIDGE study have suggested that bipolar II disorder is even more pernicious than hitherto appreciated ( Angst et al .", "label": "", "metadata": {}, "score": "79.24887"}
{"text": "Male or female outpatients ( age 18 to 65 ) with a DSM - IV 19 diagnosis of GAD as assessed by the Mini International Neuropsychiatric Interview 20 were eligible for inclusion in the study .", "label": "", "metadata": {}, "score": "79.2861"}
{"text": "AEs potentially related to sexual dysfunction ( MedDRA preferred terms : libido decreased and ejaculation delayed ) were reported by 2.9 % of patients in the quetiapine XR + SSRI / SNRI group and no patients in the placebo + SSRI / SNRI group .", "label": "", "metadata": {}, "score": "79.34651"}
{"text": "Adler LE , Gerhardt GA , Franks R , Baker N , Nagamoto H , Drebing C , Freedman R. Sensory physiology and catecholamines in schizophrenia and mania .", "label": "", "metadata": {}, "score": "79.35679"}
{"text": "History of / or active hematologic / oncologic illness .Dementia .Human Immunodeficiency Virus / Acquired Immunodeficiency Syndrome .History of organ transplant .History of gastric bypass .", "label": "", "metadata": {}, "score": "79.36138"}
{"text": "\"C n \" is the measured concentration of an active agent in the plasma at about n hours after administration . \" C 24 \" is the measured concentration of an active agent in the plasma at about 24 hours after administration .", "label": "", "metadata": {}, "score": "79.379456"}
{"text": "References .Am J Psychiatry 2006 , 163 ( 2):313 - 5 .PubMed .American Psychiatric Association : Diagnostic and Statistical Manual of Mental Disorders , Fourth Edition , Text Revision .", "label": "", "metadata": {}, "score": "79.5886"}
{"text": "After 26 weeks of treatment , the mean increase in body weight was 4.4 kg .In order to adjust for normal growth over 26 weeks an increase of at least 0.5 standard deviation from baseline in BMI was used as a measure of a clinically significant change ; 18.3 % of patients on quetiapine met this criterion after 26 weeks of treatment .", "label": "", "metadata": {}, "score": "79.601555"}
{"text": "Patients with bipolar II depression in the BOLDER I trial did not show a statistically significant difference in HAM - A total score from placebo ( Hirschfeld et al .", "label": "", "metadata": {}, "score": "79.79172"}
{"text": "Abstract ] .Swann AC , Secunda SK , Stokes PE , Croughan J , Davis JM , Koslow SH , Maas JW .Stress , depression , and mania : relationship between perceived role of stressful events and clinical and biochemical characteristics .", "label": "", "metadata": {}, "score": "79.9217"}
{"text": "Sachs GS , Guille C , McMurrich SL .A clinical monitoring form for mood disorders .Bipolar Disord .Ketter TA , Wang PW , Chandler RA , et al .", "label": "", "metadata": {}, "score": "79.993904"}
{"text": "In the present invention , the preferred solvate is hydrate .[ 0026 ]In one embodiment , the active agent is selected from those having a solubility of greater than or equal to about 2.0 mg / ml in an aqueous medium at room temperature .", "label": "", "metadata": {}, "score": "79.99658"}
{"text": "The controlled - release composition of claim 1 , wherein the soluble , non - gelling pharmaceutically acceptable excipient is a sugar polyol , a monosaccharide , a disaccharide , a polysaccharide , or a combination thereof .", "label": "", "metadata": {}, "score": "80.02332"}
{"text": "Recently , the modulation of the [ ( 35)S]GTPgammaS binding to G - proteins has been introduced as a suitable measure of receptor activity in postmortem human brain .", "label": "", "metadata": {}, "score": "80.06581"}
{"text": "Calibration Standards and Quality Control Samples .An eight point linear calibration curve standards were prepared using diluents solutions in the concentration range of 2.01 to 50.20 g / Lt .", "label": "", "metadata": {}, "score": "80.17197"}
{"text": "This mechanism aids in achieving blood levels sufficient to result in a once a day composition .[ 0018 ] In the present invention , the release of the active agent from the controlled - release composition is extended for longer than it would be in an immediate - release dosage form , e.g. , at least over several hours .", "label": "", "metadata": {}, "score": "80.21405"}
{"text": "Pinson L , Gray GE .Psychopharmacology : number needed to treat : an underused measure of treatment effect .Psychiatr Serv .Rynn MA , Brawman - Mintzer O .", "label": "", "metadata": {}, "score": "80.27602"}
{"text": "Depression is the prevailing phase of illness in patients with bipolar II disorder ( Judd et al .2003 ; Kupka et al .2007 ) .", "label": "", "metadata": {}, "score": "80.297714"}
{"text": "The coating may comprise about 0 wt % to about 40 wt % of the composition .The coating material can comprise optional components , such as , for example , pharmaceutically acceptable plasticizers , colorants , dyes , pigments , surfactants , flavorants , or combinations comprising at least one of the foregoing .", "label": "", "metadata": {}, "score": "80.324585"}
{"text": "For compounds with two or more asymmetric elements , these compounds can additionally be mixtures of diastereomers .For compounds having asymmetric centers , all optical isomers in pure form and mixtures thereof are encompassed .", "label": "", "metadata": {}, "score": "80.33416"}
{"text": "Study Type ICMJE .Interventional .Study Phase .Phase 1 .Study Design ICMJE .Allocation : Randomized Endpoint Classification : Bio - equivalence Study Intervention Model : Crossover Assignment Masking : Open Label Primary Purpose : Treatment .", "label": "", "metadata": {}, "score": "80.338295"}
{"text": "Discussion .To our knowledge this pooled post hoc analysis of patients with bipolar II disorder experiencing an acute episode of depression represents the largest population available for evaluation to date .", "label": "", "metadata": {}, "score": "80.34752"}
{"text": "Adults .Administer twice daily totaling 400 to 800 mg / day as adjunct to lithium or divalproex .Generally , in the maintenance phase , patients continued on the same dose on which they were stabilized . 2.3", "label": "", "metadata": {}, "score": "80.35538"}
{"text": "Interruption of selective serotonin reuptake inhibitor treatment .Double - blind , placebo - controlled trial .Br J Psychiatry .Hommel G .A stagewise rejective multiple test procedure based on a modified Bonferroni test .", "label": "", "metadata": {}, "score": "80.38141"}
{"text": "There was no interference in the drug and internal standard , from the blank .The peak - shape and symmetry were found to be good when the mobile - phase composition of 50 : 50 v / v was used with better resolution of the drug and internal standard .", "label": "", "metadata": {}, "score": "80.40227"}
{"text": "This was an 11-week , multicenter , randomized , double - blind , parallel - group , placebo - controlled study ( D1441L00016 , Palladium ; NCT00534599 ) .", "label": "", "metadata": {}, "score": "80.42046"}
{"text": "The injection volume is 10 \u00b5 L. Diluents consists of 50 : 50 ( v / v ) methanol and 0.1 % orthophosphoric acid .Preparation of Solutions .", "label": "", "metadata": {}, "score": "80.4942"}
{"text": "Extremely high blood sugar can lead to coma or death .If you have diabetes or risk factors for diabetes ( such as being overweight or a family history of diabetes ) your healthcare provider should check your blood sugar before you start quetiapine fumarate tablets and during therapy . high fat levels in your blood ( increased cholesterol and triglycerides ) .", "label": "", "metadata": {}, "score": "80.61086"}
{"text": "PubMed .Maina G , Albert U , Bellodi L , Colombo C , Faravelli C , Monteleone P , Bogetto F , Cassano GB , Maj M : Health - related quality of life in euthymic bipolar disorder patients : differences between bipolar I and II subtypes .", "label": "", "metadata": {}, "score": "80.63699"}
{"text": "This 3DCEI technique offers the potential to aid interventional therapeutic procedures for treating ventricular arrhythmias arising from epicardial or endocardial sites and to noninvasively assess the mechanisms of these arrhythmias .", "label": "", "metadata": {}, "score": "80.649574"}
{"text": "[ 0078 ] By \" subunit \" , it is meant to include a composition , mixture , particle , pellet , etc . , that can provide an oral dosage form alone or when combined with other subunits .", "label": "", "metadata": {}, "score": "80.74362"}
{"text": "A second traditional assessment , the Clinical Global Impression ( CGI ) , reflects the impression of a skilled observer , fully familiar with the manifestations of schizophrenia , about the overall clinical state of the patient .", "label": "", "metadata": {}, "score": "80.75218"}
{"text": "Dr. Atkinson receives grant / research support from AstraZeneca , Eli Lilly and Company , Forest Pharmaceuticals , Lundbeck , Merck , Naurex , Otsuka , Pfizer , Sunovion , Takeda , and Targacept ; and is a consultant to Eli Lilly and Company .", "label": "", "metadata": {}, "score": "80.75957"}
{"text": "Alternatively , controlled can mean that the release of the active agent is extended for longer than it would be in an immediate - release dosage form , e.g. , at least over several hours .", "label": "", "metadata": {}, "score": "80.776535"}
{"text": "Sheehan DV , Lecrubier Y , Sheehan KH , et al .The Mini - International Neuropsychiatric Interview ( M.I.N.I. ) : the development and validation of a structured diagnostic psychiatric interview for DSM - IV and ICD-10 .", "label": "", "metadata": {}, "score": "80.77959"}
{"text": "In addition , fetal weights were decreased in both species .Maternal toxicity ( observed as decreased body weights and/or death ) occurred at 2 times the MRHD in rats and approximately 1 to 2 times the MRHD ( all doses tested ) in rabbits .", "label": "", "metadata": {}, "score": "80.84297"}
{"text": "15 )Gamo NJ , Arnsten AF Molecular modulation of prefrontal cortex : rational development of treatments for psychiatric disorders .Behav Neurosci .2011 Jun;125(3):282 - 96 .", "label": "", "metadata": {}, "score": "80.99147"}
{"text": "Montgomery SA : The under - recognized role of dopamine in the treatment of major depressive disorder .Int Clin Psychopharmacol 2008 , 23 ( 2 ) : 63 - 69 .", "label": "", "metadata": {}, "score": "81.03433"}
{"text": "In addition , levels of the major DA metabolite , homovanillic acid ( HVA ) were significantly decreased ( -46 % ) in parietal cortex and HVA / DA ratios were significantly reduced ( -66 % ) in occipital cortex obtained from bipolar compared to control subjects .", "label": "", "metadata": {}, "score": "81.03926"}
{"text": "The primary endpoint was change from randomization to week 8 in Hamilton Anxiety Rating Scale ( HAM - A ) total score .Secondary variables were HAM - A psychic / somatic clusters , response , and remission , and Clinical Global Impression - Severity of Illness ( CGI - S ) score .", "label": "", "metadata": {}, "score": "81.083496"}
{"text": "high levels of total cholesterol , triglycerides or LDL - cholesterol or low levels of HDL - cholesterol .low or high blood pressure .pregnancy or plans to become pregnant .", "label": "", "metadata": {}, "score": "81.1664"}
{"text": "Synthesis of results .Efficacy .No significant heterogeneity was found on all efficacy outcomes , except HAM - D scores .According to the pooled response rate obtained from all trials , the NNT ( 95%CI ) was 7.2 ( 5.2 - 11.7 ) .", "label": "", "metadata": {}, "score": "81.167534"}
{"text": "0010 ] The present controlled - release composition does not contain a lipophilic component .As used herein , the term \" lipophilic component \" denotes an ingredient which is lipophilic .", "label": "", "metadata": {}, "score": "81.30854"}
{"text": "Formulas A and C contain Eudragit L-100 55 and L-100 respectively .Tablets from these products did not erode .These ionic non - gelling matrix polymers are soluble at pHs above 5.5 and 6 , respectively .", "label": "", "metadata": {}, "score": "81.32674"}
{"text": "The stability of the drug is determined by using QC samples kept at room temperature up to 12 hours and then analyzing them .Further , autosampler stability for up to 24 hrs and long - term stability unto 30 days were also established .", "label": "", "metadata": {}, "score": "81.34396"}
{"text": "The studies with two risks or less were included .The efficacy outcomes were the mean change scores of depression rating scales , the overall response rate , and the overall remission rates .", "label": "", "metadata": {}, "score": "81.35364"}
{"text": "[ PubMed Citation ] [ Order full text from Infotrieve ] .8) Han C , Pogwizd SM , Killingsworth CR , He B Noninvasive reconstruction of the three - dimensional ventricular activation sequence during pacing and ventricular tachycardia in the rabbit heart .", "label": "", "metadata": {}, "score": "81.357025"}
{"text": "However , in a preliminary peri / postnatal study , there were increases in fetal and pup death , and decreases in mean litter weight at 3 times the MRHD .", "label": "", "metadata": {}, "score": "81.42086"}
{"text": "CNS Drugs .2012 Feb 1;26(2):135 - 53 .Fibromyalgia is a syndrome characterized by chronic generalized pain associated with different somatic symptoms , such as sleep disturbances , fatigue , stiffness , balance problems , hypersensitivity to physical and psychological environmental stimuli , depression and anxiety .", "label": "", "metadata": {}, "score": "81.4281"}
{"text": "At 3 weeks , there were negative correlations between reductions in catecholamine measures and lithium concentrations .These data suggest that there are changes in the sensitivity of behavior and catecholamine function to lithium during treatment .", "label": "", "metadata": {}, "score": "81.46363"}
{"text": "Competing interest .NM has received travel reimbursement from GlaxoSmithKline , Pfizer , Janssen - Cilag and Lundbeck .BM has received honoraria and/or travel reimbursement from GlaxoSmithKline , and Pfizer .", "label": "", "metadata": {}, "score": "81.52995"}
{"text": "Trisha Suppes , for the period 2008 - 2011 , has received research funding or medication support from Abbott Laboratories , AstraZeneca , JDS Pharmaceuticals , NIMH , Pfizer , the Stanley Medical Research Institute , and Sunovion Pharmaceuticals .", "label": "", "metadata": {}, "score": "81.54813"}
{"text": "He has not been compensated for consulting or speaking on behalf of these companies , nor does he own stock in any of these or other pharmaceutical companies .", "label": "", "metadata": {}, "score": "81.554214"}
{"text": "Pearson correlations between symptom rating scores and cortisol secretion variables were not significant .CONCLUSION :The increases in cortisol secretion in patients in both the depressed and manic phases of bipolar disorder suggest that cortisol level is probably not a state marker in bipolar disorder . \" [ Abstract ] [ I include this to show that cortisol abnormalities may be different in non rapid cycling bipolar disorder than in rapid cycling bipolar disorder . ] Wehr TA , Muscettola G , Goodwin FK .", "label": "", "metadata": {}, "score": "81.675705"}
{"text": "A test of heterogeneity is necessary for evaluating the similarity of the study results .Before conducting this meta - analysis , we hypothesized that the effect size may differ due to the methodological quality of the studies .", "label": "", "metadata": {}, "score": "81.693436"}
{"text": "Department of Psychiatry , Faculty of Medicine , Chiang Mai University .Brandon Lane Neuropsychiatry Clinic .References .Waraich P , Goldner EM , Somers JM , Hsu L : Prevalence and incidence studies of mood disorders : a systematic review of the literature .", "label": "", "metadata": {}, "score": "81.72351"}
{"text": "The 95 % CIs for change did not cross 0 on the CGI - S or GAF for either treatment group , suggesting significant improvements .", "label": "", "metadata": {}, "score": "81.72696"}
{"text": "During acute lithium administration ( first week ) there was no consistent pattern of change in MHPG .Comparing the predrug period with the third and fourth week of treatment , all of the responders showed an increase in MHPG , while the non - responders showed no change or a decrease .", "label": "", "metadata": {}, "score": "81.74495"}
{"text": "Subsequently , the dose was titrated to a target dose of 400 mg / day or 600 mg / day using increments of 100 mg / day , given in divided doses two or three times daily .", "label": "", "metadata": {}, "score": "81.79239"}
{"text": "498 - 505 , 2007 .View at Publisher \u00b7 View at Google Scholar WARNING : INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA - RELATED PSYCHOSIS ; and SUICIDAL THOUGHTS AND BEHAVIORS .", "label": "", "metadata": {}, "score": "81.92001"}
{"text": "Judd LL , Akiskal HS , Schettler PJ , et al .A prospective investigation of the natural history of the long - term weekly symptomatic status of bipolar II disorder .", "label": "", "metadata": {}, "score": "81.92014"}
{"text": "5.2 Suicidal Thoughts and Behaviors in Adolescents and Young Adults .Suicide is a known risk of depression and certain other psychiatric disorders , and these disorders themselves are the strongest predictors of suicide .", "label": "", "metadata": {}, "score": "81.9331"}
{"text": "Cataracts : Lens changes have been observed in patients during long - term quetiapine treatment .Lens examination is recommended when starting treatment and at 6-month intervals during chronic treatment ( 5.10 ) .", "label": "", "metadata": {}, "score": "81.95833"}
{"text": "For changes in mood status , CGI - S , GAF , weight , and BMI , analytic statistics were assessed .\u03c7 2 or Fisher exact tests were used for categorical variables , and 95 % confidence intervals ( 95 % CIs ) were used for continuous variables .", "label": "", "metadata": {}, "score": "81.9666"}
{"text": "A non - functional coating can have some impact on the release of the active agent due to the initial dissolution , hydration , perforation of the coating , etc . , but would not be considered to be a significant deviation from the non - coated composition .", "label": "", "metadata": {}, "score": "82.02635"}
{"text": "The controlled - release composition of claim 1 , wherein the solid dosage form is a tablet , a capsule , a granule , a mini - tablet , or a pellet .", "label": "", "metadata": {}, "score": "82.04169"}
{"text": "Hyperprolactinemia , regardless of etiology , may suppress hypothalamic GnRH , resulting in reduced pituitary gonadotrophin secretion .This , in turn , may inhibit reproductive function by impairing gonadal steroidogenesis in both female and male patients .", "label": "", "metadata": {}, "score": "82.057014"}
{"text": "Stress testing of the drug substance can help identify the likely degradation products ; we can also validate the stability and specificity of the analytical procedure .", "label": "", "metadata": {}, "score": "82.07399"}
{"text": "NWCRC enrolled 17 patients in the trial of quetiapine XR for generalized anxiety disorder .In 2009 Dr. Khan founded Columbia Northwest Pharmaceuticals , LLC , and is Medical Director of the company .", "label": "", "metadata": {}, "score": "82.24477"}
{"text": "Susan L McElroy has served as a consultant to or on the advisory boards of Alkermes , AstraZeneca , Bracket , Corcept , Eli Lilly , Jazz Pharmaceuticals , MedAvante , Pfizer , Shire , and Teva .", "label": "", "metadata": {}, "score": "82.32892"}
{"text": "Inactive ingredients : microcrystalline cellulose , colloidal silicon dioxide , silicon dioxide , crospovidone , anhydrous citric acid , polysorbate 80 , magnesium stearate , lactose monohydrate , hypromellose , polyethylene glycol and titanium dioxide .", "label": "", "metadata": {}, "score": "82.35112"}
{"text": "Beckmann H , Goodwin FK .Urinary MHPG in subgroups of depressed patients and normal controls .Overall there was no difference in MHPG between the depressed patients and controls .", "label": "", "metadata": {}, "score": "82.355484"}
{"text": "[ 0006 ] The present invention includes a controlled - release composition in a solid dosage form comprising a matrix .As used herein , the term \" matrix \" denotes a homogeneous solid mixture composed of evenly dispersed ingredients throughout .", "label": "", "metadata": {}, "score": "82.39342"}
{"text": "In one embodiment , as the pH modifier is eventually dissolved from the matrix by the gastrointestinal fluids , the pH of the matrix will experience the pH of the immediate surrounding environment .", "label": "", "metadata": {}, "score": "82.4252"}
{"text": "[ 0020 ] By \" controlled - release \" , it is meant a dosage form in which the release of the active agent is controlled or modified over a period of time .", "label": "", "metadata": {}, "score": "82.487045"}
{"text": "Evid Based Ment Health 2004 , 7 ( 3):91 .PubMed .J Affect Disord 2007 , 103 ( 1 - 3):181 - 6 .PubMed .", "label": "", "metadata": {}, "score": "82.48875"}
{"text": "2011Aug 15;70(4):357 - 65 .[ PubMed Citation ] [ Order full text from Infotrieve ] .20 ) Dell'Osso B , Palazzo MC , Oldani L , Altamura AC The noradrenergic action in antidepressant treatments : pharmacological and clinical aspects .", "label": "", "metadata": {}, "score": "82.489944"}
{"text": "The present invention includes a controlled - release composition having a matrix .The matrix contains a pharmaceutically effective amount of an active agent or a pharmaceutically acceptable salt or solvate thereof , an ionic non - gelling matrix polymer , and a pH modifier .", "label": "", "metadata": {}, "score": "82.51144"}
{"text": "[0009 ] The present controlled - release composition can optionally be further coated with a non - functional coating .As used herein , the term \" non - functional coating \" denotes a coating that is not a functional coating , for example , a cosmetic coating .", "label": "", "metadata": {}, "score": "82.519"}
{"text": "The pH modifier is a pharmaceutically acceptable organic acid , or an alkali metal or alkaline earth metal salt thereof .[ 0086 ] In one embodiment of the present invention , the controlled - release composition is in a solid dosage form and comprises a matrix and a non - functional coating .", "label": "", "metadata": {}, "score": "82.545616"}
{"text": "Linearity .The calibration curve constructed was evaluated by its correlation coefficient .The peak area ratio of the drug and internal standard was linear , and the range is 2.01 and 50.20 \u00b5 g / mL. The linearity was determined in three sets ; the correlation coefficient ( . ) was consistently greater then 0.999 ( Table 4 ) .", "label": "", "metadata": {}, "score": "82.582184"}
{"text": "\" [ Abstract ] .Post RM , Stoddard FJ , Gillin JC , Buchsbaum MS , Runkle DC , Black KE , Bunney WE Jr. Alterations in motor activity , sleep , and biochemistry in a cycling manic - depressive patient .", "label": "", "metadata": {}, "score": "82.61174"}
{"text": "Judd LL , Akiskal HS , Schettler PJ , et al .Psychosocial disability in the course of bipolar I and II disorders : a prospective , comparative , longitudinal study .", "label": "", "metadata": {}, "score": "82.65802"}
{"text": "PubMed .Valtonen H , Suominen K , Mantere O , Leppamaki S , Arvilommi P , Isometsa ET : Suicidal ideation and attempts in bipolar I and II disorders .", "label": "", "metadata": {}, "score": "82.928856"}
{"text": "Abstract III-155 .Dr. Bonner is a speaker for Pfizer , Inc. Drs .Culver , Marsh , and Nam report no financial relationships with any company whose products are mentioned in this article or with manufacturers of competing products .", "label": "", "metadata": {}, "score": "82.93298"}
{"text": "Safety assessments .Safety and tolerability assessments included the incidence and severity of adverse events and discontinuations because of adverse events , which were recorded at each visit .", "label": "", "metadata": {}, "score": "83.01174"}
{"text": "Further adjustments should be in increments no greater than 100 mg / day within the recommended dose range of 400 to 600 mg / day .", "label": "", "metadata": {}, "score": "83.05663"}
{"text": "The flow rate of the method is 0.6 mL / min .Diluent is prepared in the same way as mobile phase which consists of ( 50 : 50 ) methanol and 0.1 % orthophosphoric acid without addition of tri - ethyl amine .", "label": "", "metadata": {}, "score": "83.06197"}
{"text": "However , not all samples could be confirmed as fasted despite there being an 8-hour interval since the last meal , as patients could have had caloric intake .", "label": "", "metadata": {}, "score": "83.144066"}
{"text": "Detailed Description .The study was conducted with 54 healthy adult subjects .In each study period , a single 25 mg dose of either test or reference was administered to the subjects as per the randomization schedule in each study period with about 240 mL of water at ambient temperature in sitting position .", "label": "", "metadata": {}, "score": "83.21173"}
{"text": "Processes such as simple or complex coacervation , interfacial polymerization , liquid drying , thermal and ionic gelation , spray drying , spray chilling , fluidized bed coating , pan coating , electrostatic deposition , may be used .", "label": "", "metadata": {}, "score": "83.60597"}
{"text": "These results , therefore , should be viewed as the very preliminary findings .Fourthly , as with all meta - analyses , publication bias must be considered .", "label": "", "metadata": {}, "score": "83.614716"}
{"text": "Female subjects not willing to use acceptable method of contraception from the date of screening until the completion of the study .Gender .Both .", "label": "", "metadata": {}, "score": "83.621445"}
{"text": "There was no indication of increased QTc interval in either group .TABLE 4 presents changes in body weight , glucose and lipid data and the proportions of patients with clinically relevant shifts from normal in these parameters from randomization to treatment end in the fasting status confirmed safety population .", "label": "", "metadata": {}, "score": "83.637764"}
{"text": "Progress in molecular and functional brain imaging techniques has provided a new understanding of these phenomena , illuminating the relationship between thyroid function , mood modulation and behavior .", "label": "", "metadata": {}, "score": "83.64082"}
{"text": "Using items from the Schedule for Affective Disorders and Schizophrenia ( SADS ) , episodes were divided into environment - sensitive ( high perceived role of stressful events ) and autonomous ( minimal or no perceived role of stressful events ) .", "label": "", "metadata": {}, "score": "83.66452"}
{"text": "Schildkraut JJ , Orsulak PJ , Schatzberg AF , Gudeman JE , Cole JO , Rohde WA , LaBrie RA .Toward a biochemical classification of depressive disorders .", "label": "", "metadata": {}, "score": "83.6657"}
{"text": "Metabolic and Nutritional System : Infrequent : weight loss , alkaline phosphatase increased , hyperlipemia , alcohol intolerance , dehydration , hyperglycemia , creatinine increased , hypoglycemia ; Rare : glycosuria , gout , hand edema , hypokalemia , water intoxication .", "label": "", "metadata": {}, "score": "83.77785"}
{"text": "Found positive in urine test for drugs of abuse done before check - in for each study period .Refusal to abstain from consumption of tobacco products 24.00 hours prior to dosing until the last blood sample collection of last study period .", "label": "", "metadata": {}, "score": "83.816086"}
{"text": "This pattern of urinary MHPG excretion may reflect a rhythm in central noradrenergic function .The physiological changes in levels of MHPG excretion associated with the circadian rhythm were at least as great as pathological changes associated with manic - depressive illness .", "label": "", "metadata": {}, "score": "83.94113"}
{"text": "Bipolar Depression-Adults .Administer once daily at bedtime .Day 1 : 50 mg Day 2 : 100 mg Day 3 : 200 mg Day 4 : 300 mg .", "label": "", "metadata": {}, "score": "84.11253"}
{"text": "With Ostomy , chronic diarrhea .Diabetes , type 1 or type 2 .Open wound(s ) or unhealed wound(s ) at topical medication application site ( anterior forearm ) .", "label": "", "metadata": {}, "score": "84.144936"}
{"text": "Subsequently , the dose was titrated to the target dose of 400 mg / day or 800 mg / day using increments of 100 mg / day , divided and given two or three times daily .", "label": "", "metadata": {}, "score": "84.17502"}
{"text": "There may be new information .This information does not take the place of talking to your healthcare provider about your medical condition or your treatment .", "label": "", "metadata": {}, "score": "84.190414"}
{"text": "Washington , DC : American Psychiatric Association ; 2000 .American Psychiatric Association : Practice guideline for the treatment of patients with bipolar disorder ( revision ) .", "label": "", "metadata": {}, "score": "84.25726"}
{"text": "Previous research has supported a possible association of response to plasma levels and to changes in plasma homovanillic acid ( HVA ) .These findings were here extended to bupropion slow - release ( SR ) , a formulation with slower release kinetics .", "label": "", "metadata": {}, "score": "84.30494"}
{"text": "Kupka RW , Luckenbaugh DA , Post RM , Leverich GS , Nolen WA : Rapid and non - rapid cycling bipolar disorder : a meta - analysis of clinical studies .", "label": "", "metadata": {}, "score": "84.36676"}
{"text": "Version 5.1.0 ( Updated March 2011 ) .Edited by : Higgins JPT , Green S. The Cochrane Collaboration ; 2011 .Papakostas GI : Tolerability of modern antidepressants .", "label": "", "metadata": {}, "score": "84.425446"}
{"text": "According to one embodiment , the first aqueous fluid pH can be equal to or less than about 4.5 .Preferably , the first aqueous fluid pH is from about 1.0 to about 4.5 .", "label": "", "metadata": {}, "score": "84.43616"}
{"text": "SDM has received honoraria , consultancy fees and research grants from Astra Zeneca , Eli Lilly , Janssen - Cilag , Sanofi - Aventis , Novartis and Wyeth .", "label": "", "metadata": {}, "score": "84.48285"}
{"text": "2 risk of suicidal thoughts or actions ( antidepressant medicines , depression and other serious mental illnesses , and suicidal thoughts or actions ) .Depression and other serious mental illnesses are the most important causes of suicidal thoughts and actions .", "label": "", "metadata": {}, "score": "84.6796"}
{"text": "Therefore , examination of the lens by methods adequate to detect cataract formation , such as slit lamp exam or other appropriately sensitive methods , is recommended at initiation of treatment or shortly thereafter , and at 6-month intervals during chronic treatment .", "label": "", "metadata": {}, "score": "84.68123"}
{"text": "Even more preferably , the first aqueous fluid pH is from about 1.0 to about 3.5 .The second aqueous fluid pH can be greater than about 4.5 .", "label": "", "metadata": {}, "score": "84.73534"}
{"text": "PubMed .Bipolar Disord 2013 , 15 ( 1):1 - 44 .PubMed .Young RC , Biggs JT , Ziegler VE , Meyer DA : A rating scale for mania : reliability , validity and sensitivity .", "label": "", "metadata": {}, "score": "84.815384"}
{"text": "Sites of initial activation were estimated to be ? 7 mm from the measured initiation sites for both the paced beats and ectopic beats .For the polymorphic VTs , beat - to - beat dynamic shifts of initiation site and activation pattern were characterized by the reconstruction .", "label": "", "metadata": {}, "score": "84.86962"}
{"text": "System Suitability .The % RSD of the peak area and the retention time for both drug and internal standard are within the acceptable range ( Table 1 ) .", "label": "", "metadata": {}, "score": "84.99663"}
{"text": "Depressive symptoms in bipolar disorder have a substantial impact on patients ' quality of life and their ability to function in everyday activities ( Rosa et al .", "label": "", "metadata": {}, "score": "85.00241"}
{"text": "Unstable unipolar depression , defined as hospitalization for depression within 1 year or changes to an antidepressant regimen within 6 months .History of seizure or seizure disorder .", "label": "", "metadata": {}, "score": "85.036194"}
{"text": "Mood stabilizer : lithium or divalproex ; SD : standard deviation ; SE : standard error ; LS Mean : least - squares mean ; CI : unadjusted confidence interval .", "label": "", "metadata": {}, "score": "85.11478"}
{"text": "Blood collection began at 0800 and continued at hourly intervals for 24 h. Serum cortisol levels were assayed using a validated commercial radioimmunoassay kit .the mean AUCs of the patients in the depressed ( 263.4 micrograms / dL ) and hypomanic ( 262.2 micrograms / dL ) phases were beyond the 95 % confidence interval for the controls ( 120.9 - 253.3 micrograms / dL ) .", "label": "", "metadata": {}, "score": "85.13054"}
{"text": "[ 0024 ] By \" pharmaceutically effective amount \" , it is meant the amount of an active agent that , when administered to a patient for treating a disease , is sufficient to effect such treatment for the disease .", "label": "", "metadata": {}, "score": "85.1351"}
{"text": "The discontinuation rate due to adverse events was a measure of tolerability .Relative risks ( RRs ) and weighted mean differences ( WMDs ) with 95 % confidence intervals ( CIs ) were computed by using a random effect model .", "label": "", "metadata": {}, "score": "85.14437"}
{"text": "It should also be noted that the probability levels were not adjusted for multiplicity .Categorical changes , such as MADRS response and remission , were analyzed with the Cochran - Mantel - Haenszel test .", "label": "", "metadata": {}, "score": "85.34476"}
{"text": "The resulting release profiles are provided in Table 2 below as percent released .Tablets prepared from Formula B eroded faster than those prepared from Formulas A and C and the dissolution rate was faster .", "label": "", "metadata": {}, "score": "85.48833"}
{"text": "Your healthcare provider may do blood tests to check your thyroid hormone level . increases in prolactin levels .Your healthcare provider may do blood tests to check your prolactin levels . sleepiness , drowsiness , feeling tired , difficulty thinking and doing normal activities . increased body temperature . difficulty swallowing .", "label": "", "metadata": {}, "score": "85.73285"}
{"text": "These include people who have ( or have a family history of ) depression , bipolar illness ( also called manic - depressive illness ) , or suicidal thoughts or actions .", "label": "", "metadata": {}, "score": "85.77757"}
{"text": "Data from analyses of patient - reported outcome measures of functioning and quality of life have been reported elsewhere ( Gustafsson and Fajutrao 2011 ) .", "label": "", "metadata": {}, "score": "85.85126"}
{"text": "More preferably , the second aqueous fluid pH is from about 5.0 to about 7.5 .An exemplary first aqueous fluid can be human gastric fluid , and an exemplary second aqueous fluid can be human intestinal fluid .", "label": "", "metadata": {}, "score": "85.86572"}
{"text": "If you are close to your next dose , skip the missed dose .Just take the next dose at your regular time .Do not take 2 doses at the same time unless your healthcare provider tells you to .", "label": "", "metadata": {}, "score": "85.914185"}
{"text": "Early in treatment , there was a negative correlation between lithium concentrations and severity of mania .During treatment , there was a negative correlation between RBC lithium and urinary MHPG excretion .", "label": "", "metadata": {}, "score": "85.92746"}
{"text": "This incomplete dissolution is usually aggravated after food intake .Consequently , elimination of a portion of an undissolved gelling matrix results in the elimination of the active agent bound therein .", "label": "", "metadata": {}, "score": "86.11831"}
{"text": "Northwest Clinical Research Center , Bellevue , Washington , USA ; Duke University School of Medicine , Department of Psychiatry and Behavioral Sciences , Durham , North Carolina , USA .", "label": "", "metadata": {}, "score": "86.163414"}
{"text": "Exemplary solid dosage forms include tablets , capsules , pellets , compressed powders , mini - tablets , and granules .An oral dosage form may optionally comprise a plurality of subunits such as , for example , microcapsules or microtablets .", "label": "", "metadata": {}, "score": "86.19033"}
{"text": "Authors ' original submitted files for images .Below are the links to the authors ' original submitted files for images .Competing interests .Michael Berk has received grant / research support from NIH , NHMRC , Simons Autism Foundation , Stanley Medical Research Foundation , MBF , Beyond Blue , Geelong Medical Research Foundation , Bristol - Myers Squibb , Eli Lilly , Glaxo SmithKline , Organon , Novartis , MaynePharma , and Servier .", "label": "", "metadata": {}, "score": "86.20323"}
{"text": "A relative risk of one indicates no difference between comparison groups .For an unwanted outcome , an RR lesser than one suggests the less likelihood of the occurrence of such outcome .", "label": "", "metadata": {}, "score": "86.36027"}
{"text": "The glidant can be present in the matrix in amounts of up to about 10 wt % , specifically about 0.25 to about 5 wt % , and more specifically about 0.5 to about 1 wt % of the total weight of the controlled - release composition .", "label": "", "metadata": {}, "score": "86.44966"}
{"text": "Confirming and agreeing to , not using any prescription and over the counter medications including vitamins and minerals for 14 days prior to study and during the course of the study .", "label": "", "metadata": {}, "score": "86.58391"}
{"text": "Also , he was a consultant at AstraZeneca , Bristol - Myers Squibb , Eli Lilly , Glaxo SmithKline , Janssen Cilag , Lundbeck , and Servier .", "label": "", "metadata": {}, "score": "86.60802"}
{"text": "System Suitability .System suitability is an integral part of the LC method .They are used to verify that resolution .Reproducibility is adequate .", "label": "", "metadata": {}, "score": "86.61842"}
{"text": "Endicott J , Nee J , Harrison W , et al .Quality of Life Enjoyment and Satisfaction Questionnaire : a new measure .Psychopharmacol Bull .", "label": "", "metadata": {}, "score": "86.65527"}
{"text": "That is , it is practically insoluble and unswellable at a first aqueous fluid pH , and soluble at a second aqueous fluid pH. In one embodiment of the present invention , the pH of the first aqueous fluid is lower than the pH of the second aqueous fluid .", "label": "", "metadata": {}, "score": "86.6729"}
{"text": "Exemplary amounts include about 2.0 to about 50 wt % , specifically about 5.0 to about 20 wt % , and more specifically about 10 to about 15 wt % based on the total weight of the controlled - release composition .", "label": "", "metadata": {}, "score": "86.87432"}
{"text": "400 to 800 mg / day .800 mg / day .Bipolar Mania - Children and Adolescents ( 10 to 17 years ) , Monotherapy .", "label": "", "metadata": {}, "score": "86.95543"}
{"text": "In the present review , the WMDs or the SMDs were planned to be calculated if the retrieved studies used the same rating scale or different rating scales , respectively .", "label": "", "metadata": {}, "score": "86.98515"}
{"text": "No relevant , unpublished study meeting the inclusion criteria was identified .Study characteristics .The study periods of the three trials ranged from 8 to 11 weeks .", "label": "", "metadata": {}, "score": "87.01828"}
{"text": "PubMed View Article .Sterne JAC , Egger M , Moher D : Addressing Reporting Biases .In Cochrane Handbook for SystematicReviews of Interventions .Version 5.1.0 ( Updated March 2011 ) edition .", "label": "", "metadata": {}, "score": "87.05635"}
{"text": "The Stanford Administrative Panel on Human Subjects approved the protocol for the assessment and longitudinal monitoring of naturalistic treatment , and all patients provided verbal and written consent prior to participation .", "label": "", "metadata": {}, "score": "87.08782"}
{"text": "Furthermore , the complete dissolution of the ionic non - gelling matrix polymer is delayed until after it is exposed to the pH at which the ionic non - gelling matrix polymer is soluble .", "label": "", "metadata": {}, "score": "87.13461"}
{"text": "[ 0003 ] For a drug to achieve its therapeutic effect , it needs to reach the target site in the body and further maintain the required level of blood or plasma concentration .", "label": "", "metadata": {}, "score": "87.13647"}
{"text": "[ 0083 ]The present composition may be further coated with a non - functional coating .The coating material may include a polymer , such as a film - forming polymer .", "label": "", "metadata": {}, "score": "87.16211"}
{"text": "In the MITT population , 95.1 % and 95.5 % of patients in the quetiapine XR + SSRI / SNRI and placebo + SSRI / SNRI groups , respectively , were treatment adherent .", "label": "", "metadata": {}, "score": "87.1862"}
{"text": "It is present in tablets as the fumarate salt .All doses and tablet strengths are expressed as milligrams of base , not as fumarate salt .", "label": "", "metadata": {}, "score": "87.20637"}
{"text": "These findings suggested that DST could be helpful in diagnosis , discrimination of subtypes , and in assessment of severity of symptoms .In 32 of the 64 depressed inpatients , urinary MHPG X", "label": "", "metadata": {}, "score": "87.36054"}
{"text": "World J Biol Psychiatry .Canadian Psychiatric Association .Management of anxiety disorders .Can J Psychiatry .NICE guidelines .Anxiety : management of anxiety ( panic disorder , with or without agoraphobia , and generalised anxiety disorder ) in adults in primary , secondary and community care .", "label": "", "metadata": {}, "score": "87.450356"}
{"text": "Written informed consent was obtained from all patients prior to study participation .Details on the study design have been reported previously ( Calabrese et al .", "label": "", "metadata": {}, "score": "87.48486"}
{"text": "[0002 ] The present invention generally relates to a controlled - release composition as well as a method of preparing and using the composition .", "label": "", "metadata": {}, "score": "87.536125"}
{"text": "Families and caregivers of patients should be advised to look for the emergence of such symptoms on a day - to - day basis , since changes may be abrupt .", "label": "", "metadata": {}, "score": "87.60713"}
{"text": "The groups did not differ with respect to age , gender , education , socioeconomic group , diagnosis , severity of illness , or eventual response to treatment .", "label": "", "metadata": {}, "score": "87.668015"}
{"text": "Medical dictionary for regulatory activities .MMRM : . Declarations .Acknowledgments .We thank AnushaBolonna , PhD , and Chris Langford , PhD , from PAREXEL MMS , who provided medical writing support funded by AstraZeneca .", "label": "", "metadata": {}, "score": "87.75062"}
{"text": "Any medical or surgical conditions , which might significantly interfere with the functioning of gastrointestinal tract , blood - forming organs etc . .History of cardiovascular , renal , hepatic , ophthalmic , pulmonary , neurological , metabolic , hematological , gastrointestinal , endocrine , immunological or psychiatric diseases and bleeding tendency .", "label": "", "metadata": {}, "score": "87.779625"}
{"text": "Art therapy and psychotherapy are not well studied .Preserving creative motivation can help creativity and other aspects of well - being in all patients , not just artists or researchers .", "label": "", "metadata": {}, "score": "87.81761"}
{"text": "Detection and Quantization Limits ( Sensitivity ) .Figures 2 and 3 represent the six replicate injections of the limit of detection and limit of quantification .", "label": "", "metadata": {}, "score": "87.915565"}
{"text": "Changes in CGI - S and GAF from baseline to endpoint are summarized in TABLE 2 .Overall , both CGI - S and GAF scores improved .", "label": "", "metadata": {}, "score": "87.91973"}
{"text": "Secondary efficacy outcomes .MADRS item analyses .Difference in mean change from baseline in MADRS individual item scores at week 8 ( ITT population ; LOCF ) .", "label": "", "metadata": {}, "score": "87.922134"}
{"text": "PubMed .Am J Psychiatry 2005 , 162 ( 7):1273 - 80 .PubMed .Bipolar Disord 2007 , 9 ( 5):531 - 5 .PubMed .", "label": "", "metadata": {}, "score": "88.09349"}
{"text": "\u00a9 1998 - 2016 Mayo Foundation for Medical Education and Research .All rights reserved .Abstract .Background .Despite being present in up to 1 % of the population , few controlled trials have examined the efficacy of treatments for bipolar II depression .", "label": "", "metadata": {}, "score": "88.10361"}
{"text": "As the composition travels further in the gastrointestinal tract where the pH further increases , the ionic non - gelling matrix polymer will be solubilized thereby releasing the remaining active agent .", "label": "", "metadata": {}, "score": "88.26043"}
{"text": "To view updated drug label links , paste the RSS feed address ( URL ) shown below into a RSS reader , or use a browser which supports RSS feeds , such as Safari for Mac OS X. .", "label": "", "metadata": {}, "score": "88.26833"}
{"text": "32 High placebo response often is a major contributory factor , although other possibilities include : inclusion / exclusion criteria ; high attrition rates ; outcome measure sensitivity ; unreliable rating scales ; misdiagnosis ; severity of illness ; and study design .", "label": "", "metadata": {}, "score": "88.29295"}
{"text": "The detection limit was defined as the lowest concentration level resulting in a peak area of three - times baseline noise .The quantization limit was defined as the lowest concentration level that provided a peak area with signal - to - noise ratio higher than 10 , with precision ( % CV ) and accuracy with ( \u00b1)10 % .", "label": "", "metadata": {}, "score": "88.2998"}
{"text": "All forms are contemplated herein regardless of the methods used to obtain them .[ 0023 ] \" Salts \" include derivatives of an active agent , wherein the active agent is modified by making acid or base addition salts thereof .", "label": "", "metadata": {}, "score": "88.31061"}
{"text": "After a three - day baseline period , carbidopa , 100 mg three times a day , was given for seven days .While the patients tended to excrete less MHPG in the baseline period , these differences became somewhat larger , and statistically significant when peripheral contributions were reduced with carbidopa .", "label": "", "metadata": {}, "score": "88.31688"}
{"text": "Summary measures .Outcomes of interest included efficacy , acceptability and tolerability .Efficacy measures relied on the mean change scores of a rating scale for MDD and the response rates defined by any set of criteria .", "label": "", "metadata": {}, "score": "88.359695"}
{"text": "Culpepper L : Understanding the burden of depression .J Clin Psychiatr 2011 , 72 ( 6 ) : e19 .View Article .Rush AJ , Wisniewski SR , Zisook S , Fava M , Sung SC , Haley CL , Chan HN , Gilmer WS , Warden D , Nierenberg AA , et al .", "label": "", "metadata": {}, "score": "88.38228"}
{"text": "HAM - A scores were also determined at the start of placebo run - in .CGI - I scores were determined at weeks 1 to 4 , 6 , and 8 .", "label": "", "metadata": {}, "score": "88.404724"}
{"text": "HPA activity was similar in mixed manic and agitated depressed patients .These data suggest that mixed manics combine certain biological abnormalities considered to be characteristic of mania and of depression .", "label": "", "metadata": {}, "score": "88.44751"}
{"text": "Changes in glucose and lipid data and body weight and the proportions of patients with clinically relevant shifts from normal in these parameters from randomization to treatment end ( safety population ) .", "label": "", "metadata": {}, "score": "88.46135"}
{"text": "Sachs GS , Thase ME , Otto MW , et al .Rationale , design , and methods of the systematic treatment enhancement program for bipolar disorder ( STEP - BD ) .", "label": "", "metadata": {}, "score": "88.63997"}
{"text": "Blood donation within 90 days prior to the commencement of the study .Subjects with positive HIV tests or Hepatitis - B or Hepatitis - C tests .", "label": "", "metadata": {}, "score": "88.64463"}
{"text": "Adults : Asymptomatic , transient and reversible elevations in serum transaminases ( primarily ALT ) have been reported .These hepatic enzyme elevations usually occurred within the first 3 weeks of drug treatment and promptly returned to pre - study levels with ongoing treatment with quetiapine .", "label": "", "metadata": {}, "score": "89.08613"}
{"text": "PubMed .Bauer M , Beaulieu S , Dunner DL , Lafer B , Kupka R : Rapid cycling bipolar disorder - diagnostic concepts .Bipolar Disord 2008 , 10 ( 1 Pt 2):153 - 62 .", "label": "", "metadata": {}, "score": "89.17993"}
{"text": "Body surface potentials and intramural bipolar electrical recordings were simultaneously measured in a closed - chest condition in thirteen healthy rabbits .Single - site pacing and dual - site pacing were performed from ventricular walls and septum .", "label": "", "metadata": {}, "score": "89.25866"}
{"text": "[0068 ]The pH modifiers suitable for the present invention include organic acids or their salts , such as , alkali metal salts and alkaline earth metal salts prepared from the organic acids .", "label": "", "metadata": {}, "score": "89.34967"}
{"text": "5 mm .These promising results suggest that 3-DCEI is feasible to non - invasively localize the origins and image activation sequence of focal ventricular arrhythmias .", "label": "", "metadata": {}, "score": "89.40021"}
{"text": "It is depicted in ( Figure 4 ) .Accuracy and Precision .Accuracy of assay method was determined for both intraday and interday variations using triplicate analysis of the QC samples .", "label": "", "metadata": {}, "score": "89.46663"}
{"text": "However , the findings of this study need to be approached with considerable caution in view of important limitations , including the brief duration ( 12 weeks ) , the lack of a control condition , and the small sample size ( 39 trials ) .", "label": "", "metadata": {}, "score": "89.47832"}
{"text": "These complications have varied in severity ; while in some cases symptoms have been self - limited , in other cases neonates have required intensive care unit support and prolonged hospitalization .", "label": "", "metadata": {}, "score": "89.585266"}
{"text": "The release rate can be modified faster or slower in each case by increasing or decreasing the ionic non - gelling matrix polymer content .[ 0123 ] The terms \" a \" and \" an \" do not denote a limitation of quantity , but rather denote the presence of at least one of the referenced item .", "label": "", "metadata": {}, "score": "89.74563"}
{"text": "All authors conceived the idea , prepared the study protocol , prepared the manuscript , and approved the manuscript in its current form .NM and BM searched the databases , extracted the data , and analysed the data .", "label": "", "metadata": {}, "score": "89.78524"}
{"text": "Controlled and additional observational studies appear warranted to confirm these results .ACKNOWLEDGEMENTS :This project was funded by a grant from GlaxoSmithKline , Inc. , Research Triangle Park , NC .", "label": "", "metadata": {}, "score": "90.26249"}
{"text": "Accordingly , this invention includes all modifications and equivalents of the subject matter recited in the claims appended hereto as permitted by applicable law .Moreover , any combination of the above - described elements in all possible variations thereof is encompassed by the invention unless otherwise indicated herein or otherwise clearly contradicted by context .", "label": "", "metadata": {}, "score": "90.3313"}
{"text": "There were positive correlations between the RBC lithium concentration and the RBC / plasma lithium ratio and their maximal values in a single - dose pharmacokinetic experiment before treatment .", "label": "", "metadata": {}, "score": "90.34413"}
{"text": "A comparison of various methods with present study has been tabulated in ( Table 11 ) .So , the authors have developed a new internal standard method which is more rugged , precise , and accurate .", "label": "", "metadata": {}, "score": "90.44725"}
{"text": "Risk of bias across studies .To detect the reporting biases , a funnel plot , a simple plot of the intervention effect estimating from individual studies against some measure of each study 's size or precision [ 38 ] , was applied .", "label": "", "metadata": {}, "score": "90.47952"}
{"text": "\" [ Abstract ] .Beckmann H , ST - Laurent J , Goodwin FK .The effect of lithium on urinary MHPG in unipolar and bipolar depressed patients .", "label": "", "metadata": {}, "score": "90.71255"}
{"text": "Original Primary Outcome Measures ICMJE ( submitted : May 21 , 2012 ) .Bioequivalence is based on Cmax and AUC parameters .[ Time Frame : 8 months ] [ Designated as safety issue : No ] .", "label": "", "metadata": {}, "score": "90.77911"}
{"text": "The acceptance criterion is \u00b11 % for the percent coefficient of the variation for the peak area and retention times for both drug and internal standard .", "label": "", "metadata": {}, "score": "90.78181"}
{"text": "Mammary gland adenocarcinomas were statistically significantly increased in female rats at all doses tested ( 0.3 , 1 , and 3 times the MRHD on mg / m 2 body surface area ) .", "label": "", "metadata": {}, "score": "90.79051"}
{"text": "Methods .Study design .All studies adhered to the current amendment of the Declaration of Helsinki and the International Conference on Harmonisation / Good Clinical Practice guidelines .", "label": "", "metadata": {}, "score": "90.805084"}
{"text": "Joseph Calabrese has received federal funding from the Department of Defense , Health Resources Services Administration and National Institute of Mental Health .He has received research support from Abbott , AstraZeneca , Bristol - Myers Squibb , Cephalon , Cleveland Foundation , Eli Lilly , GlaxoSmithKline , Janssen , NARSAD , Repligen , Stanley Medical Research Institute , Takeda , and Wyeth .", "label": "", "metadata": {}, "score": "90.83559"}
{"text": "Patient population .The first patient was enrolled on August 31 , 2007 , and the last patient completed the study on September 2 , 2008 .", "label": "", "metadata": {}, "score": "90.9394"}
{"text": "Benazzi F : Bipolar II , disorder : epidemiology , diagnosis and management .CNS Drugs 2007 , 21 ( 9):727 - 40 .PubMed .", "label": "", "metadata": {}, "score": "90.948105"}
{"text": "Total turnover ( NE + NMN + MHPG + VMA ) was reduced in this sample of unipolar and bipolar depressed patients .MHPG concentration did not distinguish unipolar from bipolar depressed patients and was not significantly different from that in healthy volunteers .", "label": "", "metadata": {}, "score": "91.02728"}
{"text": "Study appraisal and synthesis methods .All abstracts identified by the electronic searches were examined .The full reports of relevant studies were assessed , and the data of interest were extracted .", "label": "", "metadata": {}, "score": "91.03692"}
{"text": "a Variables were not assessed statistically .b The HAM - A psychic cluster comprised the following items : anxious mood , tension , fears , insomnia , intellectual difficulties , depressed mood , and behavior at interview .", "label": "", "metadata": {}, "score": "91.08731"}
{"text": "PubMed Central PubMed .Arch Gen Psychiatry 2011 , 68 ( 3):241 - 51 .PubMed Central PubMed .Montgomery SA , Asberg M : A new depression scale designed to be sensitive to change .", "label": "", "metadata": {}, "score": "91.60365"}
{"text": "High blood sugar can happen if you have diabetes already or if you have never had diabetes .High blood sugar could lead to : . build up of acid in your blood due to ketones ( ketoacidosis ) .", "label": "", "metadata": {}, "score": "91.6671"}
{"text": "Randomization in the studies was achieved using an interactive voice - response central randomization system , and numbers were not sequential within a site .No member of the investigational teams had access to the randomization schemes during the conduct of the studies .", "label": "", "metadata": {}, "score": "91.89005"}
{"text": "Dropout data and baseline similarity were reported in all studies .Only two studies [ 32 , 33 ] reported sequence generation of randomization and allocation concealment .", "label": "", "metadata": {}, "score": "92.06279"}
{"text": "Healthy adult volunteers ( 18\u201065 years old ) willing to undergo a general health screen consisting of blood pressure , heart rate , respiratory rate , height , weight , temperature , and electrocardiogram will be identified .", "label": "", "metadata": {}, "score": "92.10916"}
{"text": "For most instances , the assumption of one true effect size may be implausible .Although the included studies are relatively similar , there is generally no reason to assume that they are exactly the same .", "label": "", "metadata": {}, "score": "92.12898"}
{"text": "When an outcome is measured by different instruments across studies , it may not be possible to compare or combine study results directly .By expressing the effect as a standardized value , the results can be combined since they have no unit .", "label": "", "metadata": {}, "score": "92.17958"}
{"text": "Day 3 : Twice daily dosing totaling 200 mg .Day 4 : Twice daily dosing totaling 300 mg .Day 5 : Twice daily dosing totaling 400 mg .", "label": "", "metadata": {}, "score": "92.19884"}
{"text": "Efficacy assessments .The primary efficacy outcome measure in all four studies was the change from baseline to week 8 in Montgomery - \u00c5sberg Depression Rating Scale ( MADRS ) total score ( Montgomery and Asberg 1979 ) , and this is consequently utilized in the current post hoc analysis .", "label": "", "metadata": {}, "score": "92.37044"}
{"text": "Refusal to abstain from fluid for at least 01.00 hour prior to study drug administration and for at least 01.00 additional hour post - dose , in each study period except about 240 mL of water given during administration of study drug .", "label": "", "metadata": {}, "score": "92.406006"}
{"text": "SPSS version 12 was used for statistical analysis .All measures were analyzed using the last observation carried forward method .Thus , when discontinuation occurred before 12 weeks , data at 12 weeks were imputed from the last postbaseline data .", "label": "", "metadata": {}, "score": "92.42679"}
{"text": "The lubricant can be any substance capable of reducing friction by making surfaces smooth or slippery .[ 0076 ] The glidant can be any substance that enhances the flow of a granular mixture by reducing interparticle friction and that is used in the pharmaceutical production of tablets , capsules , pellets , etc .", "label": "", "metadata": {}, "score": "92.46561"}
{"text": "These results should be viewed as the very preliminary one .Further studies in this area are warranted .Funding .This review had no funding .", "label": "", "metadata": {}, "score": "92.60617"}
{"text": "150 to 750 mg / day .750 mg / day .Schizophrenia-Adolescents ( 13 to 17 years ) .Day 1 : 25 mg twice daily .", "label": "", "metadata": {}, "score": "92.63075"}
{"text": "Disputes were resolved through consensus .Data collection process .We developed a data extraction form .A reviewer ( NM ) extracted the data into the form .", "label": "", "metadata": {}, "score": "92.687225"}
{"text": "The right brain and temporal lobe contribute skill in novelty detection , while the left brain and frontal lobe foster approach motivation and more easily generate new patterns of action from the novel perceptions .", "label": "", "metadata": {}, "score": "92.69219"}
{"text": "Class Effect : Symptoms of dystonia , prolonged abnormal contractions of muscle groups , may occur in susceptible individuals during the first few days of treatment .", "label": "", "metadata": {}, "score": "92.70536"}
{"text": "Synthesis of results .Both fixed effect and random effect models can be used for data synthesis .For the fixed effect approach , we assume that all included studies share a common effect size .", "label": "", "metadata": {}, "score": "92.71041"}
{"text": "The specifications for various EUDRAGIT \u00ae products including the above - mentioned ones can be found in the manufacture 's product manual or on the website for the corresponding EUDRAGIT \u00ae product , the content of which is incorporated by references in its entirety .", "label": "", "metadata": {}, "score": "92.71135"}
{"text": "To reduce scoring variability , the same rater conducted all assessments for a given patient for a specific scale whenever possible .Health - related quality of life .", "label": "", "metadata": {}, "score": "92.754"}
{"text": "PubMed View Article .Cipriani A , Furukawa TA , Salanti G , Geddes JR , Higgins JP , Churchill R , Watanabe N , Nakagawa A , Omori IM , McGuire H , et al .", "label": "", "metadata": {}, "score": "92.75533"}
{"text": "PubMed Central PubMed .Goodwin GM : Evidence - based guidelines for treating bipolar disorder : recommendations from the British Association for Psychopharmacology .J Psychopharmacol 2003 , 17 ( 2):149 - 73 .", "label": "", "metadata": {}, "score": "92.79501"}
{"text": "6 sets of 1 mL aliquots were taken and transferred into ria vials .All the samples are kept under stress condition for 24 hrs before final analysis .", "label": "", "metadata": {}, "score": "92.810486"}
{"text": "Psychol Med 2008 , 38 ( 2 ) : 289 - 300 .PubMed View Article .Higgins JPT , Altman DG : Assessing risk of bias in included studies .", "label": "", "metadata": {}, "score": "93.11314"}
{"text": "The gelling or swelling polymer is typically non - pH dependent .That is , the aqueous solubility of the gelling or swelling polymer at various pH is the same or substantially the same .", "label": "", "metadata": {}, "score": "93.20991"}
{"text": "If there is an effect on the hypothalamic - pituitary axis , measurement of TSH alone may not accurately reflect a patient 's thyroid status .", "label": "", "metadata": {}, "score": "93.215706"}
{"text": "23The change from randomization at week 8 in Q - LES - Q percent maximum total score ( items 1 to 14 ) , item 15 ( satisfaction with medication ) , and item 16 ( overall life satisfaction ) were recorded .", "label": "", "metadata": {}, "score": "93.27878"}
{"text": "0127 ] Embodiments of this invention are described herein , including the best mode known to the inventors for carrying out the invention .Variations of those preferred embodiments may become apparent to those of ordinary skill in the art upon reading the foregoing description .", "label": "", "metadata": {}, "score": "93.300644"}
{"text": "Day 2 : Twice daily dosing totaling 200 mg .Day 3 : Twice daily dosing totaling 300 mg .Day 4 : Twice daily dosing totaling 400 mg .", "label": "", "metadata": {}, "score": "93.37567"}
{"text": "History of or active cardiovascular disease ( except hypertension meeting the inclusion criteria for blood pressure ) , severe kidney disease ( i.e. needing dialysis ) , or liver disease .", "label": "", "metadata": {}, "score": "93.4124"}
{"text": "2012 Jun 12 ; Evidence from previous studies suggests autonomic dysregulation in patients with major depressive disorder ( MDD ) .Antidepressant treatment may also affect central autonomic function .", "label": "", "metadata": {}, "score": "93.45941"}
{"text": "Secondary analyses reported nominal 5 % levels of significance .No confirmatory analyses were made for secondary variables other than Q - LES - Q percent maximum total score .", "label": "", "metadata": {}, "score": "93.47596"}
{"text": "The dried granulates were milled through a fitzmill using a 20 mesh screen with medium speed .The remaining microcrystalline cellulose and colloidal silicon dioxide were blended with the dried granulates ; magnesium stearate was then added and blended .", "label": "", "metadata": {}, "score": "93.71751"}
{"text": "Milli - Q water was purchased from Ranbaxy fine chemicals limited ( RFCL ) .All chemicals used were of analytical grade .Instrumentation .The HPLC system consisted of a Shimadzu Class VP Binary pump LC-10Atvp , SIL-10Dvp Autosampler , CTO-10Avp column temperature Oven , PDA - UV Detector .", "label": "", "metadata": {}, "score": "93.8105"}
{"text": "Seriousness of Intent of Worst Suicide Attempt earlier in life correlated significantly and negatively with both MHPG and 5HIAA .Subjective Anger was positively and Overt Anger negatively associated with thoughts of suicide .", "label": "", "metadata": {}, "score": "93.88811"}
{"text": "Diagnostic and statistical manual of mental disorders , 4th edition .Washington , DC : American Psychiatric Association ; 1994 .Sheehan DV , Lecrubier Y , Sheehan KH , et al .", "label": "", "metadata": {}, "score": "93.91043"}
{"text": "Day 2 : Twice daily dosing totaling 100 mg .Day 3 : Twice daily dosing totaling 200 mg .Day 4 : Twice daily dosing totaling 300 mg .", "label": "", "metadata": {}, "score": "94.06242"}
{"text": "Current Primary Outcome Measures ICMJE ( submitted : July 5 , 2012 ) .Bioequivalence is based on Cmax and AUC parameters .[ Time Frame : 8 months ] [ Designated as safety issue : No ] .", "label": "", "metadata": {}, "score": "94.35916"}
{"text": "Repeatability refers to the use of the analytical procedure within the laboratory over the shorter period of the time that was evaluated by assaying the QC samples during the same day .", "label": "", "metadata": {}, "score": "94.60335"}
{"text": "NDC 47335 - 903 - 61 .100 mg tablets are yellow , round , biconvex , film - coated tablets , debossed with ' 904 ' on one side and plain on the other side and are supplied as : Bottles of 30 's with Child Resistant Cap .................. NDC 47335 - 904 - 83 Bottles of 100 's with Child Resistant Cap ................. NDC 47335 - 904 - 88 Bottles of 1000 's with Non Child Resistant Cap .......... NDC 47335 - 904 - 18 Unit - dose blister pack of 100 ( 10 \u00d7 10 ) tablets ............", "label": "", "metadata": {}, "score": "94.65408"}
{"text": "Tell the healthcare provider about all the medicines that you take or recently have taken including prescription medicines , over-\u00adthe - counter medicines , herbal supplements and vitamins .", "label": "", "metadata": {}, "score": "94.770874"}
{"text": "For example , the matrix does not include a composition containing a core and one or more outer layers , nor a composition containing a drug reservoir and one or more portions surrounding the drug reservoir .", "label": "", "metadata": {}, "score": "95.078995"}
{"text": "Two reviewers ( NM and BM ) independently examined all abstracts identified by electronic searches to determine those meeting the eligible studies described above .The full - text articles of relevant studies were obtained .", "label": "", "metadata": {}, "score": "95.09439"}
{"text": "Talk to your healthcare provider about ways to control weight gain , such as eating a healthy , balanced diet , and exercising . movements you can not control in your face , tongue , or other body parts ( tardive dyskinesia ) .", "label": "", "metadata": {}, "score": "95.10941"}
{"text": "Food can affect dissolution and absorption of a tablet matrix in a number of ways including changes in pH , emulsifiers / surface tension , gastric retention , attrition , lipids , and transport .", "label": "", "metadata": {}, "score": "95.22304"}
{"text": "View Article .Uher R , Farmer A , Maier W , Rietschel M , Hauser J , Marusic A , Mors O , Elkin A , Williamson RJ , Schmael C , et al .", "label": "", "metadata": {}, "score": "95.31712"}
{"text": "Inclusion Criteria : .BMI within range of 18.5kg / m2 - 30 kg / m2 .Subjects with normal findings as determined by baseline history , physical examination and vital signs ( blood pressure , pulse rate , respiration rate and oral temperature ) .", "label": "", "metadata": {}, "score": "95.44546"}
{"text": "The locus coeruleus ( LC ) comprises the largest group of norepinephrine containing neurons in the mammalian brain .These norepinephrinergic LC neurons are able to generate NO .", "label": "", "metadata": {}, "score": "95.44578"}
{"text": "2012 Jan 1;302(1):H244 - 52 .Single - beat imaging of myocardial activation promises to aid in both cardiovascular research and clinical medicine .Body surface potentials were measured simultaneously with bipolar electrical recordings in a closed - chest condition in healthy canines .", "label": "", "metadata": {}, "score": "95.4577"}
{"text": "The following formulas have been used for the calculation of USP resolution : .Detection and Quantization Limits ( Sensitivity ) .Limits of detection ( LOD ) ( Figure 2 ) and quantization ( LOQ )", "label": "", "metadata": {}, "score": "95.50787"}
{"text": "The compounds may contain one or more asymmetric elements , such as stereogenic centers , stereogenic axes , and the like , e.g. , asymmetric carbon atoms , so that the compounds can exist in different stereoisomeric forms .", "label": "", "metadata": {}, "score": "95.590805"}
{"text": "University of Cincinnati College of Medicine .Department of Psychiatry , University of Pennsylvania School of Medicine .Department of Psychiatry and Behavioral Sciences , Stanford Medical Center and VA Palo Alto Health Care System .", "label": "", "metadata": {}, "score": "95.7806"}
{"text": "Bottles of 30 's with Child Resistant Cap .................. NDC 47335 - 902 - 83 Bottles of 100 's with Child Resistant Cap ................. NDC 47335 - 902 - 88 Bottles of 1000 's with Non Child Resistant Cap .......... NDC 47335 - 902 - 18 Unit - dose blister pack of 100 ( 10 \u00d7 10 ) tablets ............", "label": "", "metadata": {}, "score": "95.964905"}
{"text": "Ventricular arrhythmias represent one of leading causes for sudden cardiac death , a significant problem in public health .Noninvasive imaging of cardiac electric activities associated with ventricular arrhythmias plays an important role in better our understanding of the mechanisms and optimizing the treatment options .", "label": "", "metadata": {}, "score": "96.17592"}
{"text": "By \" highly acidic pH \" , it is meant a pH from about 1 to about 4 .By \" less acidic to basic pH \" , it is meant a pH of greater than about 4 to about 7.5 , specifically about 6 to about 7.5 .", "label": "", "metadata": {}, "score": "96.5688"}
{"text": "Food intake may substantially reduce the amount of free water for gel hydration .Water is particularly depleted in the lower gastrointestinal tract resulting in the possibility of unhydrated matrix being eliminated together with the active agent bound therein .", "label": "", "metadata": {}, "score": "96.75267"}
{"text": "Linear measures of heart rate variability were extracted to assess cardiac autonomic control .Sample entropy ( SampEn ) was computed to assess the complexity of heart rate and respiratory signals , and cross - SampEn was calculated to measure the nonlinear interaction of both signals .", "label": "", "metadata": {}, "score": "96.8611"}
{"text": "There was no significant heterogeneity on both discontinuation outcomes .Risk of bias across studies .Tests for funnel plot asymmetry is normally used in the meta - analysis with at least 10 studies included ; the power of the tests is too low to distinguish chance from real asymmetry , if fewer studies [ 38 ] .", "label": "", "metadata": {}, "score": "97.02207"}
{"text": "To receive all DailyMed Updates for the last seven days .What will I get with the DailyMed RSS feed ?DailyMed will deliver notification of updates and additions to Drug Label information currently shown on this site through its RSS feed .", "label": "", "metadata": {}, "score": "97.073685"}
{"text": "Pellets produced from extrusion / spheronization or fluid bed layering can be filled into capsules .Techniques and compositions for making tablets ( compressed and molded ) , capsules ( hard and soft gelatin ) are also described in Remington 's Pharmaceutical Sciences , 1553 - 1593 ( 1980 ) .", "label": "", "metadata": {}, "score": "97.09116"}
{"text": "Participants .Thirty - nine trials in 38 patients were included in this study ( 37 patients had 1 trial , and 1 patient had 2 trials ) .", "label": "", "metadata": {}, "score": "97.202896"}
{"text": "EXAMPLES .[0117 ] The following examples further illustrate the invention but , of course , should not be construed as in any way limiting its scope .", "label": "", "metadata": {}, "score": "97.20369"}
{"text": "NDC 47335 - 907 - 61 .Store at 20 \u00b0 to 25 \u00b0 C ( 68 \u00b0 to 77 \u00b0 F ) ; excursions permitted between 15 \u00b0 and 30 \u00b0 C ( 59 \u00b0 and 86 \u00b0 F ) [ see USP Controlled Room Temperature].", "label": "", "metadata": {}, "score": "97.32765"}
{"text": "Psychol Med 2011 , 42 ( 6 ) : 1 - 19 .Ust\u00fcn TB , Ayuso - Mateos JL , Chatterji S , Mathers C , Murray CJ : Global burden of depressive disorders in the year 2000 .", "label": "", "metadata": {}, "score": "97.37216"}
{"text": "The 90 % CI limits for a ratio of the geometric mean of logarithmic transformed C max for the two products or methods can have a wider acceptance range when justified by safety and efficacy considerations .", "label": "", "metadata": {}, "score": "97.394394"}
{"text": "In Tables 15 - 16 dystonic event included nuchal rigidity , hypertonia , and muscle rigidity ; parkinsonism included cogwheel rigidity and tremor ; akathisia included akathisia only ; dyskinetic event included tardive dyskinesia , dyskinesia , and choreoathetosis ; and other extrapyramidal event included restlessness and extrapyramidal disorder .", "label": "", "metadata": {}, "score": "97.39682"}
{"text": "2012 Feb;50(2):11 - 4 .The brain reward system consists of extensive neural pathways that mediate reward behavior such as pleasure and motivation .These pathways may be involved in the development of symptoms such as apathy , anhedonia , and cognitive dysfunction seen in patients with major depression .", "label": "", "metadata": {}, "score": "97.62952"}
{"text": "Orygen Youth Health Research Centre , Centre for Youth Mental Health .The Mental Health Research Institute of Victoria .Department of Psychiatry , Melbourne University .", "label": "", "metadata": {}, "score": "97.65323"}
{"text": "Hamilton M : The assessment of anxiety states by rating .Br J Med Psychol 1959 , 32 ( 1):50 - 5 .PubMed .Hamilton M : A rating scale for depression .", "label": "", "metadata": {}, "score": "97.93782"}
{"text": "All analyses were conducted using the RevMan 5.1 ( The Nordic Cochrane Centre , Copenhagen , Denmark ) .Results .Study selection .After the remove of duplicates , 141 trials remained .", "label": "", "metadata": {}, "score": "98.08545"}
{"text": "4 , pp .969 - 977 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .I. V. Somaraju , P. Raghuram , and J. Sriramulu , Chromatographia , vol .", "label": "", "metadata": {}, "score": "98.091965"}
{"text": "Glucose ( mg / dL ) b .Total cholesterol ( mg / dL ) b .HDL - cholesterol ( mg / dL ) b .", "label": "", "metadata": {}, "score": "98.15996"}
{"text": "[0124 ] All publications and patent applications herein are incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference .", "label": "", "metadata": {}, "score": "98.31936"}
{"text": "Results and Discussions .Method Development and Validation .The HPLC procedure was optimized with a view to develop a stability indicating assay method .However , good resolution , less tailing , and high theoretical plates are obtained with Genesis column C18 50 \u00d7 4.6 cm .", "label": "", "metadata": {}, "score": "98.879265"}
{"text": "The dried granulates were milled through a fitzmill using a 20 mesh screen with medium speed .The magnesium stearate was blended with the dried granulates and blended .", "label": "", "metadata": {}, "score": "98.99316"}
{"text": "Ms. She , Mr. Leathers , and Dr. Pathak are employees of AstraZeneca .REFERENCES .Bruce SE , Yonkers KA , Otto MW , et al .", "label": "", "metadata": {}, "score": "99.20748"}
{"text": "MADRS , HAM - D , HAM - A , CGI - S , CGI - I , PSQI , SAS , BARS , CSFQ , Q - LES - Q , 18-item TDSS scale .", "label": "", "metadata": {}, "score": "99.21278"}
{"text": "MADRS , HAM - D , HAM - A , CGI - S , CGI - I , PSQI , SAS , BARS , CSFQ , Q - LES - Q , 18-item TDSS scale .", "label": "", "metadata": {}, "score": "99.21278"}
{"text": "Goodwin GM : Evidence - based guidelines for treating bipolar disorder : revised second edition - recommendations from the British Association for Psychopharmacology .J Psychopharmacol 2009 , 23 ( 4):346 - 88 .", "label": "", "metadata": {}, "score": "99.37494"}
{"text": "Vital signs and body weight were recorded at enrollment and all subsequent visits .Simpson - Angus Scale ( SAS ) 25 and Barnes Akathisia Scale ( BAS ) 26 total scores were assessed at randomization and weeks 2 , 4 , 6 , and 8 .", "label": "", "metadata": {}, "score": "99.55466"}
{"text": "The column temperature is maintained at 25 \u00b0 C .At the reported flow rate peak shape was excellent ; however , increasing or decreasing the flow rate increased the tailing factor and resulting in poor peak shape and also resolution between the drug and internal standard also decreased .", "label": "", "metadata": {}, "score": "99.748726"}
{"text": "Know all of the medicines that you or your family member take .Keep a list of all medicines to show the healthcare provider .Do not start new medicines without first checking with your healthcare provider .", "label": "", "metadata": {}, "score": "99.91605"}
{"text": "NDC 47335 - 905 - 61 300 mg tablets are white , capsule - shaped , biconvex , film - coated tablets , debossed with ' 906 ' on one side and plain on the other side and are supplied as : Bottles of 30 's with Child Resistant Cap .................. NDC 47335 - 906 - 83 Bottles of 60 's with Child Resistant Cap .................. NDC 47335 - 906 - 86 Bottles of 100 's with Child Resistant Cap ................. NDC 47335 - 906 - 88 Bottles of 1000 's with Non Child Resistant Cap .......... NDC 47335 - 906 - 18 Unit - dose blister pack of 100 ( 10 \u00d7 10 ) tablets ............", "label": "", "metadata": {}, "score": "99.9376"}
{"text": "The study was approved by the institutional review board or independent ethics committee for each site and performed in accordance with the Declaration of Helsinki , the International Conference on Harmonisation Guideline for Good Clinical Practice , and applicable regulatory requirements .", "label": "", "metadata": {}, "score": "99.99567"}
{"text": "The terms \" comprising \" , \" having \" , \" including \" , and \" containing \" are to be construed as open - ended terms ( i.e. , meaning \" including , but not limited to \" ) .", "label": "", "metadata": {}, "score": "100.53806"}
{"text": "Hamilton rating scale for depression total score .Hamilton rating scale for anxiety total score .Mean change from baseline to week 8 in HAM - A total score ( ITT population ; LOCF ) .", "label": "", "metadata": {}, "score": "100.76109"}
{"text": "BMI : body mass index ; CGI - S : Clinical Global Impression - Severity of Illness ; HAM - A : Hamilton Rating Scale for Anxiety ; LSM : least squares means ; MITT : modified intention - to - treat ; Q - LES - Q : Quality of Life Enjoyment and Satisfaction Questionnaire .", "label": "", "metadata": {}, "score": "101.165085"}
{"text": "Primary efficacy endpoint .The PP population analysis of the primary efficacy variable confirmed the results of the primary analysis in the MITT population .MMRM analysis ( OCs , MITT population ) results were also similar to the primary efficacy analysis results .", "label": "", "metadata": {}, "score": "101.18585"}
{"text": "The online version of this article ( doi : 10 .1186/\u200b2194 - 7511 - 1 - 10 ) contains supplementary material , which is available to authorized users .", "label": "", "metadata": {}, "score": "101.93166"}
{"text": "CORRESPONDENCE : Terence A. Ketter , MD , Department of Psychiatry and Behavioral Sciences , Stanford University School of Medicine , 401 Quarry Road , Room 2124 Stanford , CA 94305 USA E - mail : tketter@stanford.edu", "label": "", "metadata": {}, "score": "102.41619"}
{"text": "Major depressive disorder ( MDD ) is a common mental illness with a lifetime prevalence rate of 6.7 % ( 3.8 % for men and 7.5 % for women ) [ 1 ] .", "label": "", "metadata": {}, "score": "102.84622"}
{"text": "All AEs of suicidality ( suicide attempts , ideation , completed suicide , and suicidal behavior ) were monitored during the study .A physical examination and electrocardiogram ( ECG ) were conducted at enrollment and week 8 .", "label": "", "metadata": {}, "score": "103.12255"}
{"text": "Inability or unwillingness of individual to give written informed consent .Reprint Permissions .A single copy of these materials may be reprinted for noncommercial personal use only . \"", "label": "", "metadata": {}, "score": "103.403175"}
{"text": "Any disputes between reviewers were resolved by consensus .If no agreement could be reached , the third author ( MS ) would decide .Data items .", "label": "", "metadata": {}, "score": "103.80043"}
{"text": "All authors were involved in drafting the manuscript or revising it critically for important intellectual content .All authors read and approved the final manuscript .", "label": "", "metadata": {}, "score": "103.89762"}
{"text": "FIGURE 2 : Patient disposition a Completed the randomized treatment period and the 2-week posttreatment period .b Subset of MITT population that includes only patients who completed 8 weeks of treatment and entered the posttreatment period .", "label": "", "metadata": {}, "score": "104.36392"}
{"text": "This was done by observing the results presented by graphical display and using the test of heterogeneity .An I 2 of 50 % or higher was considered as significant heterogeneity of results .", "label": "", "metadata": {}, "score": "105.36973"}
{"text": "Statistical analysis .The per - protocol ( PP ) population was a subset of the MITT population who had no significant protocol violations or deviations that would potentially affect efficacy .", "label": "", "metadata": {}, "score": "105.57313"}
{"text": "The term \" practically insoluble \" or \" insoluble \" denotes about 10,000 mL or more of solvent required to dissolve 1 gram of solute , as defined in the USP .", "label": "", "metadata": {}, "score": "105.58295"}
{"text": "[0126 ] Unless defined otherwise , all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs .", "label": "", "metadata": {}, "score": "106.292274"}
{"text": "16 ) Flaherty AW Brain illness and creativity : mechanisms and treatment risks .Can J Psychiatry .2011 Mar;56(3):132 - 43 .Brain diseases and their treatment may help or hurt creativity in ways that shape quality of life .", "label": "", "metadata": {}, "score": "106.51898"}
{"text": "Participant eligibility includes age , gender , type and stage of disease , and previous treatments or health concerns .Guidelines differ from study to study , and identify who can or can not participate .", "label": "", "metadata": {}, "score": "107.098145"}
{"text": "0125 ] The foregoing detailed description has been given for clearness of understanding only and no unnecessary limitations should be understood therefrom as modifications will be obvious to those skilled in the art .", "label": "", "metadata": {}, "score": "108.84582"}
{"text": "( canceled ) .Description : .CROSS REFERENCE TO RELATED APPLICATION .[ 0001 ] This application is a continuation - in - part of U.S. patent application Ser .", "label": "", "metadata": {}, "score": "110.10761"}
{"text": "A profile is characterized by the test conditions selected such as , for example , apparatus type , shaft speed , temperature , volume , and pH of the dissolution medium .", "label": "", "metadata": {}, "score": "110.27585"}
{"text": "Day 1 : 25 mg twice daily .Increase in increments of 25 mg to 50 mg divided two or three times on Days 2 and 3 to range of 300 to 400 mg by Day 4 .", "label": "", "metadata": {}, "score": "110.70537"}
{"text": "Female subject , demonstrating positive urine pregnancy test at the time of screening .Female subject , demonstrating positive Serum ( \u00df ) Beta- hCG ( Human Chorionic Gonadotropin ) test before check - in for each study period .", "label": "", "metadata": {}, "score": "111.00472"}
{"text": "In 2000 , depression was an important cause of disease burden accounting for 4.4 % of the total disability adjusted life years or 12 % of all total years lived with disability worldwide [ 4 ] .", "label": "", "metadata": {}, "score": "111.68547"}
{"text": "Department of Psychiatry , Imperial College .University Hospitals Case Medical Center , Case Western Reserve University .Formerly AstraZeneca R&D .School of Medicine , Deakin University .", "label": "", "metadata": {}, "score": "111.86848"}
{"text": "If you no longer wish to have this DailyMed RSS service , simply delete the copied URL from your RSS Reader .Study IDs .About this study .", "label": "", "metadata": {}, "score": "112.853615"}
{"text": "Contents are carefully transferred into a centrifuge tube and centrifuged for 4000 rpm for 20 mins .This sample is analyzed in triplicate .The accuracy and concentration are determined using regression equation .", "label": "", "metadata": {}, "score": "113.20338"}
{"text": "Copyright .\u00a9 Young et al . ; licensee Springer .This article is published under license to BioMed Central Ltd.Sign up to receive free email alerts when patent applications with chosen keywords are published SIGN UP .", "label": "", "metadata": {}, "score": "114.20674"}
{"text": "Recruitment Information .Recruitment Status ICMJE .Completed .Enrollment ICMJE .Completion Date .November 2011 .Primary Completion Date .November 2011 ( final data collection date for primary outcome measure ) .", "label": "", "metadata": {}, "score": "114.50322"}
{"text": "Blood pressure less than 160/99 mmHg and greater than 105/50 mmHg .Heart rate between 50\u2010100 beats per minutes .Respiratory rate between 10\u201030 breaths per minute .", "label": "", "metadata": {}, "score": "116.05078"}
{"text": "By \" substantially continuous coating \" , it is meant a coating which retains a smooth and continuous appearance when magnified 1000 times under a scanning electron microscope and wherein no holes or breakage of the coating are evident .", "label": "", "metadata": {}, "score": "116.613884"}
{"text": "Each item was scored on a scale of 1 ( very poor ) to 5 ( very good ) for overall satisfaction .The total score was the sum of the scores for items 1 to 14 .", "label": "", "metadata": {}, "score": "119.433334"}
{"text": "Sex , female ( % ) .Age ( years , mean\u00b1SD , 95 % CI ) .40.1\u00b114.9 [ 10.3 to 69.9 ] .41.1\u00b116.2 [ 8.7 to 73.5 ] .", "label": "", "metadata": {}, "score": "120.68312"}
{"text": "Received 9 December 2011 ; Revised 8 May 2012 ; Accepted 21 May 2012 .Copyright \u00a9 2013 Kiran B. Venkata et al .This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "132.29315"}
